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Langerhans cells and local cellular immunity in the cervix uteri
Summary
Dermatological research has shown there is a likely role for 
Langerhans' cells in initiating the local immune response. They 
are known to act as antigen presenting cells. Antigen presentation 
is essential for the generation of the T-cell response. The 
process involves helper T-cell interaction in the afferent limb of 
the immune response, with cytotoxic T-cells involved in efferent 
response. The resultant immune response has been shown to be 
dependent on the numbers of Langerhans' cells in the epithelium. 
T-cell mechanisms are primarily involved in immunity to tumours 
and to viral infections. The study was designed to investigate the 
possible role of the Langerhans' cell and local immune system in 
the cervix in relation to neoplastic changes especially since a 
virus - human papillomavirus (HPV) - is currently thought to be 
implicated in the aetiology of cervical neoplasia.
The investigation of the local immune system with special 
regard to tumour immunosurveillance is relevant and well suited 
to studies in the cervix, although access to tissue is limited 
without specialised techniques such as colposcopy and biopsy. The 
well documented and easily identifiable preinvasive phase 
associated with carcinoma of cervix makes it possible to study the 
whole spectrum of neoplastic change in the cervix. The study 
therefore involved examination of normal patients, those with 
cervical carcinoma, patients with cervical intraepithelial 
neoplasia (CIN), patients at high risk of such changes and other 
groups of patients in whom T-cell function is known to be 
compromised.
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Several methods of identifying Langerhans' cells in the 
cervix were evaluated. However, the indirect immunoperoxidase 
technique on frozen sections proved optimal since with the range 
of specific monoclonal available, Langerhans' cells and T-cell 
subsets could be easily identified in-situ. The simplest method of 
quantification used a standard length of basement membrane as the 
denominator (100 basal cells) but counts with computerised image 
analyser techniques were also used. Good correlation was shown 
between the Langerhans' cell count per 100 basal cells and the 
other methods of enumeration investigated.
Studies in normal patients showed that Langerhans' cells were 
a consistent finding in the cervical epithelium of the 
transformation zone and ectocervix, being present in both areas in 
similar numbers. Examination showed the majority of the cellular 
infiltrate in the epithelium and stroma was of T-cell origin. 
Helper T-cells were shown to predominate in the stroma and 
cytotoxic T-cells in the epithelium. The image analyser was most 
useful in quantifying this lymphocytic infiltrate. The T-cell 
infiltrate was shown to be similar in the ectocervix and 
transformation zone.
A series of 142 patients with CIN were investigated using the 
same techniques. Internal control biopsies of ectocervix were 
available for comparison in most instances. Analysis of results 
showed that two groups were distinguishable, one with concomitant 
histological features of human papillomavirus infection and the 
other without. The Langerhans' cells were significantly reduced in 
the first group and significantly increased in the second compared 
with the numbers in internal control biopsies.
In the lesions showing histological evidence of HPV infection
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the lymphocytic infiltrate appeared to be influenced by the 
presence of class II Major Histocompatibility (MHC) antigens on 
the epithelial cells. The number of helper and cytotoxic T-cells 
were significantly greater in the epithelium and stroma of MHC 
class II positive lesions. The percentage composition of the 
infiltrate was not different comparing the MHC class II positive 
with the class II negative lesions.
In CIN with low numbers of Langerhans' cells (< 7 per 100 
basal cells) and lacking MHC class II antigens on the epithelial 
cells, a significant positive correlation was noted between the 
numbers of Langerhans' cells and number of helper and cytotoxic 
T-cells in the epithelium. There was no such correlation seen in 
the stroma.
Investigation of the relationship between Langerhans' cell 
numbers and specific HPV subtypes, as demonstrated by slot blot 
DNA hybridisation, showed reductions associated with HPV 18 and a 
suggestion that the reduction seen in the presence of HPV 16 may
be related to viral copy numbers per cell. Increased numbers of
Langerhans' cells were confirmed in the absence of HPV genomes.
Female renal transplant recipients on systemic 
immunosuppressant therapy represent a group at high risk of 
cervical neoplasia. However, there is little published data on the 
results of screening this high risk group. Screening by colposcopy
and cytology was therefore performed in 38 patients. The local
immunocompetent cells were also studied in these patients to 
determine whether reductions in Langerhans' cells or alterations 
in other constituents of the local immune system could be 
implicated in the development of cervical neoplasia. Results of 
screening confirmed a high prevalence of CIN (6/38) and of HPV
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infection (12/38), with cytology alone producing false negative 
results in three of the six patients with CIN. Immunohistochemical 
studies showed significantly reduced numbers of Langerhans" cells 
and helper T-cells in the typical transformation zone of this 
group compared with the normal transformation zone. There was no 
difference in the Langerhans" cell or helper T-cell numbers 
comparing the patients on azathioprine and prednisolone with those 
on cyclosporin and prednisolone.
Patients in renal failure are also reported to be 
immunocompromised. Since it was difficult to be certain that the 
changes seen in the cervix of the transplant patients were not 
secondary to uraemia, 15 women in chronic renal failure were also 
studied. The results of colposcopic and cytologic screening 
suggest that the high prevalence of CIN and HPV infection seen in 
the transplant patients represents an increased incidence 
following commencement of systemic immunosuppressant therapy. 
Compared with the post transplant patients, the patients in renal
failure have significantly greater numbers of Langerhans" cells
and helper T-cells in the cervix. There were no significant
differences in the T-cell subsets in the cervix comparing the 
patients in renal failure with the normal patients. However, the 
Langerhans" cells were reduced in seven uraemic patients who were 
not being dialysed.
Pregnancy is another situation in which T-cell function is 
impaired. Examination of 20 patients in early pregnancy showed no 
significant differences in the numbers of Langerhans" cells or in 
the composition of the T-cell infiltrate of the cervix when
compared with normal patients.
The diversity of the local immune response was emphasised
page 19
when specimens from 10 patients with stage lb or Ha carcinoma of 
cervix were examined. The predominant cells identified stained 
with T-cell markers although B-cells, macrophages and natural 
killer cells were also noted. The number of Langerhans" cells in 
the malignant epithelium varied greatly. Variation was also noted 
in the pattern of MHC class II antigen expression on the 
epithelial cells. Loss of MHC class I antigens from the malignant 
cells was found in one tumour which had metastasised to pelvic 
lymph nodes.
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Chapter 1
Background and historical review of Langerhans" cells and cervical 
intraepithelial neoplasia
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Chapter 1
Introduction
The recent increase in patients with abnormal cervical smears 
has reached almost epidemic proportions and has been highlighted 
in the popular press. Deaths from cervical carcinoma remain a 
significant problem, especially in young women. These deaths are 
potentially preventable by the diagnosis and appropriate treatment 
of detectable epithelial changes which preceed the development of 
cervical carcinoma. Such changes are encompassed by the term 
cervical intraepithelial neoplasia (CIN).
This thesis explores the role of the irrmune system in the 
cervix in relation to CIN. In the first chapter the nomenclature, 
natural history and aetiology of CIN together with specialised 
techniques for its detection are introduced. The history, staining 
characteristics and evidence supporting a central role for a 
specialised cell - the Langerhans" cell, in coordinating the 
local immune response to such epithelial changes, are discussed. A 
historical review of the pertinent literature is included.
Nomenclature used in CIN
The term CIN was introduced by Richart in 1966 (1966a,b)
because he believed that the nomenclature used up to that time to 
describe the histological changes seen in the cervix was 
inappropriate. For instance, cervical epithelial dysplasia was 
thought, by sane, to be a benign condition whilst carcinoma-in- 
situ (CIS) was considered pre-malignant. Richart, on the other 
hand thought that they were both part of the same spectrum of 
disease which could preceed squamous carcinoma of the cervix. It
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took some years before Richart s concept of CIN as a single entity 
became accepted, but it has now been universally adopted.
Diagnostic criteria
CIN is a histological diagnosis based on the arrangement and 
nuclear morphology of the epithelial cells. It is characterised by 
an increased nucleocytoplasmic ratio, variation in nuclear size, 
abnormal mitoses and the absence of normal cellular maturation and 
differentiation. It is graded according to the extent of the 
epithelial changes. If they are confined to the basal third of the 
epithelium this constitutes CIN I; if the changes extend to occupy 
two-thirds then CIN II exists. CIN III is present if over 
two-thirds of the epithelium are involved (Buckley, Butler & Fox
1982). When correlated with the previously used terms, CIN I is 
synonymous with mild dysplasia, CIN II with moderate dysplasia and 
CIN III encompasses both severe dysplasia and carcinoma-in-situ.
Natural history
Richart"s belief that all neoplastic cellular changes limited 
to cervical epithelium were part of the same disease process was 
followed by a study in which he and Barron (Richart & Barron 1969) 
showed that all grades of dysplasia could advance to higher grades 
and to carcinoma in-situ. Other studies support these findings by 
confirming the progression from dysplasia to carcinoma-in-situ 
(Stern & Neely 1963; Fox 1967).
There is considerable evidence establishing the malignant 
potential of CIN, although this has not been a uniformly held 
opinion (Green & Donovan 1970). The first of two studies from 
Copenhagen reported that the progression rate for intraepithelial
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disease to cancer was 11% at three years and 33% at nine years 
(Petersen 1956). In the second study, Lange (1960), found that in 
a group of women with lesions bordering on early invasion one 
third developed carcinoma after 32 months compared to a group with 
intraepithelial disease alone of whom one fifth progressed to 
carcinoma after an average of five years. Another long-term 
prospective study in women with carcinoma-in-situ confirmed the 
progression to invasive carcinoma (Koss et al. 1963; Jordan, Bader 
& Day 1964). Mclndoe et al. (1984) showed the importance of
long-term surveillance and treatment of residual abnormality in
patients with CIS when they reported that progression to invasion 
occurred in 22% of patients with persistent abnormal cytology and 
in 1.5% of patients with normal cytology after a minimum follow-up 
of five years.
There is some evidence that the change from intraepithelial 
disease to invasive carcinoma may occur, in some cases, via an 
intermediate stage - microinvasive carcinoma (Way, Hennigan &
Wright 1968). This stage can be further divided histologically 
into a group with minimal stromal invasion and another with
microcarcinoma (Burghardt 1976).
The malignant potential of CIN is no longer questioned, but 
its natural history is better illustrated by examining data from 
large populations. Using the incidence of carcinoma-in-situ and 
carcinoma Fidler, Boyes & Worth (1968) calculated that 43% of CIS 
progressed to carcinoma over an average duration of 12 years. A 
statistical model for the natural history of the condition was 
constructed by Barron, Cahill & Richart (1978) using figures 
obtained from population screeening in British Columbia and 
Barbados. They concluded that the duration of CIS was between 3
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and 10 years. Way et al. (1968) agreed that pre-invasive lesions
may exist for 10 years, but added that a further 10 years may
lapse before symptoms or clinical signs develop.
While CIN may progress to cervical carcinoma in some
instances, it is recognised that many more lesions regress. Mild 
(CIN I) and moderate (CIN II) dysplasias regress much more
frequently than severe dysplasia and CIS (CIN III) (Koss 1963; 
Richart 1966b; Fox 1967; Hall & Walton 1968).
What factors might influence the natural history of CIN?. 
Several studies indicate that the biopsy from which the diagnosis 
is made influences the regression of CIN (Rawson & Knoblich 1957; 
Koss et al. 1963; Richart 1966b). Regression followed biopsy in 
over 80% of lesions sudied by Rawson & Knoblich (1957). Where 
cytology and colposcopy, without biopsy, have been used to follow 
the natural history, progression has been recorded in up to 60% of 
patients with abnormal smears (Fox 1967). A study that compared
biopsied with non-biopsied CIN confirmed that regression was more
common and progression less common after the biopsy (Nasiell, 
Nasiell & Vaclavinkova 1983). There is not uniform agreement on 
the effect of biopsy (Stern & Neely 1964) but it is agreed that 
CIN should be a histological diagnosis (Buckley et al. 1982).
The presence of human papillomavirus (HPV-one of the proposed 
aetiological factors in cervical neoplasia) with CIN may also 
influence the progression or regression of the condition. In a 
recent study Campion et al. (1986) described the progression from 
mildly abnormal smears to CIN III, within 24 months, in 26% of 
lesions which contained HFV 16 genome sequences. A defect in this
study is that the initial diagnosis was made from colposcopy and
cytology alone, whereas the final diagnosis was on histological
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criteria. More detailed inspection of the data implicating HPV 
indicates that patient age and diagnostic criteria are confusing 
variables. The cytological evidence of viral infection in CIN 
decreases with increasing age (Syrjanen, Heinonen & Kauraniemi
1981) while conversely Meanwell et al. (1987) showed that viral 
detection by (HPV) genome sequences increases with age.
The immune response to CIN is likely to be a factor which 
will influence the natural history as indicated by the high 
prevalence of the condition in immunosuppressed patients 
(Schneider, Kay & Lee 1983). The difficulty in any serial study 
examining local immunity is the requirement of tissue biopsies 
which, as mentioned above, may themselves contribute to the 
regression rate.
Colposcopy in the diagnosis of CIN
Cervical neoplasia most frequently develops in the area of 
cervix known as the transformation zone, which lies between the 
'original' and the 'new' squamocolumnar junctions i.e. in the area 
where columnar epithelium has been transformed to squamous 
epithelium (Richart 1967; Johnson 1969). The junction between the 
transformation zone and original ectocervix is marked by the so 
called histological 'last gland' (Burghardt 1976). The 
transformation zone may be identified in-vivo using a colposcope 
which is a modified binocular microscope that allows the cervix to 
be viewed between 6 and 40 times magnification. Following exposure 
o£ the cervix using a speculum, cotton wool swabs are used to 
remove cervical mucus, The application of saline on cotton wool 
swabs permits detailed examination of the subepithelial capillary 
network of the cervix. The vascular pattern is note clearly seen
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with the interposition of a green filter which causes the vessels 
to appear black. Frankly abnormal irregular and cork-screw 
superficial vessels are suspicious of invasive disease. The 
vascular features are generally best seen before the application 
of acetic acid which is used to define epithelial abnormalities.
Acetic acid (5%) causes cell swelling and transiently 
denatures the nuclear proteins. Areas of abnormal epithelium whose 
cells contain increased amounts of nuclear protein become opaque 
and appear 'aceto-white'. The 'punctate' and 'mosaic' appearances 
that often appear in the aceto-white epithelium occur where the 
epithelium is thinnest allowing the pink of the capillaries or 
stromal ridges to show through. Several colposcopic features 
assist in the differential diagnosis of aceto-white epithelium. 
These include the presence of sharp borders to the lesion, the 
response to acetic acid, the surface contour of the lesion, the 
vascular pattern, the site and extent of the lesion, the response 
to Schiller's iodine, the presence of multiple abnormalities and 
the presence of keratinisation (Burghart 1984). Reid et al. (1984) 
have formed a 'colposcopic index' based on what they considered to 
be the most important features in distinguishing the lesser 
degrees epithelial abnormality from the major abnormalities.
Despite the well described colposcopic appearances, biopsy 
of areas of aceto-white epithelium or areas with abnormal 
vasculature is required for definitive diagnosis. Biopsies can be 
taken with punch biopsy forceps such as Leech-Wilkinson forceps. 
This is an outpatient procedure which causes little discomfort and 
requires no analgesia. Colposcopy therefore allows accurate 
identification of the biopsy site (Navratil et al. 1958) and with 
experience high correlation between the histology obtained from
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colposcopically directed punch biopsies and the definitive 
histology at cone biopsy or hysterectomy can be obtained (Donohue 
& Meriwether 1972 ; Stafl & Mattingly 1973; Reid et al. 1984).
The technique of colposcopy was first introduced in Europe by 
Hinselmann (1925) and was initially used, like cytology, as a 
screening technique. In this country, however, colposcopy is most 
widely practised following abnormal cervical cytology and is 
recommended prior to definitive treatment (Jordan, Sharp & Singer
1982). Recent reports have highlighted the problems of relying on 
cytology alone as a screening test. Walker, Dodgson & Duncan 
(1986) have shown a poor correlation between mildly atypical 
cytology and histology. Campion et al. (1986) re-emphasised this 
when they showed that 26% of young women with mildly abnormal 
smears had CIN III on biopsy. The need for reintroducing primary 
screening by colposcopy in identifiable patients at particular 
high risk of cervical neoplasia has been proposed (Cordiner, Sharp 
& Briggs 1980).
In addition to the diagnostic benefits afforded by colposcopy 
and biopsy, they have permitted a trend towards more conservative 
treatment of CIN which is especially appropriate for younger women 
who have not completed their families. Multiple punch biopsies, 
cold coagulation, electrodiathermy, electrocautery, cryosurgery 
and carbon dioxide laser ablation have all been used as 
alternatives to formal cone biopsy or hysterectomy in the 
management of CIN.
Aetiology of cervical neoplasia
Inherent in Richart's concept of CIN as a single entity 
preceding cervical carcinoma is that the same aetiological factors
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are implicated in both.
Sexual activity has long been associated with cervical 
neoplasia (Rigoni-Stern 1842). Epidemiological studies have shown 
that early age at first intercourse, multiple partners and 
unstable marital relationships are commonly found behavioural 
characteristics in women who develop cervical neoplasia (Wynder et 
al. 1954; Rotkin & King 1962; Meisels, Begin & Schneider 1977; 
Harris et al. 1980). Perhaps linked to these observations is the 
fact that CIN is more common in imprisoned women prostitutes than 
in other women (Keighley 1968).
Associations with CIN have been shown for socio-enconomic 
status and sexually transmitted disease (Beral 1974). A male 
factor has also been implicated (Kessler 1976) and Singer, Reid & 
Coppleson (1976) proposed the concept of the high risk male. Other 
associations include the presence of genital warts (Walker et al.
1983), smoking (Trevathan et al. 1983), immunosuppression 
(Schneider et al. 1983) and perhaps the oral contraceptive which 
seems to predispose to early cervical neoplasia when compared to 
use of the intrauterine contraceptive device (IUCD) (Vessey et al.
1983), although this effect may be related to duration of pill use 
(WHO Collabrative Study 1985)
From this background, the search for the aetiological agent 
causing cervical neoplasia has investigated several sexually 
related factors. Smegma was implicated following observations of 
low incidences of cervical neoplasia amongst Jewish and Fijian 
populations where the practice of circumcision is common (Handley 
1936; Kennaway 1948; Weiner, Burke & Goldberger 1951). However 
studies from USA, Scotland and Lebanon have cast serious doubt on 
this theory (Rotkin & King 1962; Aitken-Swan & Baird 1965;
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Abou-Daoud 1967).
Research from Sydney (Coppleson & Reid 1968; Coppleson 1969) 
demonstrated that metaplastic cervical epithelial cells possessed 
the ability to phagocytose sperm. They postulated that the 
ingested sperm protein or nucleic acids had transforming 
properties and that mutation resulted in neoplastic cell lines 
(Reid & Coppleson 1975). Furthermore males from different 
socio-economic groups were shown to have different amounts of 
arginine-containing protamine in the sperm head but the 
signifiance of these findings remains unclear.
Herpes Simplex Virus type 2 (HSV 2) was thought a likely 
candidate after several large seroepidemiological studies showed a 
link between the presence of antibodies to HSV 2 and cervical 
neoplasia (Skinner, Thouless & Jordan 1971; Nahmias, Naib & Josey 
1974; Thomas & Rawls 1978). These studies were questioned in the 
light of cross reactivity between HSV 1 and HSV 2 (Lonsdale 1979). 
Large variations in the presence of antibodies in control groups 
made the evidence even less convincing (Melnick & Adam 1978).
A group working in Glasgow (Eglin et al. 1981; Sharp et al.
1981) were able to demonstrate HSV 2 ribonucleic acid (RNA) in 
biopsies of CIN and invasive squamous cell carcinoma. However, 
other groups were unable to consistently demonstrate HSV specific 
deoxyribonucleic acid (DNA) in cervical cancer (zur Hausen et al. 
1974; McDougall, Galloway & Fenoglio 1980). The inability to find 
HSV DNA in neoplastic cervical tissue using the sensitive 
diagnostic techniques of DNA hybridisation has cast serious doubt
on HSV 2 as the causative agent.
The consistent presence of human papillomavirus (HPV) genome 
sequences in CIN and in invasive carcinoma has led to some
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authorities claiming that HPV is the causal agent (Crum et al. 
1984; zur Hausen, Gissman & Schlehofer 1984). The venereal 
transmission of HPV is well documented (Oriel 1983) and Campion, 
Singer & Clarkson (1985) have shown a relationship between CIN and 
penile condylomata in the consort.
There are many HPV subtypes and the list is ever expanding. 
Types 6 and 11 have been shown to be present in benign papillomas 
of the female genital tract and low grade CIN (Gissman et al.
1983) whereas types 18 and 16 have been more comnonly found in CIN 
III and frequently in invasive cancers (Crum et al. 1983; Durst 
et al. 1983 ; McCance et al. 1985; Millan et al. 1986). HPV 31, 33 
and 35 have also been sequenced from invasive cancers (Editorial 
1987b). Integration of the viral genome may be a risk factor in 
malignant transformation by HPV infection (Di Luca et al. 1986) 
but its prognostic significance is uncertain since integrated HPV 
genome sequences have been observed in the chronically inflamed 
cervix (Millan et al. 1986) and in the normal cervix (Cox et al. 
1986; Murdoch et al. 1988).
The carcinogenic potential of the papillomavirus is supported 
by the presence of HPV DNA in cervical cancer-cell lines (Schwartz 
et al. 1985) and its role in the development of various cancers in 
animals. For instance the Shope papillomavirus induces malignant 
transformation of papillomas in domestic rabbits (Rous & Friedwald 
1944) while bovine papillomavirus is the causal agent of 
oesophageal and intestinal carcinoma in cattle (Jarrett 1981). 
Papillomaviruses have also been implicated in the development of 
ocular tumours in cattle (Ford et al. 1982) and skin cancer in 
sheep (Vaneslow, Spradbrow & Jackson 1982). In these situations 
the papillomavirus is acting with other cofactors such as chemical
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carcinogens in rabbits, and bracken in cattle. Ultraviolet light 
appears to be neccessary for the generation of ocular and skin 
cancer in these animals.
In man there is also evidence that papillomaviruses require 
cofactors to enhance their malignant potential. Epidermodysplasia 
verruciformis (EV) is a rare, possibly autosomally inherited 
cutaneous disorder in which papillomas undergo malignant 
transformation when exposed to ultraviolet light (Orth et al. 
1979; Kremsdorf et al. 1982). HPV 5 is the subtype implicated with 
neoplastic change in the warts. In addition to ultraviolet light, 
impaired T-cell immunity is also a feature of EV and could be 
another factor involved in the malignant transformation (Glinski 
et al. 1976). HPV 5 has also been found in benign and malignant 
lesions in a renal transplant recipient, on azathioprine, in sun 
exposed sites (Lutzner et al. 1983). Here again exogenous 
immunosuppression, especially of T-cell function, and exposure to 
ultraviolet light are possible cofactors.
In cervical neoplasia zur Hausen (1982) has postulated that 
HSV 2 may act synergistically with the papillomavirus, with HPV 
initiating cell proliferation and HSV acting as a potent mutagen 
on the proliferating cells. Smoking may also act as a cofactor via 
a possible toxic effect on the epithelium (Singer, Walker & 
McCance 1984) or via an immunosuppressant effect (Miller et al.
1982).
The weight of research opinion behind HPV as the causative 
agent of cervical neoplasia has diminished from its peak when some 
authorities were suggesting that routine screening for HPV (type 
16) by DNA hybridisation should be introduced (Editorial 1987a). 
On current evidence Murdoch, Cordiner & Macnab 1987; Murdoch et
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al. 1988) have concluded that such screening is not justified.
Immunological considerations
In animals and man there appears to be a link between
malignant transformation of HPV induced lesions and 
immunosuppressive insults such as exposure to ultraviolet light 
and drugs. The relationship between CIN and immunosuppresion is a 
theme explored further in this thesis which includes an assessment 
of the local immune response in cervix in a variety of
immunosuppressive conditions. Consideration is also given to the 
effects of specific HPV subtypes in an attempt to explore the 
contribution which local immunity plays in the genesis of cervical 
neoplasia.
The immune system has the capacity to identify and react
specifically against foreign antigens, even without having had
prior exposure to the antigen and without acting against 
autologous (self) antigens. The idea that self and foreign 
antigens would result in tolerance or rejection of transplanted 
tissue lead to the discovery of a group of antigens in mice which, 
when matched between donor and recipient, greatly improved the 
survival of the grafted tissue. These antigens became known as 
histocompatibility antigens. It was also noted that the gene 
products of a localised chromosomal area were able to control the 
process of graft rejection and this area was labelled the Major 
Histocompatibility Complex (MHC). Although initial experiments 
were performed using in-bred strains of mice, similar major 
histocompatibility systems have been shown in all mammals. In man 
the system was.first defined on the human leukocyte system A 
(HLA). In mice the MHC is present on chromosome 17, where it is
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refered to as the H-2 region, but in humans the MHC is located on 
chromosome 6.
In man the MHC consists of at least four regions named HLA - 
A,B,C and D. The D region contains several loci DR, DC, DQ and DP. 
Although first identified by its role in graft rejection the 
glycoprotein products of the MHC are now known to be involved in 
many aspects of the regulation of the immune response (Benacerraf 
1981). Regions A, B and C (HLA-A,B and C) produce class I major 
histocompatibility antigens, while region D codes for class II 
major histocompatibility antigens. Class I antigens are expressed 
on all nucleated cells while class II antigens are found on 
certain immunologically competent cells (Roitt, Brostoff & Male 
1985).
The immunologically active cells were identified as
lymphocytes and shown to differentiate into two groups, T-cells
(thymus-derived) and B-cells each with distinct functions. Cell
mediated immunity is dictated by T-cells and antibody production 
from B-cell derivatives, plasma cells.
The complexity of the immune system was emphasised by the 
demonstration of sub-groups of T-cells with regulatory and
effector functions which may be distinguished by cell surface 
antigens. For instance T4 (CD 4) positive cells have helper - 
inducer functions in vitro (Thomas et al. 1980; Reinherz et al. 
1979, 1981), while in vitro cytotoxic suppressor activity is 
performed by T8 (CD 8) positive T-cells (Friedman et al. 1981; 
Reinherz & Schlossman 1981; Thomas et al. 1981). The value of 
separating the T-cell subsets on the basis of these antigens has 
been emphasised by Van Waue & Goossens (1981), but the functional 
separation may not be as exact as once believed (Robins & Baldwin
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1985)
The MHC and its class I and II products are the means by 
which immune recognition between immunologically active cells 
takes place. In the case of cytotoxic T-cells they recognise 
foreign antigen such as viral antigens in association with the 
class I antigens present on the cell surface of the target cell. 
Helper/inducer cells only recognise foreign antigen in association 
with class II products. The resultant T-cell function is wholly 
dependent on this MHC recognition. The importance of this feature 
will be discussed in relation to the findings in CIN.
In addition to the B-cells and T-cells described above there 
are other cells with important immunological functions. Effector 
cells include killer (K) cells and natural-killer (NK) cells and 
activated macrophages. Macrophages also have the capacity to 
present antigen to the immune system, a role dependent on the 
possession of surface class II antigens. These antigens are also 
found on Langerhans' cells present in squamous epithelium. The 
main immune response to tumours and to viral infections is thought 
to be T-cell mediated (Lee & Eisinger 1976; Robins & Baldwin 
1985). The evidence suggesting a central role for the Langerhans' 
cell in the implementation of T-cell immunity will now be 
discussed following review of the history of the Langerhans' cell 
and its staining characteristics since these are essential to the 
work carried out in this thesis.
History of the Langerhans' cell
An epithelial dendritic cell was first described by and named 
eponymously after Paul Langerhans (Langerhans 1868). He utilised a 
gold chloride staining method on human skin. This method also
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stained neural crest elements and led to the Langerhans' cell 
initially being labelled as of neuroectodermal origin. Other early 
opinions considered them to be lymphocytes, worn out melanocytes 
or artefacts.
The electron microscopic demonstration of a characteristic 
rod shaped granule in the cytoplasm of these cells (Birbeck, 
Aodan & Everall 1961) stimulated an upsurge in interest as these 
dendritic cells of unknown origin and function could now be 
identified specifically. In the light of electron microscope 
studies the neuroectodermal and melanocyte theories were 
challenged when Birbeck granule containing cells were demonstrated 
outside skin in Histiocytosis X (Bassett & Turiaff 1965).
A possible mesenchymal origin was postulated (Breathnach et 
al. 1968; Wolff 1972). Experiments to determine such an origin 
were performed by Katz, Tamaki & Sachs (1979) using skin 
transplantation and chimera studies in mice. First, parental skin 
was transplanted to Fl hybrids. By three weeks later the majority 
of Langerhans' cells in the transplanted skin were shown to be of 
recipient origin, whereas the keratinocytes were of donor origin. 
In the second part of the same study irradiated mice, which had 
subsequently undergone marrow transplantation, were shown to have 
a Langerhans' cell population derived from the donor marrow. 
Combining these observations they proposed that the Langerhans' 
cells were derived from a pool of precursor cells located in the 
bone marrow and the mesenchymal bone marrow origin of Langerhans' 
cells was thus accepted.
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Identification of Langerhans' cells
Special staining techniques are required to identify 
Langerhans cells as they are not recognised in normal 
haematoxylin and eosin sections. These have been extensively 
reviewed by Wolff (1972) and Rowden (1981) and are summarised 
below.
Histochemical markers
1) Gold Methods. A gold chloride method was the first used 
(Langerhans 1868) and although other gold methods have been 
utilised none have been widely adopted due to their poor 
reproducibi1ity.
2) Osmium and osmium-zinc-iodide. These method gives good 
results in some laboratories. A variation described by Niebauer et 
al. (1969) showed the Birbeck granule staining positively. 
Rodriguez & Caorsi (1978) published a method allowing progression 
from light to electron microscopy. However other studies have 
indicated that melanocytes and keratinocytes may also be stained 
with osmium-zinc-iodide (Breathnach & Goodwin 1965).
3) Adenosine Triphosphatase (ATP-ase). ATP-ase is a cell 
membrane enzyme which is present in Langerhans' cells and allows 
their demonstration. There are many minor variations of the 
technique, some apparently being specific for Langerhans' cells 
while others show ATP-ase actvity in melanocytes and 
keratinocytes. Wolff & Winklemann (1967) showed that 
ultrastructurally ATP-ase was present in cells containing Birbeck 
granules, ATP-ase activity being observed in the cytomembrane and 
dendrites with none in the cytoplasm or cellular organelles. This 
study also showed ATP-ase activity was almost totally confined to 
Langerhans' cells, with virtually none found in melanocytes thus
page 37
confirming the apparent 'specificity' of this particular 
technique. Thomas et al. (1984) showed, by using a double 
labelling method, that ATP-ase marked the same epidermal cells as 
a Langerhans' cell specific monoclonal antibody NA 1/34 (see T6 
antigen).
One of the disadvantages of using ATP-ase in orthagonally 
sectioned specimens is that these sections require to be cut 
several times thicker than routine sections for haematoxylin and 
eosin staining; this significantly impairs the histological 
interpretation. Thick sections are required in order to expose 
more of the cell membrane containing the enzyme to the substrate.
The use of ATP-ase in epidermal sheets does not avoid the 
problem of histological interpretation, but does permit full 
visualisation of the Langerhans' cell and its dendrites thus 
facilitating easy identification and quantification.
The inconsistency of ATP-ase when compared to monoclonal 
antibodies is a limitation confirmed by Nordlund & Ackles (1981a) 
but is to some extent offset by the low cost, sinplicity and 
results obtained especially in epithelial sheets.
4) Langerhans' cells contain other enzymes which have been 
used to demonstrate their presence. These include aminopeptidase, 
non-specific esterase, alkaline phosphatase, acid phosphatase, 
peroxidase, cholinesterase and mannosidase. Some, such as acid 
phosphatase are associated with phagocytic activity but the low 
levels of such enzymes suggest that Langerhans' cells are poorly 
phagocytic although metabolically very active. None of these 
methods have become popular principally because of their lack of 
specificity.
5) Light microscopic observation of Langerhans cells is also
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possible by using L-dopa or other catecholamines, especially in 
epithelial sheets. Supravital stains have also been used.
Antigenic markers
In addition to the histochemical markers already described 
there exists a group of antibodies to antigens present on the 
Langerhans cell which can also act as markers for their 
identification. Also, while there is no known function for cell 
surface ATP-ase, study of some of the cell surface antigens reveal 
a little of the likely immunological cellular interactions of the 
Langerhans' cell.
1) T6 antigen. T6 is an antigen originally detected on 
immature thymocytes and is found on 70% of T-cells maturing in the 
thymic cortex. It is a glycoprotein with a molecular weight of 
49000 daltons (Van Agthoven & Terhorst 1982). It is not present 
on circulating T-cells being replaced by antigens associated with 
the T-cell subsets T4 and T8; other antigens such as T3 (CD 3) 
and Tl (CD 5) are common to virtually all T-cells.
The same antigen was unexpectedly detected on epidermal cells 
(Fithian 1981; Fithian et al. 1981; Murphy et al. 1981b). These 
cells were suprabasal dendritic cells and were thought to be 
Langerhans' cells. Immuno-transmission electron microscopy 
confirmed the presence of Birbeck granules in the positively 
stained cells (Murphy et al. 1981a).
The presence of T-cells in a keratinising environment of 
ectodermal origin is the current theory behind T6 staining of 
epithelial but not circulating Langerhans' cells (Patterson & 
Edelson 1982) although the exact reason for this is unclear.
T6 staining is currently taken as the 'gold standard for 
Langerhans'cell enumeration (Harrist et al. 1983; MacKie & Turbitt
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1983).
Commercial preparations of anti-T6 antibody are available as 
OKT 6 (Fithian 1981; Fithian et al. 1981), NA 1/34 (McMichael et 
al. 1979) and as Leu 6. The preparation used in this study is NA 
1/34 (MacKie 1982). Frozen sections are used most widely but 
epithelial sheets and single cell suspensions may also be stained 
and immuno-electron microscopy is also possible (Fithian et al. 
1981; Murphy et al. 1981a).
2) HLA-DR. Langerhans' cells express class II
histocompatibility antigens which are thought to be necessary in 
generation of the immune response. Ia antigens in mice are the 
equivalent of the human DR antigens (Rowden, Lewis & Sullivan 
1977). As mentioned before (p. 34) MHC class II antigens and their 
related genes are particularly involved in the interactions 
between antigen presenting cells and T-lymphocytes (Rosenthal 
1978; Braathen & Thorsby 1982). The presence of DR antigens on 
Langerhans' cells and on macrophages is further evidence that 
these cells are components of the mononuclear phagocyte system.
Langerhans' cell staining with DR antigens have been shown 
in-situ and in cell suspensions (Rowden 1980; Tjernlund 1981). 
Rowden (1977) confirmed the presence of Birbeck granules in 
positively stained cells.
The problems with anti-DR antibodies in demonstrating 
Langerhans' cells include the inconvenience of requiring frozen 
section specimens, neoplastic epithelial cell expression of these 
antibodies and presence of infiltrating activated lymphocytes with 
the same antigens (Fu et al. 1978); Ceuppens, Goodwin & Searles
1981). In addition, it has been shown that anti DR antibodies 
identify consistently fewer Langerhans' cells than other more
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specific monoclonal antibodies. Harrist et al. (1983) showed 
between 18-63% of T6 positive Langerhans' cells were identified by 
anti-la antibodies. MacKie & Turbitt (1983) demonstrated that up 
to 75% of dendritic cells stained with both anti-DR and anti-T6 
antibodies while a further 25% stained with anti-T6 alone. The 
significance of DR negative/T6 positive and DR positive/T6 
positive cells is not known (Murphy et al. 1982). Despite 
agreement between the above authors Liu, Schroeter & Muller (1986) 
have claimed that anti-T6 is no better a marker than anti-DR with 
joint reactivity in 97-100% of dendritic cells in both epithelial 
sheets and in frozen sections using a double labelling technique.
3) S—100. Staining of epidermal Langerhans' cells and 
melanocytes with a protein originally identified as a 'brain 
specific' protein was shown by Cocchia, Michetti & Donato (1981) 
and Nakajima et al. (1982). It was called S-100 because of its 
solubility in 100% ammonium sulphate solution at neutral pH (Moore 
1965). The protein is present in the central, peripheral and 
autonomic nervous system mainly in astrocytes, oligodendrocytes, 
Schwann cells and in some neurones. It has been identifed in 
tumours of nervous and non-nervous tissue origin (Nakajima et al. 
1982a; Nakajima et al. 1985).
The biochemical characteristics of S-100 have been 
extensively reviewed (Moore 1972 ; Isobe & Okuyama 1978) but as 
yet no specific function for the protein has been identified. 
However, it does have similar structure to the calcium binding 
proteins calmodulin, light chain myosin and troponin C (Isobe & 
Okuyama 1978) suggesting that conformational changes on binding 
calcium may be the clue to its function.
Electron microscopic localisation of S-100 staining reveals
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that the protein is present in the cytoplasm of the cells and 
absent from the endoplasmic reticulum, Golgi apparatus, 
mitochondria and Birbeck granule (Cocchia et al. 1981; Nakajima et 
al. 1982b). Close relations of the Langerhans' cell ie. 
interdigitating cells and veiled cells (Derxhage et al. 1979; 
Thorbecke, Silberberg-Sinakin & Flotte 1980) also exhibit positive 
staining (Nakajima et al. 1982c) as do the Birbeck granule 
containing cells of Histiocytosis X (Nakajima et al. 1982c).
S-100 is absent from macrophages and this may indicate some 
divergence in differentiation between Langerhans' cells and 
macrophages.
The main advantage of utilising S-100 staining for Langerhans 
cells is that the protein appears to resist the effects of 
denaturation by fixatives thus rendering possible Langerhans' cell 
identification in conventionally fixed and stored tissue which 
makes retrospective review possible. The disadvantages include the 
concomitant staining of melanocytes and the great variability in 
results obtained probably due to variations in fixation medium, 
time or concentration or temperature of processing. Lastly the 
numbers of Langerhans' cells identified are substantially less 
than with anti T-6 or anti HLA-DR antibodies (see chapter 2).
Cytoplasmic and other markers
In addition to the monoclonal antibodies previously described 
to cell surface antigens, Majdic et al. (1981) showed that 
antibodies to some B-cell lines reacted with the cytoplasm of 
Langerhans' cells. Cloning produced a cell line which reacted to 
antigenic determinants of both Langerhans' cells and B-cells. This 
anti CY-1 antibody also marks other members of the mononuclear 
phagocyte system such as the Kupffer cells of the liver and
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monocytes of peripheral blood. The antigen is not related to 
cytoplasmic equivalents of DR antigens nor to S-100 protein.
A further recent addition to the antigenic cytoplasmic 
markers of Langerhans' cells has been the use of antisera against 
cellular enzymes eg. beta-glucuronidase (Mackenzie, Bickenbach & 
Rittman 1982) but whether this proves to have any advantages over 
the methods previously described remains uncertain.
Mention should be made of other 'immunological' cell surface 
receptors which may be used as markers of Langerhans' cells. 
Stingl et al. (1977) demonstrated the presence of receptors for 
the Fc portion of IgG and for the C3 component of complement on 
the Langerhans' cell. These observations strengthened the theory 
of the Langerhans' cell as a member of the mononuclear phagocyte 
system, but the presence of these receptors does not help in 
localisation of Langerhans'cells in tissue sections or epithelial 
sheets. They are however of considerable value in the isolation of 
Langerhans' cells from epidermal cell suspensions. The Fc and C3 
receptors are thus exposed and able to become involved in rosette 
formation (Berman & Gigli 1980). This rosetting enables the 
Langerhans' cells to be isolated following density gradient 
centrifugation. The cells identified by this method are ATP-ase 
and la positive and usually contain Birbeck granules at electron 
microscopy.
Kashihara et al. (1986) recently described an antibody which 
specifically stains the Langerhans' cell granule and can be used 
for light microscopic identification. This antibody is discussed 
further in the following section.
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Electon microscopy (EM)
The Birbeck granule is the definitive marker of the 
Langerhans cell, it is only seen at the ultrastructural level. 
Quantitation studies of Langerhans' cells using electron 
microscopy are, however, severely limited by the small size of 
specimen which may be examined.
The major ultrastructural features of the Langerhans' cell 
were established by Birbeck et al. (1961). They have no desmosomal 
attachment to surrounding keratinocytes and no tonofilaments, the 
nucleus is lobulated or indented and the cytoplasm is clear, 
containing the characteristic organelle. Melanosomes are not found 
except in association with phagocytic activity and lysosomes are 
relatively uncommon. The cells rarely appear as dendritic at the 
ultrastructural level due to the very slim chance of observing the 
cell in the correct profile. However, the dendrites are commonly 
observed between the other cells of the epidermis.
Since their original description as disc shaped granules, 0.3 
microns in diameter no definite function has been ascribed to 
Birbeck granules. They are not always granules and often appear as 
rods with an expanded ends similar to a tennis racket. They tend 
to be associated with the Golgi apparatus but are seldom uniformly 
distributed. They have also been observed in the dendrites, 
nucleus and associated with the cell membrane but their affinity 
with the Golgi and smooth endoplasmic reticulum has led some to 
consider them as secretory granules (Niebauer et al. 1969). The 
similar staining of the Golgi and Birbeck granule with
zinc-iodide-osmium has been used to support this idea. However, a 
more likely explanation is the affinity of the stain for lipid 
which is present in both organelles. Further support for an origin
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from the Golgi apparatus comes from ultrastructural evidence that 
a Langerhans cell granule (LAG) antibody stains the Birbeck 
granule and the associated Golgi apparatus but not the cell 
membrane (Kashihara et al. (1986).
The associaton of the Birbeck granule with the cell membrane 
led others to consider a phagocytic role more appropriate 
(Hashimoto 1971; Takahashi & Hashimoto 1985) but Langerhans' 
cells are poorly phagocytic. Phagocytosis is performed by small 
vesicles and not by Birbeck granules.
Electron microscopy has used been used to confirm the 
specificity of many of the methods described above including 
iodide-zinc-osmium (Rodriguez & Caorsi 1987), ATP-ase (Hanau et 
al. 1986) and HLA-DR (Rowden 1977) in addition to S-100 and T-6 
already described.
The Langerhans' cell in skin
Potten & Allen (1976) suggested that Langerhans' cells could 
influence the differentiation and maturation of keratinocytes. 
However, the only roles supported by experimental evidence involve 
immunologic functions. Possible secretory and phagocytic functions 
mentioned above require clarification.
The common origin and relationship of the Langerhans' cell to 
other cells of the mononuclear phagocyte system, especially 
macrophages have been discussed. The Langerhans' cell is not, 
however, a typical macrophage, its phagocytic potential is low, 
whereas, the antigen presenting capacity appears highly developed.
Initial evidence for a role as an antigen presenting cell 
came from experiments conducted in contact sensitivity reactions. 
Shelley & Juhlin (1976) showed in epithelial sheets exposed to
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various contact allergens that they were selectively taken up by 
high level ATP-ase positive dendritic cells. They concluded that 
Langerhans cells formed a reticulo-epithelial network or trap for 
contact allergens.
Silberberg-Sinakin et al. (1976) found, following 
intradermal challenge with ferritin, that Langerhans' cells were 
detectable by electron microscopy in the marginal sinus and cortex 
of draining lymph nodes as early as four hours. They were seen to 
migrate via afferent lymphatics. The reaction was more marked when 
previously sensitised with ferritin. The postulate made was that 
the Langerhans' cells capture antigenic material in skin, 
circulate to lymph nodes and cause activation of specific T-cells.
A late effect after antigenic challenge was reduction in 
number and damage to Langerhans' cells with lymphocytes in 
apposition. From these observations the authors concluded that the 
Langerhans' cell could also act as the target for the efferent arm 
of the immune response in cutaneous delayed-type hypersensitivity 
reactions (Silberberg-Sinakin & Thorbecke 1980).
In earlier experiments the same group found that Langerhans' 
cells could also act as the target for the immune response in 
immune complex reactions. The presence of complement caused cell 
damage, decreased phagocytosis and impaired their passage to lymph 
nodes. It was concluded that such immune complex reactions could 
affect subsequent cell mediated reactions to foreign material 
(Silberberg-Sinakin et al. 1977).
Experiments by Streilein, Toews & Bergstresser (1980) 
suggested that the actual numbers of Langerhans' cells could 
influence the resultant immune response. Sensitising the mouse in 
areas of low Langerhans' cell density produced less than one-third
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of the response to re-challenge compared to initial sensitisation 
in areas with normal numbers. This held true in areas with 
normally low numbers and in those where the Langerhans' cell 
population had been artificially depleted by ultraviolet light 
exposure. Contradictory evidence has been presented by Cooper et 
al. (1986) who found decreased antigen presentation was a function 
of ultraviolet light induced Langerhans' cell damage and bore no 
relation to numbers.
Some investigators have shown that immune tolerance can 
result if the allergens are presented in areas of low Langerhans' 
cell density (Toews, Bergstresser & Streilein 1980a). Ptak et al. 
(1980) noted a marked impairment in response to further exposure 
to exogenous antigen if the normal process of antigen presentation 
to helper T-cells was by-passed. They proposed that the resulant 
tolerance was induced by 'suppressor' T-cells activated by 
exogenous antigen. Immunity was able to induced if the suppressor 
cells were inhibited by cyclophosphamide. Rheins & Nordlund (1986) 
also demonstrated that decreased numbers of Langerhans' cells 
suppressed both the afferent and efferent response in contact 
sensitivity reactions while increased numbers were noted to 
augment both limbs of the immune response.
Stingl et al. (1978) showed Langerhans' cells isolated from 
epidermal suspensions from mice and guinea-pigs could substitute 
for macrophages in an in-vitro test of antigen presenting 
function. Purified T-cells sensitised to simple chemical haptens 
or to soluble protein antigens were incubated with a variety of 
primed stimulator cells and T-cell proliferation was assessed 
after three days. Langerhans' cells, but not other epidermal 
cells, proved as efficient as macrophages in stimulating T-cell
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proliferation. Similar results have been obtained using human 
epidermal Langerhans' cells (Braathen, Bjercke & Thorsby 1984). It 
has also been shown that Langerhans' cells are more potent than 
blood monocytes in inducing some antigen specific T-cell responses 
including to viral infection (Braathen et al. 1984).
Modification of the antigen is also part of the presentation 
process and is necessary before the interaction between the 
antigen presenting cell and responder lymphocytes can take place. 
The final result is T-cell proliferation. The basis of the 
interaction is histocompatibility between the Langerhans' cell and 
the responder group of T-cells in the gene products coded for in 
the D-region of the the major histocompatbility complex (Unanue 
1981; Braathen & Thorsby 1982).
The in-vitro model for this interaction between antigen 
presenting cells and T-lymphocytes is the mixed leukocyte reaction 
(MLR). It has been shown that the rajority of the responder cells 
are T-4 positive - mainly helper T-cells (Biddison et al. 1982). 
The helper T-cells recognise the processed foreign antigen in 
association with class II antigens. The interaction is abolished 
when antibodies to the class II antigens and complement are added 
to the MIR (Stingl et al. 1978). Aberer et al. (1986), however, 
Suggest that ih-vivo effects of anti-la on Langerhans' cell 
function are ISss than on other antigen presenting cells.
The data presented above suggests that the Langerhans' cell 
is ideally placed and able to act as the most peripheral lookout 
ift the the afferent limb1 of the local immune system. If the 
conclusion Si peham^rger et al. (1983) are confirmed it may be 
bKdt they also h#6essafy for full development of the efferent 
limb - cytotoxic T-cells.
page 48
The relationship between Langerhans' cells and skin cancer is 
complex. Ultraviolet radiation is strongly linked with development 
of malignant proliferation of melanocytes and keratinocytes 
(Kripke & Fisher 1976). It also produces various effects on 
Langerhans cells depending on the wavelength of incident light 
(Aberer et al. 1981; Nordlund & Ackles 1981b). Kripke & Fisher 
(1976) suggested that mice irradiated with ultraviolet light were 
unable to reject strongly antigenic tumours which were easily 
rejected by non-irradiated recipients. This may be secondary to a 
reduction in Langerhans' cell numbers or to impaired function 
(Sauder et al. 1983) allowing neoantigens to escape 
immunosurveillance. Suppressive mechanisms may ultimately be 
induced following this, similar to the situation occuring in 
contact sensitivity reactions. Thus it may be possible that cells 
transformed by an oncogenic stimulus may escape detection and 
subsequently proliferate undetected by the immune system if the 
change is occurring in an area deficient in Langerhans' cells. 
These changes could explain the link between exposure to 
ultraviolet light and the malignant transformation of skin 
lesions containing HPV 5 mentioned earlier (p. 32).
Rowden (1981) pointed out that in guinea-pigs experimentally 
infected with cytomegalovirus the viral particles are almost 
exclusively taken up by Langerhans' cells. It has been postulated 
that viral infection of Langerhans' cells may alter their 
function. MacKie (1981) suggested that persistent infection of 
Langerhans' cells could iirpair their interaction with helper 
T-cells allowing the helper T-cells to accumulate in skin in
mycosis fungoides.
A possible relationship exists between Langerhans' cells in
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skin, human papillomavirus (HFV) and squamous cell neoplasia. In 
epidermodysplasia verruciformis the possible role of inpaired 
T-cell immunity and ultraviolet light exposure have been discussed 
(p. 32). However, Haftek et al. (1987) have also shown that the 
Langerhans' cells are reduced in number in the flat wart lesions 
compared with non-involved skin. Since these lesions are at high 
risk of malignant transformation especially in the presence of HFV 
5 it is possible that this effect is promoted by impaired local 
immunosurveillance. Studies on the human cervix will be discussed 
later but they suggest that Langerhans' cells are decreased in 
association with HFV infection.
In summary, evidence from skin research shows the Langerhans' 
cell has antigen presenting properties in the afferent immune 
response which are dependent on helper T-cell recognition of 
genetically defined surface determinants. Their circulation 
locally enables them to intercept antigens at the most peripheral 
outpost probably engaging in similar cell interactions to the well 
documented effects following contact hypersensitivity reactions. 
Escape from the normal immune surveillance may be one trigger to 
neo-antigen and tumour tolerance in the host.
The Langerhans' cell is assumed to have a similar role in the 
cervix as has been documented in skin (Toews, Bergstresser & 
Streilein 1980b). In the context of this thesis it is their 
immunosurveillance role in relation the effects of virally 
transformed and neoplastic cells that is investigated further.
Other interactions and cells involved in local immunity
Before discussing the Langerhans' cell in the cervix it is 
necessary to consider other cells which may be implicated in local
page 50
immunosurveillance. Streilein (1978) proposed the concept of skin 
associated lymphoid tissue (SALT) that involved Langerhans' cells, 
keratinocytes and T-cells which specifically recirculate through 
skin and draining peripheral lymph nodes. However, evidence 
suggesting such a specific T-cell recirculation is, to a large 
extent, circumstantial. The presence of a malignant epithelial 
T-cell infiltrate in the Sezary syndrome (Patterson & Edelson
1982) and the discovery of a THY-1 antigen bearing bone marrow 
derived epidermal cell in murine epithelium have been used as 
supportive evidence.
Recently, more interest has concentrated on the role of the 
keratinocyte than on the epidermotrophic T-cell. Antigen 
presentation to specific T-cells requires initial processing and 
presentation in association with histocompatible class II 
antigens. Following this initial interaction soluble factors are 
released which influence the subsequent response. Interleukin 1 
(IL-1) is produced by the Langerhans' cells (Sauder, Dinarello & 
Morhenn 1984) and interleukin 2 (IL-2) by the helper T-cells.
Epidermal T-cell activating factor (ETAF) is a product of 
keratinocytes (Luger et al. 1981,1983) and is indistinguishable 
from IL-1, a powerful chemotactic agent for mononuclear, 
polymorphonuclear cells and T-cells (Luger et al. 1983). It 
promotes T-cell proliferation and differentiation by stimulating 
the helper T-cell production of interleukin 2 (T-cell growth 
factor) and/or increasing the expression of receptors for IL-2. 
The recruited T-cells may then help other T-cells to become 
cytotoxic T-cells. Following initiation it is not clear whether 
subsequent events occur in the epithelium or in the regional lymph 
nodes. However, T-cell division takes place in the draining lymph
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node and effector cytotoxic T-cells exit the lymph node into the 
blood stream. They are principally active through recognition of 
MHC class I antigens (HLA A,B,C) in association with the allogenic 
stimulus.
Keratinocytes have also been shown to secrete other soluble 
factors including interleukin 3 (Luger et al. 1985) which promotes 
growth of bone marrow derived cells.
MHC class II antigen expression on keratinocytes has also
been reported in various pathologic conditions involving a T-cell 
response, eg graft versus host disease, allograft rejection and 
allergic contact dermatitis. In-vitro experiments have shown that 
gamma interferon (Nickoloff et al. 1986), a product frcm activated 
T-cells, can induce synthesis by keratinocytes of class II
antigens. The function of these class II antigens is unknown but
it has been postulated that they may be the stimulus to
Langerhans' cell migration into the epithelium (Daynes et al.
1985). The cytotoxic T-cell response to allogenic targets is
greatly enhanced when a class II stimulus is also provided
(Sollinger & Bach 1976), so the presence of class II antigens on 
keratinocytes may be acting as both stimulators and as targets of 
the immune response.
The work described in this thesis concentrates on the 
cervical Langerhans' cells as they appear to have a central role 
in the local immune response but, given the above discussion, it 
is likely that the epithelial cells have more than just a passive 
role in the process and their possible contribution especially 
the MHC class II positive cells, will be considered together with 
the local lymphocytic infiltrate.
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Langerhans' cells in cervix
Zwillenberg (1958) was the first to describe Langerhans' 
cells in the cervix. He noted the presence of dendritic epithelial 
cells in separated sheets of cervical (and vaginal) epithelium and 
reported their presence in both normal and dysplastic cervical 
tissue.
Younes, Robertson & Bencosme (1968) noted cells with the 
ultrastructural features of Langerhans' cells in normal cervix. 
Increased numbers were found in carcinoma-in-situ and were 
postulated to be secondary to 'abnormal epithelial turnover'. They 
made no mention of any apparent change in Langerhans' cell 
morphology in the dysplastic cervix. This publication was followed 
by another (Younes 1969) repeating these observations. The author 
suggested that exfoliated Langerhans' cells could result in 
confusing cytology, but, no confirmatory evidence has since been 
presented.
Hackemann, Grubb & Hill (1968) compared the ultrastructural 
detail of normal skin with normal cervix and found that, apart 
from lack of keratin and absence of melanocytes, both were 
essentially similar. Once again the presence of Langerhans' cells 
containing Birbeck granules was confirmed in the cervix. The 
authors incorrectly believed they were the first to record these 
features.
Figueroa & Caorsi (1980) were the first to provide any 
detail on the distribution and morphology of Langerhans' cells in 
the cervix. In their initial paper they utilised modifications of 
a method described by Rodriguez & Caorsi (1978) which allowed 
identification of Langerhans' cells using a zinc-iodide-osmium 
technique. The method they used stained both the Langerhans' cell
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membrane and Birbeck granules when examined ultrastructurally. 
Light microscopy was used for quantitative and morphologic 
assessment. They reported their findings from only 3 cervices. The 
mean number of Langerhans' cells detected in epithelial sheets by 
this method was 8.34 (SE 0.92) per square millimetre. They 
reported that distribution was variable with an apparent increase 
in the vicinity of the external os. The gross morphology of the 
Langerhans' cells was classified according to the number of 
dendrites they possessed and the authors postulated that 
increased surface area in association with increased dendrites 
represented increased antigen presenting capacity. This theory has 
not been substantiated.
Armed with their previous observations of the Langerhans'
cell in normal cervix they proceeded to investigate their presence
in CIN overlying early invasive carcinoma using the techniques
they had established (Caorsi & Figueroa 1984). Three cases were
examined, with apparently minimal amounts of tissue being
submitted for routine histological diagnosis. Quantitative
analysis was again performed on epithelial sheets. The average
2Langerhans cell density was 30.07 cells/mm (SE 3.62), an 
increase of more than three fold compared with their previous
study. Once again they found highest numbers of Langerhans' cells 
close to the external os and commented that the degree of
intraepithelial neoplasia followed a similar trend, being most 
severe near the external os and diminishing gradually in severity
towards the ectocervix. The more branched variety of Langerhans'
cells predominated in the epithelial sheets examined. Electron 
microscopy confirmed Langerhans'cell migration into the underlying 
stroma. Hypertrophy of the rough and smooth endoplasmic reticulum
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suggested an increase in their metabolic activity. Characteristic 
surface contact was seen between Langerhans' cells and lymphocytes 
analogous to the situation in skin. They concluded that 
Langerhans' cells increased according to the degree of CIN and 
suggested that this was an immune response to the neoplastic 
process.
They supported their conclusions in their most recent 
publication (Caorsi & Figueroa 1986) in which four further cases, 
with neoplastic epithelium overlying early invasive carcinoma, 
were examined. Strong correlation was again noted between the 
degree of CIN and an increase in Langerhans' cells numbers. There 
was no mention of any histological evidence of wart virus 
infection in any of the cases presented. The authors proposed 
three possible mechanisms for the increased numbers of Langerhans' 
cells found, namely increased bone marrow migration, 
intraepithelial division or retention in the neoplastic
epithelium.
Increased numbers of Langerhans' cells were also observed in 
CIN by MacLean (1984b) before treatment with laser. His studies 
concentrated predominantly on the epithelial changes occurring in 
the post laser cervix. The earliest Langerhans cells were
observed 14 days after treatment. These reports were made from 
sections stained for ATP-ase activity. Morris et al. (1983a) made 
similar observations regarding maturing metaplastic cervical 
epithelium stained with an anti T-6 monoclonal antibody (NAl/34).
In addition to the above findings, Morris et al. (1983a) 
reported that Langerhans' cells were a consistent component of 
cervical epithelium in subjects ranging from 30 week fetuses to 62 
year old adults. They reported little difference between
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ectocervix and the transformation zone with the Langerhans' cell 
density in post-natal life ranging between 74 and 145 cells/mm^ *
Bjercke et al. (1983) also noted similar numbers of 
Langerhans' cells in pre and post menopausal women, with counts 
between 1% and 3% of cervical epithelium stained with anti-HLA DR 
antigens, but they did not directly compare ectocervix with 
transformation zone.
It is of note that only one 'normal' adult premenopausal 
patient is included in the study by Morris et al. (1983a). A 
single pregnant patient also had Langerhans' cell numbers within 
the range of values obtained in non-pregnant cervical tissue. No 
statistics from the results were presented.
Morris et al, (1983a) also examined the lymphocytic 
infiltrate in the cervix with special regard to the type and 
distribution of lymphocytes in the epithelium and stroma. The vast 
majority of epithelial lymphocytes in these normal cervices were 
of the cytotoxic/suppressor type, (T8 positive), whereas in the 
stroma, helper T-cells predominated. Contacts between the 
Langerhans' cells and lymphocytes, Langerhans' cells and capillary 
endothelium and between Langerhans' cells and stromal 'hugging 
cells' suggested to the authors a central role in the processing 
and presentation of exogenous antigen to strcmal lymphocytes or 
other immunocompetent cells. B-cells were noted in the stroma 
occasionally but were absent from the epithelium.
Studies followed on wart virus infection and intraepithelial 
neoplasia (Morris et al. 1983b). The findings in four patients 
with 'wart only' features on histology were described. The 
Langerhans' cells in these were consistently reduced, restricted 
to the basal zone and had stunted dendrites. The lymphocytic
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infiltrate was also markedly reduced in the epithelium
corresponding to areas of reduced Langerhans' cell activity. The 
cytotoxic/suppressor sub-group of lymphocytes predominated in the 
epithelium. Another finding was patchy epithelial cell membrane 
labelling to the mid-zones with anti-HLA class II antibodies.
Three patients were studied with CIN III only. The
Langerhans' cells were increased and again showed altered dendrite
morphology. Class II antigen staining of epithelial cells showed
marked perinuclear and cytoplasmic staining extending diffusely 
throughout the epithelium. In the lymphocytic infiltrate, 
cytotoxic/suppressor cells predominated with helper cells 
apparently reduced. The infiltrate appeared increased and was 
confined to the area of CIN. B-cells were again an uncommon 
finding. Five patients in the second study (Morris et al. 1983b)
had biopsies taken from epithelium adjacent to lesions and in the
non-affected epithelium the Langerhans' cell distribution was 
normal.
The authors speculated that wart virus could be exerting a 
cytopathic effect on the Langerhans' cells or that it could be 
causing increased migration from infected epithelium. They 
postulated that depletion could allow persistence of wart virus 
infection and possibly promote malignant transformation while the 
increased numbers in CIN were interpreted as a specific immune 
response recruting T-cells to the lesion. Once again no 
statistical analysis was presented frcm the very small numbers of 
cases studied.
The finding of class II epithelial cell staining was 
confirmed in another study by the same group (Morris et al. 1983c)
in wart virus infection, CIN, combined HPV / CIN and in carcinoma.
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Edwards & Morris (1985) used the same monoclonal antibody (NA 
1/34) as used in the studies described here to demonstrate 
Langerhans cells. They examined the distribution of Langerhans' 
cells in cervix, vagina and vulva. Fifteen biopsies were studied 
from each area. The counts were taken per 100 basal cells and 
statistical analysis performed by Kruskal-Wallace one way analysis 
of variance. In the cervix, Langerhans' cells were equally 
distributed between ectocervix and transformation zone. The count 
ranged from 4.7 to 22.7 with a median of 12.9 per 100 basal 
cells. This was significantly greater than counts from vagina 
(median 5.5) and less than counts from vulva (median 18.7).
Langerhans' cells were observed in proximity to vascular 
endothelium which also expressed class II antigens. The 
possibility that antigen primed endothelium could act as the 
recognition site for returning stimulated lymphocytes was raised.
Examination of the lymphocyte subsets in cervical epithelium 
showed that cytotoxic/suppressor T-cells exceeded helper T-cells 
by 8-9:1 in both ectocervix and transformation zone. The stroma of 
the two areas differed markedly however with the infiltrate being 
markedly reduced in the ectocervix. This difference between 
ectocervix and transformation zone prompted Edwards and Morris to 
propose that the transformation zone was an area of 'enhanced 
immunological activity' similar to that previously proposed for 
skin (Streilein 1978). They proposed that 'cervical lymphoid 
tissue' (CLT) should include the Langerhans' cells, lymphocytes 
and metaplastic epithelial cells of the transformation zone. They 
thought the increased lymphocyte population of the transformation 
zone could be due to more active Langerhans' cells in the 
transformation zone recruiting lymphocytes or, more likely, that
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the metaplasic epithelial cells themselves were contributing to 
the lymphocyte recruitment and differentiation by production of 
soluble factors as had previously been shown in skin. This has 
been discussed more fully in an earlier section (p. 52).
Di Girolamo, Goni & Laguens (1985) compared the Langerhans' 
cell distribution in the ectocervix of 4 normal patients with 
biopsies of colposcopically abnormal epithelium in 9 patients 
which showed immature and mature metaplastic epithelium on 
histology. They found similar numbers in the mature transformation 
zone and ectocervix but found no Langerhans' cells in incomplete 
metaplastic epithelium. This is in contrast to findings by MacLean 
(1984a) and Morris et al. (1983a) who both noted increased numbers 
in maturing cervical epithelium.
Vayrynen et al. (1984) studied Langerhans' cells in combined 
HPV/CIN lesions followed for an average interval of 16 months. 
They used a monoclonal anti-T6 antibody to identify them in the 
inflammatory infiltrate of the lesions. No relation was noted 
between the number of Langerhans' cells and the infiltrate, 
between the grade of CIN and Langerhans' cells, or between the 
type of HFV lesion and Langerhans' cells. No relationship was 
shown between the number of Langerhans' cells in HFV lesions which 
persisted, regressed or progressed. No age dependency was 
demonstrated. The authors highlighted the fact that no internal 
control biopsies were examined. When they examined specimens 
obtained from lesions that regressed spontaneously they found that 
the now normal epithelium contained lesser numbers of Langerhans' 
cells than previously. This study quantified the T-6 population as 
a proportion of the total inflammatory infiltrate but made no 
reference to the actual number of epithelial Langerhans' cells.
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They concluded that other factors were likely to be implicated and 
emphasised the role of the Langerhans' cell as only a part of the 
local immune system in the cervix.
The only other study presenting information on Langerhans' 
cells in the cervix which was published before commencing the 
studies reported in this thesis was a comparative study between 
the immunocompetent cells in oral mucosa, normal cervix and oral 
papillomas and leukoplakias (Becker et al. 1985). Seven biopsies 
of cervix were examined. The mean count from 10 randomly selected 
high power fields of epithelium was used in the analysis. Fewer 
Langerhans' cells were noted in cervix compared with oral mucosa. 
However, epithelial cytotoxic/suppressor T-cells were increased. 
It is not clear whether transformation zone or ectocervix or both 
were included.
Between the start of this project in August 1986, and the end 
of 1987 there have been a further four publications on Langerhans' 
cells and immunocompetent cells in the cervix. McArdle & Muller 
(1986) examined their numbers in CIN and HFV infection using 
S—100 polyclonal antibody on 79 biopsies stored in paraffin blocks 
for up to 6 years. Forty-six biopsies contained normal ectocervix 
(20 were adjacent to abnormal epithelium). No specimens were 
examined from normal patients, the 'normals' used for comparison 
being taken from cone biopsies in which ectocervix was 
fortuitously present. Wart virus alone was found in 14, CIN alone 
in 21 (14 being CIN III) and combined CIN/HPV in 20 specimens. 
Langerhans' cell counts were made per square millimetre of 
epithelium using a projected imaging technique. Statistical 
analysis between groups was performed by multiple Wilcoxon rank 
sum tests.
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Results from this analysis again showed no difference between
Langerhans' cell numbers in ectocervix and transformation zone.
The Langerhans cell population was significantly reduced,
(p=0.01), in biopsies showing histologic evidence of wart virus
infection only, when compared to the biopsies showing normal
epithelium. In lesions showing CIN only the numbers were
significantly increased (p=0.01) and showed the same significance
when CIN III lesions were examined. No results were presented
comparing normal epithelium with combined CIN and HFV lesions,
though inspection of the results suggests that there was no
2
difference (mean densities /mm 12.6 and 12.5 for normal 
ectocervix and lesional epithelium respectively). The authors do 
not appear to have included any positive or negative control 
sections in their study and in addition make no comment on the 
duration of storage affecting antigen positivity. They do not 
mention the possibility of other epithelial cells staining with 
S-100 (Takahashi et al. 1985). Perhaps some evidence of the 
disadvantages of the methodology used is gained by examining the 
variation in Langerhans' cell numbers within separate groups. The 
range is up to 100 fold in both the normal and CIN group with the 
other groups showing at least 10 fold variations. Some of these 
criticisms are the subject of a letter to the editors of the 
journal (Hawthorn & MacLean 1987a).
The other three recent papers concerning Langerhans' cells 
and the local immune response in the cervix come from Singer and 
his group at the Whittington Hospital, London. In the first paper 
Tay et al. (1987a) compared the Langerhans' cell populations using 
T-6, ATP-ase, S-100 and class II antigens in six normal cervices, 
five with HFV alone and 14 with CIN (all of whcm had concomitant
page 61
evidence of HFV infection). T-6 antigen and ATP-ase shewed the 
greatest numbers of Langerhans' cells, class II antigens 
demonstrated 60% of these and S-100 only 35% in the normal cervix. 
Analysis, using multiple Wilcoxon rank sum tests, conparing the 
normal with the two abnormal histological types showed that 
Langerhans' cells were significantly reduced by all methods in HPV 
infection alone (p<0.05). Similar results were obtained for the 
combined HFV/CIN group. The depletion was most marked in both 
groups for Langerhans' cells stained with T-6 and S-100.
In a separate study of S-100 positive Langerhans' cells 
reported in the same paper the numbers in a group of 20 normal 
patients were compared with 30 patients who had combined CIN/HFV 
lesions; 63.3% of the abnormal biopsies showed no Langerhans'
cells. The was no relation between the numbers of Langerhans'
cells and the degree of CIN. The numbers of Langerhans' cells in 
any normal adjacent epithelium were stated to be normal but these 
were not directly compared with the numbers in the lesions. The 
authors noted that the distribution of S-100 positive cells was 
not uniform, as they appeared with other methods, but were 
predominantly located around capillaries and associated with 
lymphocytic infiltrates. This uneven distribution was reflected in 
poor correlation between S-100 positive Langerhans' cells per unit 
area and per unit length. The first study illustrated a good 
correlation in the numbers, identified by T-6 antigen, ATP-ase and 
class II antigens, between the measurements per unit length and 
per unit area of epithelium.
From these results the authors concluded that the S-100 
population of Langerhans' cells might have a functional
significance. Once again the population stained by S-100 showed
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the greatest variation in range (8 to 10 fold in normal cervix) 
which questions the validity of using S-100 to quantify
Langerhans' cells in the cervix.
In their second paper (Tay et al. 1987b), the lymphocyte 
subsets in five normal patients, five with HFV alone and ten with 
HFV and CIN were examined. The lymphocytic infiltrate was located 
predominantly in the upper stroma and lower quarter of the 
epithelium. In the normal epithelium cytotoxic / suppressor cells 
exceded the helper T-cells but in the stroma the converse was 
true. In the abnormal epithelium there was a marked reduction in 
both T-cell subset numbers. The reduction was reported in the same 
areas as decreased Langerhans' cells and it was considered that 
the reduction in helper cells was of the magnitude to effectively 
reverse the mean ratio of helper cells to cytotoxic cells. 
Activated T-cells were not found and no significant reduction was 
reported in the stromal infiltrate. This group agreed with the 
earlier findings of Morris et al. (1983b) that B-cells were 
uncommon in the normal and abnormal cervix. They reported a larger 
reduction in the helper subgroup and they speculated this may be 
related to the reduced Langerhans' cells creating a localised area 
of intraepithelial immune deficiency.
Tay, Jenkins & Singer (1987) also presented data relating to 
the presence of natural killer (NK) cells, identified by Leu 7 and 
Leu 11, in CIN and papillomavirus infection. The numbers were 
very small with five normals, six HFV infection only and 12 with 
HFV/CIN. Analysis was performed by subjective semi-quantitative 
methods. Natural killer cells were rarely present in normal 
csrvix. jj} the abnormal cervix only one of the 12 patients with 
CIN had a marked infiltrate of NK cells, with two of the six
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patients with HFV infection alone showing a marked infiltrate, it 
is difficult to comment regarding the role of NK cells in such 
lesions from such a small, semi-quantitative study with no data 
analysis.
In a preliminary study Tay et al. (1987c) also examined the
macrophage infiltrate in similar lesions, though again in only a 
small number of specimens. Decreasing stromal and epithelial
macrophages were found from HFV infection alone through CIN I to 
CIN III. The signifcance of these observations is unclear.
In addition to the papers discussed above the inflammatory 
infiltrate in the cervix had been the subject of other studies. 
However, in most no attempt was made to distinguish between the 
epithelial and the stromal infiltrate. In Finland, Syrjanen (1983) 
used acid alpha-napthyl acetate esterase (ANAE) to distinguish 
between B-cells, T-cells and mononuclear phagocytes on 
morphological staining characteristics. This method lacks the
specificity of monoclonal antibodies, but differences were shown 
between CIN with and without the presence of HFV, as identified by 
HFV antigens. The B-cells declined in relation to increasing
degrees of CIN in the lesions without HPV. T-cells and macrophages 
increased in accordance with the degree of CIN in the HFV positive 
lesions. Syrjanen suggested that the increase in the T-cells could 
be due to the presence of increased numbers of cytotoxic T-cells 
and that the increased inflammatory infiltrate in the HFV lesions 
may indicate that concomitant HFV infection renders the 
intraepithelial change more antigenic.
In a subsequent paper Syrjanen et al. (1984) used a similar 
method to identify the three groups of immunocompetent cells but 
added monoclonal antibodies to identify the helper and cytotoxic/
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suppressor T-cell subsets. They examined patients with HPV or 
HFV/CIN lesions in 65 women followed for over 12 months. The 
percentages of T cells, B cells and macrophages were similar in 
both groups. There was a significant reduction (p<0.025) in the 
ratio of helper T cells to cytotoxic/suppressor cells between the 
HFV/CIN (1.44) lesions and the pure viral lesions (0.81) which was 
due to a higher percentage of cyotoxic/suppressor cells in the HFV 
only lesions. After the period of follow-up, the infiltrates in 
the lesions that had progressed, regressed or persisted were 
compared. No significant cell type differences were found in any 
of the three groups of HFV lesions. The ratio of helper to 
cytotoxic cells was least in the lesions that progressed but not 
significantly less than in the other two groups. Only three 
lesions progressed. The percentage of helper cells was similar in 
all three groups, the lesser ratio in the progressive lesions 
being due to increased cytotoxic/suppressor cells. Again Syrjanen 
et al. speculate on the role of suppressor cells acknowledging 
that the currently available monoclonal antibodies are unable to 
separate suppressor cells from those with effector functions. More 
recently Syrjanen et al. (1985) reported an inverse relationship 
between the infiltrate and progression of HPV associated lesions 
but no major differences in the infiltrate were seen comparing the 
HFV/CIN lesions with those showing CIN only.
This group have also examined prospectively the possible 
contribution of natural killer cells with Leu 7 phenotype in a 
study with mean follow up of 16 months in virus only and CIN/HFV 
lesions (Syrjanen et al. 1986). They concluded that there was no 
relation between the degree of CIN and NK cells in the associated 
infiltrate and no relation between NK cells in the lesions that
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progressed, regressed or remained static.
In these last four papers the authors made no attempt to 
distinguish the intraepithelial from the stromal infiltrate. The 
prospective studies too are difficult to interpret in view of the 
effects of biopsy on the natural history of HFV and intra­
epithelial neoplasia.
Summary and interpretation of current literature (Table 1 p. 68)
It appears that Langerhans' cells are a consistent component 
of the cervical epithelium as identified by light microscopy using 
various staining techniques, and by transmission electron 
microscopy. Similar significance has been attached to their 
presence in cervix as in skin, acting as the peripheral outpost of 
the immune surveillance system. The Langerhans' cell population 
appears equally distributed in the ectocervix and normal 
transformation zone when different methods for their 
identification are used but quantitative data comparing the 
Langerhans' cells of normal ectocervix and normal transformation 
zone from the same patient has not been presented.
In the small number of patients so far examined, Langerhans' 
cells are reduced where there is histological evidence of HFV 
infection alone, however, the reduction has not been quantified in 
all studies.
Where there are no histological features of HFV associated 
with CIN the Langerhans' cell population appears to be increased. 
Quantification of the increase has only been attempted in three 
studies which include a total of 28 cases. Included in this number 
are seven patients whose lesions were associated with underlying 
invasive carcinoma.
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In combined HFV/CIN lesions reduced or virtually absent S-100 
positive Langerhans' cells are reported. Normal controls are 
absent in one of the two studies which together total 60 patients.
Where comparative analysis has been performed all 
investigators have used a separate normal control group. None have 
attempted to use an internal control such as the ectocervix for 
comparison with the lesional number of Langerhans' cells. An 
internal control would appear to be desirable since the variation 
in Langerhans' cells even in the normal population can be as much 
as 100 fold depending on the method used. Internal control 
biopsies also eliminate the possible effects cofactors in cervical 
neoplasia such as smoking, exposure to semen and contraceptive 
habits.
Available evidence suggests T-cell mechanisms predominate in 
the cervix and B lymphocytes appear to have little importance in 
the normal or abnormal cervix. The predominant lymphocyte subtype 
in cervical epithelium is the cytotoxic / suppressor group of 
T-cells. There is disagreement on the proportions of helper and 
cytotoxic / suppressor T cells in the epithelium but 
quantification studies are limited. It is suggested that HFV 
infection with or without CIN is associated with decreased 
intraepithelial lymphocytes, especially the T-helper subgroup. A 
reduction in epithelial lymphocytes is suggested in HFV infection, 
and an increased lymphocytic infiltrate in pure CIN. The 
prognostic significance of the lymphocytic infiltrate has not been 
established but prospective studies may add little further 
information since it may be argued that the biopsy required for 
immunohistochemical studies is likely to influence the natural 
history of CIN by itself.
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Table 1. Langerhans' cells in cervical epithelium - sumnary
Author Normal Cx Abnormal Cx Comments
Tz NS Ecto V CIN CIN+V
Figueroa 3 Epithelial sheets
(1980) Tz not mentioned 
increased Lc's near 
ext os
Caorsi 3 Increase X3 vs
(1984) normals
overlying Ca Cx
Caorsi 2
(1986) 4 patients with Ca Cx 
increase Lc's with 
grade of CIN
MacLean Yes increased
(1984b) no quantation
Morris (10) 2 normal pre & post
(1983a) menopausal patients 
Tz = ectocervix
Bjercke 19 1-3% of epith cells
(1983) Class II
Morris 5 adjacent to abnormal
(1983b) 4
3
reduced
increased
Class II epith + ve 
no quantiation
Morris 4 Class II pattern
(1983c) 4
6
3
examined-no Lc's 
quantitation 
Class II epith +ve
Edwards 15 Tz = ectocervix
(1985)
Di Girolamo 4 ATP-ase
(1985) (9 patients) colposcopically
abnormal ep it Im­
mature TZ = ectocx
McArdle 46 13 no 'normal' patients
(1986)
14
21
20
Tz = ectocx 
S100-100 fold range 
decreased vs ectocx 
increased vs ectocx 
similar to ectocx
Tay Study 1 20 S100-10 fold range
(1987a) 30 absent Lc's in 63.3%
normal Lc's adjacent 
to lesions
Study 2 6 Sl00/T6/Class II/ATP
5
14
Class 11-60% T6/ATP 
SlOO-35% T6/ATP 
decreased vs normals 
decreased vs normals 
Lc's no relation to 
grade of CIN
Key: Tz=transformation zone NS=origin not stated Ecto-ectocervix 
V=virus only CIN=CIN only CIN+V=combined CIN & virus 
ALL NUMBERS REPRESENT NUMBER OF PATIENTS/BIOPSIES STUDIED
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Aims of this thesis
1) To elaborate on the distribution of Langerhans' cells in the 
normal cervix by different staining techniques. To assess any 
differences between techniques and utilise further the method 
giving the most reliable and consistent results.
2) To examine the distribution of Langerhans' cells in CIN alone 
and in CIN with associated histological features of virus 
infection in sufficient numbers of patients to allow meaningful 
statistical analysis and interpretation of the results. To 
determine if the distribution varies in the typical and 
atypical transformation zone, and to compare the atypical 
transformation zone with internal control biopsies of adjacent 
normal ectocervix.
3) To compare the distribution of Langerhans' cells in CIN, where 
the presence or absence of wart virus infection has been proven 
by the sensitive and specific method of DNA DNA hybridisation, 
with internal control biopsies to examine any effects of 
specific HPV subtypes.
4) To assess whether or not immunosuppression alters the 
Langerhans' cell numbers by examining patients compromised 
naturally in pregnancy and by systemic immunosuppressants 
following renal transplantation. In addition, to examine the 
Langerhans' cells in a group of patients prior to possible 
renal transplantation, on peritoneal, haemodialysis and in 
chronic renal failure and to screen colposcopically and 
cytologically the immunocompromised female transplant recipient
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and her pre-transplant counterpart for evidence of CIN and wart 
virus infection.
5) To examine the Langerhans' cell distribution in early invasive 
squamous cancer of cervix (stages la, lb & Ila).
6) To examine other aspects of the local immune response in 
association with Langerhans' cell numbers.
7) Using these observations to examine further the role of the 
Langerhans' cell in the cervix with special regard to its role 
in cervical neoplasia.
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Chapter 2
Techniques evaluated to demonstrate and count Langerhans' cells
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Chapter 2
Introduction
Prior to commencing this study, published work on Langerhans' 
cells in skin and cervix suggested that the most suitable methods 
for their demonstation required frozen sections for staining with 
a monoclonal antibody to T-6 antigen or ATP-ase. Epithelial 
sheets had been used with a zinc-iodide-osmium method. S-100 had 
been used on routinely processed skin.
Normal cervix was examined to detect Langerhans' cells using 
the methods described in this chapter, the details of which are 
described in Appendix I(p. 243-250). The recruitment of normal 
patients is described in chapter 3. Initial experiments were 
designed with the following aims:
1) to find the most appropriate method of preparation of
cervix for cutting frozen sections
2) to compare the various methods for Langerhans' cell
identification taking into account the effects of 
storage of tissue, and to evaluate different 
methods of enumeration
3) to establish the most appropriate methods for examining
the Langerhans' cell population in the various 
study groups to be examined.
Tissue for frozen section staining
i) Collection and freezing of tissue
Following removal of the cervix from the fresh hysterectomy 
specimen, 5-10 millimetre blocks of cervix were cut from the 
endocervical canal through the transformation zone to the
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Figure 1.
Sellotape modified microtome chuck (a) with hysterectomy specimen 
embedded in OCT above; paired cervical biopsies embedded in OCT
b).
ectocervix. This was most easily performed on the 'opened' cervix.
Initial specimens were transported to the laboratory for 
freezing but best results were obtained with snap freezing in the 
operating theatre followed by transportation to the laboratory in 
a Dewar Flask. Three methods of freezing were evaluated:
a) specimen placed on microtome chuck in a bath of 00 2 ice 
and acetone, and embedded in ice
b) specimen embedded in Tissue-Tek II (XT Compound (Lab Tek 
Products) and snap frozen onto a microtome chuck in liquid 
nitrogen vapour
c) specimen embedded in (XT and snap frozen onto a microtome 
chuck held between blocks of CC^  ice.
The last method produced the most consistent results. This 
was confirmed for the smaller punch biopsies. The time taken for 
the OCT to freeze allowed optimal orientation of the tissue and 
removal of obscuring blood. A similar method has been employed and 
reported by Fletcher, Smart & Livingstone (1985) in optimally 
freezing punch biopsies of cervix for rapid diagnosis in a 
colposcopy clinic. A modification of the microtome chucks with 
Sellotape overcame the problem of embedding the larger blocks from 
hysterectomy specimens in OCT (Figure 1). 'Small' specimens such 
as punch biopsies were of dimensions up to 8X8X3 millimeters and 
large specimens obtained from hysterectomy specimens up to 20X20X8 
millimeters.
Freezing in liquid nitrogen gave similarly good results with 
larger specimens. Cutting of these deeply frozen blocks was, 
however, often difficult due to chattering of the block on the 
microtome knife, a problem less frequently encountered following
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the slower, less profound freezing with C02 ice. Re-orientation of 
specimens in liquid nitrogen vapour is virtually impossible when 
compared with CC>2 ice. C02 ice is also more easily transported and 
handled than liquid nitrogen.
Freezing in OCT proved more satisfactory than freezing in 
distilled water for several reasons. Water produced more ice
artefact, distorting and ballooning cells. It did not allow
re-orientation of specimens due to rapid freezing and did not 
permit easy flattening of thin cryostat sections as was the case 
with OCT. Additionally the rapid freezing of the water made
complete embedding of the larger specimens obtained from
hysterectomy specimens very difficult.
ii) Cutting frozen sections
All cryostat sections were cut on a Bright 5030 microtome.
Trial and error revealed the optimal temperature for cutting 
to be -20°C.
The thickness of section was varied according to the method 
of staining used. Seven micron sections were optimal for 
monoclonal antibody techniques but thicker sections, 20 microns, 
were required for ATP-ase methods. Initial experimentation with 
the thickness of sections revealed that thin sections gave the 
best cellular detail. Seven micron sections represent a compromise 
between thinner sections which are technically very difficult to 
cut and thicker sections in which some cellular detail is 
obscured. Twenty micron sections were used for ATP-ase methods as 
thin sections did not give such good Langerhans' cell definition 
due to their lesser content of cell membrane.
The quality of sections obtained improved with the operator s 
experience. It was also dependent on the quality of microtome
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blade available. Initial sections were cut on 'old' blades but it 
rapidly became evident that this was unsuitable. The availability 
of disposable blades led to a marked improvement in quality. 
Larger blocks had to cut on reground solid blades as they scored 
and distorted the thinner disposable blades. Cutting of larger 
blocks was further improved by removing excess fibrous stroma from 
the specimens.
The best sections were obtained when the specimens were cut 
with the cervical epithelium at right angles to the knife. This 
produced less traumatic artefact to the epithelium and gave a 
larger area for staining and examination.
Up to 20 serial sections were cut from each block at any 
particular level. They were collected on gelatinised slides to aid 
adhesion and prevent 'floating' during staining. The slides were 
numbered appropriately. These were allowed to air dry and stored
at -20°C until use. A minimum of three sections at each level were
stained with haematoxylin and eosin to allow histological 
diagnosis and comparison of quality with the routinely processed 
specimens.
Methods employed for demonstration of Langerhans' cells
1) Indirect immunoperoxidase method (using monoclonal 
antibody to anti-Human Thymocyte Antigen (NA 1/34), Sera Lab -
modified from MacKie (1982); see Appendix la (p. 243) for full
description of method).
MacKie (1982) described a method for immunoperoxidase 
staining of frozen sections of skin which, with the following 
minor modifications, produced consistent results on frozen 
sections of cervix.
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Figure 2.
Langerhans' cells stained with NAl/34, and diaminobenzidene as 
the chromogen, in normal cervix.
The brown staining cell bodies are fairly uniformly distributed 
in the lower third of the epithelium (e). The basement membrane 
is shown (b) and the stroma (s).
Total magnification X 362.
Hydrogen peroxide is used to remove endogenous
peroxidase activity. Seven per cent H202 proved unsatisfactory as 
cervix contains more peroxidase activity than skin. Its use 
resulted in sections that were greatly disrupted by oxygen 
released from the reaction. This effect was most marked in larger 
sections. Three per cent H2C>2 was found to be ideal, although 
longer incubation was required. Fifteen minutes was found to be 
adequate.
Cervix contains mucus secreting 'glands' not present in 
skin. This mucus frequently caused non-specific positive staining, 
this was reduced by prolonging the incubation with normal rabbit 
serum to 20 minutes.
In practise the method is relatively free of complication but 
is labour intensive. Forty slides could be comfortably stained in 
one session. The dilution of the primary and secondary antibodies 
had been established by Dr M Turbitt. Since the same technique was 
being used in the laboratory by other workers, cross-checking of 
staining patterns was easily performed.
Diaminobenzidene (DAB) was the chromogen most frequently used 
to demonstrate the monoclonal antibody reaction. It is 
carcinogenic and has to be treated with care. It is made up in a 
fume cabinet. Pelliniemi, Dym & Karnovsky (1979) described a 
method that allows batches to be made and stored in aliquots which 
can be subsequently thawed for use when required.
DAB gives a brown reaction product (Figure 2). The main 
benefit of using DAB is that once stained, dehydrated and mounted 
the preparation is permanent allowing sections to be stored for 
examination.
Another commonly used method to demonstrate the antibody
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Figure 3.
Langerhans' cell stained with NA 1/34, and APAAP and Fast Red 
Salts as the chromogen, in normal cervix.
The cell body is indicated with dendrites extending into the 
epithelium (e). A granular deposit results with the Fast Red 
Salts. The basement membrane is indicated (b).
Total magnification X 1450.
antigen reaction is alkaline phosphatase complex (APAAP). This 
method allows amplification of the process by repeating the steps 
using the uncongugated rabbit antimouse antibody and APAAP complex 
(Cordell et al. 1984).
The final reaction product can be red (Figure 3) or blue 
depending whether fast red or blue salts are used. The use of the 
salts leaves a granular deposit. The sections can only be 
counterstained lightly with haematoxylin, and slight over staining 
cannot be removed. Sections have to be water mounted resulting in 
a preparation which is less permanent than DAB. The technique is 
also more time consuming, with no better Langerhans' cell staining 
resulting.
The specificity of the monoclonal antibody NA 1/34 is good 
with no other epithelial cell staining positively (Figures 2 & 3).
The demonstration of Langerhans'cells with the APAAP method 
offers no real advantages over DAB after initial labelling with NA 
1/34. The methods can be successfully combined in immunoperoxidase 
doubles eg. to demonstrate Langerhans' cells and helper T-cells in 
the same section. APAAP was also used to demonstrate Langerhans 
cells in an ATP-ase, NA 1/34 double method when the brown reaction 
product of the DAB would have been difficult to distinguish from 
the black of the ATP-ase.
2) Control Sections
Despite the apparent specificity of NA 1/34, multiple 
sections were stained together with at least one control known to 
be positive. Negative controls consisted of substituting other 
monoclonal antibodies for NA 1/34 in the primary incubation. The 
primary antibody was also omitted from one section. In practise 
negative controls were rarely of any practical use such is the
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specificity of the Langerhans' cell staining.
Before a new batch of any antibody was used it was compared
with the one in use. Details of the Langerhans' cell marker and
other antibodies used are shown in Table 2.
Table 2. Monoclonal antibodies utilised in the study of 
Langerhans' cells and local cellular immunity in the cervix uteri.
Monoclonal CD Specificity & Comments
antibody Code
NA 1/34 1 Cortical thymocyte marker of T-6 antigen which 
has a molecular weight of 49,000 Daltons and is 
found on Langerhans' cells and dendritic cells 
in thymus and lymph nodes.
UCHT 1 3 Marker of T-3 antigen expressed on the cell 
membrane of T cells.
UCHT 4 8 Marker of T-8 antigen present on T cells 
exhibiting cytotoxic/suppressor functions.
OKT4a 4 Marker of T-4 antigen (60,000 Daltons) present 
on about 2/3 of circulating T cells including 
most T cells with helper/inducer functions.
OKMl 15 Marker of 170,000 Dalton antigen expressed by 
monocytes & granulocytes.
Leu lib Marker of 50-70,000 Dalton antigen expressed on 
Natural Killer (NK) cells and neutrophils.
Leu 7 Marker of HNK-1 antigen on cells with Natural 
Killer/Killer function
Leu 12 22 Marker of 130,000 Dalton antigen on B cells.
DA6 231 Marker of MHC class II antigen HLA-DR.
DA6 147 Marker of MHC class II antigen HLA-D.
W6/32 Marker of MHC class I antigens HLA A,B,C.
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Figure 4.
Langerhans" cells stained with ATP-ase in a frozen section. 
Cell bodies are indicated (b) with dendites (d) extending into 
the epithelium adjacent to a capillary (c).
Total magnification X 1450.
3) Other monoclonal antibodies used
The substitution of other monoclonal antibodies for NA 1/34 
in the indirect immunoperoxidase method means that a panel of 
antibodies can be utilised to stain neighbouring frozen sections. 
This gives the benefit of being able to identify other cellular 
components of the immune system. The monoclonal antibodies used 
and their specificities are shown above (Table 2) and further 
details in Appendix II (p. 251).
4) Adenosine Triphosphatase (ATP-ase)
Several different methods have been used that depend on 
ATP-ase activity of the Langerhans" cell for their demonstration. 
The most useful and reproducible was a modification of the Calcium 
Method for Adenosine Triphosphatase reported in Pearse (1968).
Twenty micron frozen sections of cervix, as previously 
described produced the best results. The technique is simply 
performed (Appendix Ie, p. 247). Forty sections are easily stained 
in one session.
The effect of incubation time was investigated as initial 
results showed no Langerhans" cells in cervix despite their 
demonstration in control sections of skin after 30 minutes
incubation. Sections were withdrawn from the incubating medium at 
15 minute intervals to a maximum of 180 minutes. Dendritic cells 
were best demonstrated in cervix after 90 minutes (Figure 4).
The most apparent drawback of a prolonged incubation time is
an increase in the ATP-ase activity of vascular endothelium in the
sections. This effect may obscure the Langerhans cell population. 
In addition at longer incubation times some non-specific
epithelial cell nuclear staining becomes evident.
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The cost of this method is considerably less than that of the 
monoclonal antibody technique. However, it is more liable to 
failure especially towards the end of the shelf life of the stock 
reagents. Difficulties controlling the pH were also encountered. 
These problems are not experienced with the monoclonal antibody 
method.
5) S-100
Reports that S-100 was a useful marker for Langerhans" cells 
in fixed blocks stored in paraffin appeared attractive as it would 
have obviated the need for the collection and cutting of frozen 
sections. In addition it would be possible to examine specimens 
retrospectively and specimens which were not suitable for frozen 
sections, such as cone biopsies taken to exclude the possibillity 
of early stromal invasion.
A technique was evaluated to attempt to demonstrate 
Langerhans" cells in fixed tissue and is described in Appendix Ig 
(p. 249) with the APAAP modification in Appendix Id (p. 246).
Initial results were very poor compared with NAl/34 in frozen 
sections from the same cervix despite the fact the inbuilt 
positive control (nerve fibres) were staining across a wide 
variety of incubation times, dilutions and temperatures.
Sections for S-100 staining were cut from routinely fixed 
blocks of cervix by Mr R Muir head of the Department of Pathology, 
Western Infirmary. Best results were obtained with 4 micron 
sections.
Pre-treatment of sections with trypsin was found to help. 
However, sections had then to be collected on poly-lysine coated 
slides to prevent trypsin digestion of gelatin that resulted in
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the sections floating from the gelatinised slides.
S-100 staining was attempted on frozen sections in the hope 
of giving a more direct comparison between anti T-6 staining and 
S-100 in adjacent serial sections of cervix. No staining, even of 
nerve fibres, was detected. Brief fixation of frozen sections was 
attempted with formalin, glutaraldehyde and periodate-lysine- 
paraformaldehyde. In no instance was any positive staining seen in 
the fixed frozen sections. The penetration of S-100 into tissue 
would seem to be dependent on long fixation which totally blocks 
the sensitive surface T-6 antigens on the Langerhans" cell. The 
loss of antigenicity is associated fixation and processing of 
tissue (Hsu, Raine & Fanger 1981).
Other disadvantages of using S-100 to identify Langerhans" 
cells are that only a small proportion of those stained with anti 
T-6 are identified by S-100. Additionally even in the same cervix 
there are only occasional areas that show any S-100 activity. This 
great variation is probably due to vagaries of fixation and 
especially of fixation time. The importance of a standardised 
fixation time for specimens for immunohistochemical studies is 
highlighted in a thesis being submitted to The University of 
Glasgow by Dr Iain Brown, Department of Pathology, Western 
Infirmary. None of the published studies reporting S-100 positive 
Langerhans" cells have attempted any such standardisation.
6) Other methods of tissue fixation for antibody staining
As a result of the inconsistent findings with S-100 an 
alternative aproach to studying fixed biopsies was evaluated. 
McLean & Nakane (1974) reported that periodate-lysine- 
paraformaldehyde could be used as a tissue fixative for material
page 81
subsequently to be stained with monoclonal antibodies. The 
advantages of a reliable reproducible method would have been 
considerable as specimens could have been used for routine 
processing and for immunohistochemistry, thus removing the need 
for frozen sections. A more extensive range of cervical pathology 
would also have been amenable to study, especially cone biopsy 
specimens including microinvasive carcinomas. Long term use of 
such a fixative would also have allowed retrospective analysis. 
Follow through to electron microscopy was also reported to be 
possible.
Traditional fixation causes loss of tissue antigenicity 
partly because of altered tertiary structure secondary to the 
formation of cross linkages. The conformational change limits 
antibody recognition of antigen. Paraformaldehyde, lysine and 
dichrornate were reported to offer a compromise between good
fixation and good ultrastructural preservation with retention of 
tisue antigenicity (McLean & Nakane 1974). No previous study had 
reported results of staining with an anti-T6 (CDl) antibody.
Various T and B cell markers had been successfully employed 
although none had been used on the cervix.
Solutions were prepared according to the method of McLean & 
Nakane (1974).
No Langerhans" cell staining was observed despite the good 
results in paired frozen sections when stained with NA 1/34.
Variations were tried with and without 5% potassium
dichromate and using various pH"s. Again the Langerhans" cells 
showed no T-6 activity in the fixed tissue (Appendix lb, p. 244).
Enzyme digestion was also performed as removal of some of the 
cross linkages can improve staining eg. S-100 (see above).
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Digestion with trypsin and pepsin produced no significant 
improvement.
Varying the antibody concentration, even the use of undiluted 
NA 1/34 produced no recognisable Langerhans" cell staining over 
incubation periods ranging from one hour to overnight.
Demonstration of the antibody antigen reaction was also 
attempted using the sensitive amplification APAAP method, although 
again without success.
Hand processing and low temperature wax embedding was also 
tried with no success before the technique was abandoned.
7) Effects of storage on Langerhans" cell markers
The blocks of tissue for frozen sections, both from 
hysterectomy specimens and from punch biopsies, were cut within 24 
hours of collection. As mentioned above the labelled slides were 
stored in a refrigerator at -20°C. The remainder of the biopsy 
specimen was removed from the microtome chuck and placed in a box 
labelled with the number of the specimen and date of collection. 
In case further sections were required the cut surface of the 
block was covered with a thin layer of OCT to prevent the specimen 
drying out.
Staining of sections with monoclonal antibodies was 
performed within one week of collection. However, the effects of 
storage on the cut sections was investigated comparing especially 
NA 1/34 and ATP-ase.
Paired sections from two specimens were cut at 7 and 20 
microns. Nine pairs of sections were cut to allow comparison of 
the staining patterns of NA 1/34 and ATP-ase over an eight week 
period.
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Results of this comparison showed slight loss and dispersal 
of membrane ATP-ase activity when compared to NA 1/34. The quality 
of the monoclonal antibody staining remained constant throughout 
the eight week period and showed little subjective loss in quality 
when stored for periods of up to 1 year.
8) Other Methods - Langerhans" cells in epithelial sheets
Preparation of epithelial sheets
In addition to orthagonal sections of cervix, epithelial 
sheets were prepared by tetrasodium ethylenediamine tetracetic 
acid (EDTA) chelation of calcium in biopsies. The observation of 
Langerhans" cells in such sheets allows their complete 
3-dimensional profile to be observed. The advantages of 
Langerhans" cell counting in such sheets are discussed later in 
this chapter.
Once collected the biopsies were placed in a "transport 
medium". Calcium and magnesium free Hanks Buffer was found to 
produce the best results.
After storage at 4°C for at least 1 hour, tetrasodium 
ethylenediamine tetracetic acid was added (Scaletta & McCallum 
1972). Following incubation at 37°C for 1 hour the epithelium 
could be stripped from the underlying stroma using fine forceps 
under the stereo dissecting microscope.
a) ATP-ase
Using sheets prepared in the above manner ATP-ase staining 
was performed using the method outlined in Appendix If, p. 248.
This proved a very satisfactory alternative method in large 
specimens (Figure 5). However, when smaller punch biopsies of
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Figure 5.
Langerhans" cells stained with ATP-ase in an epithelial sheet.
The cell bodies with dendrites are best seen on the right of the
figure. The full thickness of the epithelial sheet allows the 3-
dimensional profile of the Langerhans" cell to be studied by
adjusting the depth of focus.
Total magnification X 725.
cervix were prepared, there was often difficulty separating the 
epithelium due to presence of epidermidised cervical crypts in the 
transformation zone. Even when successful separation was acheived 
the presence of the epidermidised crypts made counting of the 
Langerhans" cells in superficial epithelium virtually impossible. 
In addition it is impossible to establish the exact histological 
diagnosis in the area where the Langerhans" cells have been 
counted, even allowing for examination of strips of epithelium 
from the edges of the specimen (Hawthorn & MacLean 1987b).
b) Anti T-6 antibody - NA 1/34
Following the separation of the epithelial sheets, monoclonal 
antibody staining of Langerhans" cells was attempted using a 
method modified from the indirect immunoperoxidase method 
described in Appendix la, p. 243. This method has been shown to 
work satisfactorily on suction blisters of skin. After incubation 
with EDTA, however, no Langerhans" cell activity was demonstrated 
in sheets of cervical epithelium.
c) Zinc-iodide-osmium
Caorsi & Figueroa (1984; 1986) reported a method, modified 
from Niebauer et al. (1969) for Langerhans" cell identification in 
separated epithelial sheets, which was suitable in their hands, 
for examination at light and at transmission electron microscopy. 
No consistent staining of any kind was seen even with light 
microscopy and the method was abandoned.
9) Transmission electron microscopy
One millimetre cubes of cervical epithelium were cut from 
normal cervix and fixed in 2.5% glutaraldehyde. They were post 
fixed in 2% osmium tetroxide in Sorensen s phosphate buffer (pH
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Figure 6.
Birbeck granules in a Langerhans" cell from cervix.
The Birbeck granules with their characteristic racket-shaped 
heads are indicated in the electron micrograph.
Total magnification X 63,000.
7.38), before being dehydrated through alcohol to propylene oxide 
and embedded in araldite. Thick sections were stained with 
toluidine blue to identify the suprabasal layers where Langerhans" 
cells were thought most likely to be found. Appropriate thin 
sections were then cut on an LKB ultratome 1, double stained with 
uranyl acetate and lead citrate before being viewed in a Phillips 
EM 301 G microscope. The processing for EM was supervised by Mr T 
Downie, Department of Pathology, Western Infirmary, Glasgow.
Birbeck granule containing cells were identified in several 
of the specimens examined (Figure 6). The small sample size 
capable of being examined with EM meant that Langerhans" cells 
were not always observed. The Birbeck granules were seen mainly in 
relation to the Golgi apparatus and were not uniformly distributed 
through the cytoplasm. This too could account for the sampling 
errors experienced.
10) Electron microscopy following other methods
In attempts to specifically identify Langerhans" cells by 
methods described above, progression from T-6 antibody and ATP-ase 
was attempted.
a) Indirect immunoperoxidase
The method for progression from monoclonal antibody staining 
is shown in Appendix lh (p. 250). This was adapted from several
papers which had used electron microscopy to identify specifically 
other cells stained with monoclonal antibodies (Foidart et al. 
1980; Holden, Morgan & MacDonald 1982; Mutasim et al. 1985).
The method used followed the first steps of the indirect 
immunoperoxidase technique described in Appendix la . Following 
the reaction with DAB the sections were fixed in glutaraldehyde.
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The stroma underlying the epithelium was then removed with a 
scalpel using a stereo dissecting microscope. This maximised the 
area of epithelium available for ultrastructural examination. Post 
fixation in osmium tetroxide served to enhance the DAB reaction.
Langerhans cells could be identified in the sections 
following fixation and before sectioning for EM. Unfortunately, 
the intracellular ultrastructural detail was insufficiently 
preserved to allow Birbeck granule observation. Even after initial 
cryoprotection with sucrose impregnation, Birbeck granules were 
not detected. Holden et al. (1982) were able to demonstrate 
Birbeck granules in T-6 positive cells employing a similar method.
b) ATP-ase
Hanau et al. (1986) described a method allowing progression
from ATP-ase to EM. Separated sheets of epithelium were used. Once 
again Langerhans" cells could easily be identified before EM 
processing, but due to poor cellular preservation Birbeck granules 
could not be demonstrated in positively stained cells.
Quantitation of Langerhans" cells
There have been various methods used to quantitate cells in 
tissue sections. Where the cells are in the epithelium the
simplest method would be to use a standard length of epithelium 
eg. 1 mm. This would be a useful, reproducible method if the
epithelium were perfectly flat or undulated in a regular fashion. 
When considering the cervix, the ectocervix has a relatively 
smooth basement membrane and the numbers measured per linear 
millimetre of epithelium would be expected to correlate more
closely with the numbers measured per millimetre length of 
basement membrane. This relationship would not hold where the
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basement membrane was subject to marked undulations. The 
transformation zone of the cervix lies between the "last gland" 
and new squamocolumnar junction and is characterised by the 
presence of epidermidised cervical "glands" (Burghardt 1976). The 
basement membrane elongates greatly round these gland crypts and 
to make valid measurements the length of the basement membrane 
would require to be measured.
A more logical approach is to use an easily measured segment 
of basement membrane. A recognised method is to use the basal 
cells as the denominator and make the counts relative to a given 
number of basal cells. In the laboratory where this work was 
performed the standard length of basement measured is 200 basal 
cells (MacKie & Turbitt 1983; Ashworth, Turbitt & MacKie 1986). 
This is suitable for skin but in cervix the areas of abnormality 
eg showing viral features may be limited to very small areas. In 
addition the time taken to accurately count 200 basal cells is 
considerable. At higher power magnifications the slide has to be 
moved on the microscope stage thus interrupting the count. These 
are lesser problems when measurements are taken per 100 basal 
cells. The disadvantage of this method is the time involved in 
counting the 100 basal cells. The basal cells were counted with a 
hand counter from a mark on a calibrated eye-piece and the mark of 
the 100th cell was noted.
An Olyirpus BHS 312 microscope, with a photomicrography unit 
attached, was used to record and confirm the findings throughout 
the studies. The Langerhans" cell bodies were most easily counted 
over the 100 basal cells at 250 times magnification.
The Langerhans" cells were counted in representative areas of 
each specimen. The modal count was used where there was less than
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two cells variation per 100 basal cells in five fields. Where any 
marked variation was obvious (2 or greater cells difference per 
100 basal cells in 5 fields) the count was made in up to 10 areas 
and the mean value chosen for statistical analysis. Only definite 
cell bodies were counted in epithelium which showed a good basal 
array in areas cut at right angles to the surface.
In the normal cervices the transformation zone and ectocervix 
were identified as above using the "last gland" as the boundary. 
Where abnormal biopsies were being evaluated appropriate areas 
were identified in adjacent haematoxylin and eosin stained 
sections.
Observer errors in Langerhans" cell counts per 100 basal cells
The results of inter and intra observer variation are shown 
in Table 3 & 4. The intra-observer variation was calculated using 
the same field of transformation zone counted on two occasions one 
month apart in the 25 normal patients described in the next 
chapter. An assessment of the inter-observer variation was made by 
two observers counting Langerhans" cells simultaneously using a 
"double headed" microscope (Table 4). The frequency of the 
difference between the two counts are shown for the specimens with 
low and high numbers of Langerhans" cells.
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Table 3. Intra-observer variation in Langerhans' cell (LC) counts 
per 100 basal cells.________________________________________
Intra-observer differences
-2 -1 0 +1 +2
low Lc counts 
(7/100 or less)
9 1
high Lc counts 
! (8/100 or greater)
7 7 1
Table 4. Inter-observer variation in Langerhans' cell (LC) counts 
per 100 basal c e l l s , ____________________________________
Inter-observer differences
-2 -1 0 +1 +2
low Lc counts 
(7/100 or less)
1 8 1
high Lc counts 
(8/100 or greater)
3 3 4 4 1
It can be seen from the two tables that the variation in 
Langerhans' cell counts per 100 basal cells is related to whether 
there are low or high counts. At low numbers there was no 
difference in the counts by the same observer in 90% of the cases, 
and between observers there was no difference in 80% of the 
cases. Where there are higher numbers the correlation is less good
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with 7 of 15 cases counted by the same observer showing no 
difference and only 4 of the cases between observers showing no 
differrence. Despite the variation dependent on the native 
population of Langerhans' cells, with the same observer making the 
counts there was no instance where there was more than one cell 
difference.
Langerhans' cell counting in epithelial sheets
In epithelial sheets the measurement of the denominator is 
simpler and the counts are usually recorded per square millimetre 
of epithelium. Using the above equipment and a calibrated square 
counting grid in the eye-piece Langerhans' cells were quantitated 
per square millimetre.
The dendritic processes could be followed through the
epithelium and the cell bodies were easily identified. The counts
were made in small marked squares, Langerhans' cells lying on or
partly on the top and right border of each square were excluded
but those lying on or partly on the left and bottom borders of
each square were included. The small squares of the graticule
?
represent 1/625 mm *
The presence of epidermidised cervical crypts in the
separated sheets of transformation zone made counting the
Langerhans' cells almost impossible due to the three dimensional
distortion caused. The difficulties in achieving adequate
separation of the epithelium from the stroma have been previously 
mentioned. This technique therefore proved inadequate for
assessing the Langerhans' cell distribution in biopsies from 
abnormal transformation zones. Quantitation was possible in normal 
transformation zones obtained from the larger hysterectomy
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specimens (see chapter 3).
Langerhans' cells counts by image analyser
Computer assisted methods for Langerhans' cell enumeration in 
skin and cervix have been reported by several investigators. The 
counting involves a method of enhancing the cell staining to 
enable the computer to identify the cell population under 
scrutiny.
In the specimens used in this study this involved separating 
the blue counterstain from the brown of the diaminobenzidene 
reaction product. This was not easily accomplished as the image 
analyser available utilised a grey scale. Blue filters were used 
to absorb the light from the counterstained areas and this served 
to enhance the contrast between positive and counterstained cells. 
The filters were not always effective as any densely 
counterstained areas often registered above the threshold of 
detection thus artificially increasing the cell counts. The 
sensitivity of detection is easily varied and a suitable 
compromise was selected. This invariably involved some cells 
marking as three or four images while other cell bodies marked as
one. A control field was counted at the start and end of each
session and every hour to ensure no great changes in the
sensitivity of the system.
The great advantage of such a system is that large numbers of 
fields from many specimens can be rapidly evaluated. In all cases 
Langerhans' cells in 30 epithelial fields were evaluated. This 
method, although attractive, does not remove the possibility of 
observer bias but this is reduced by making multiple meaurements.
The analyser allows variation in the area from which the
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counts are made, and this area remained constant throughout the
analysis. All results have been standardised to express the
Langerhans' cell count per unit area of cervical epithelium (0.15 
2X 0.15 cm ). The thickness of the cervical epithelium rarely
exceeded 0.15 cm.
In this study an Optomax CPU 1 image analyser was used. This 
equipment is housed in the Department of Opthalmology, Western 
Infirmary and is available for use by many collaborating
departments. The image analyser was interfaced with a Hewlett
Packard 9815A calculator on which the programmes for cell counting 
were designed. The mean cell count per specimen has been used for 
statistical analysis and the results from a selection of biopsies 
are presented in the relevant chapters to provide a comparison 
with the results of the counts made per 100 basal cells.
Image analyser quantitation of the lymphocytic infiltrate
Previous work from the Department of Dermatology had shown up 
to 30% inter-observer variation when the lymphocytic infiltrate 
had been evaluated subjectively (Turbitt, personal communication). 
Some of the disadvantages of using the image analyser have been 
discussed above, but this technique was most useful in allowing 
quantitative assessment of the lymphocytic infiltrate. The major 
limiting factor in performing this part of the study was the 
qualitative differences in cell staining patterns found with the 
T3, T4 and T8 antibodies. The T4 (helper cell) marker produces a 
less dense, frequent pericellular DAB deposit in comparison with 
the more uniform dense deposits found with the other two 
antibodies. T3, T4 and T8 antibodies were used on adjacent frozen 
sections from each biopsy to limit sampling variation. Only the
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specimens showing least variation in positively stained cells were 
used.
In performing the assessment of the infiltrate the total area 
of positive staining per unit area was used and not the actual 
cell (pixel) count as used to assess the Langerhans' cells. The 
Optomax CPUl is better able to measure actual areas than cell 
counts where there are confluent areas of positive staining as in 
the stromal lymphocytic infiltrate.
The stromal infiltrate was most frequently concentrated in 
the area immediately below the basement membrane and all counts 
were made in the stroma within 0.15 cm of the basement membrane. 
The infiltrate was quantified in the epithelium up to 0.15cm above 
the basement membrane. The staining with the pan T (CD3) 
monoclonal antibody was used as an indicator of the total 
lymphocytic infiltrate in both the epithelium and stroma. 
Comparisons with this value were made to allow calculation of the 
percentages of the helper and cytotoxcic/suppressor components of 
the infiltrate in both areas. The percentages of T4 and T8 cells 
in the epithelium and stroma and the actual 'numbers' of each and 
the total infiltrate as represented by the areas of positive 
staining have been used for statistical analysis.
Subjective quantitation of other components of the cellular 
infiltrate
Macrophages and natural killer cells were rarely encountered 
and image analysis was not attempted. They were scored on a 
subjective basis from negative to very heavy. In practice these 
cells were rarely present in any significant numbers.
Class I and II epithelial antigen staining patterns were
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classified according to a basal, two thirds or full thickness and 
negative or diffuse epithelial staining patterns respectively. See 
Figures 7 and 8 (p. 125) for examples. Class II positive
Langerhans' cell were counted in the normal cervix (chapter 3).
Statistics
Advice on statistics was given by Dr Tom Aitchison, 
University Department of Statistics, Glasgow University. Analysis 
was performed using SPSS-X, through the Department of Computing, 
Glasgow University. Non-parametric tests have been used where 
there are small numbers of cases, but the majority of analyses 
have been performed using statistical tests for normally 
distributed data. Most data analysis has been performed to provide 
the mean, standard deviation of the mean and the 95% confidence 
interval of the mean. The comparison of data has been interpreted, 
in the main, using the confidence intervals of the mean to 
establish differences between the groups analysed. Where multiple
comparisons have been performed, appropriate corrections for such
analyses have been employed thus avoiding multiple T-tests.
In chapters 4 and 5 where internal control data has been used 
to provide comparative analyses, the same principal of employing 
confidence intervals has been utilised for presentation of data. 
In these paired analyses the confidence intervals of the mean 
differences in Langerhans' cell counts between normal and abnormal 
biopsies are presented. If the confidence intervals of the mean 
differences do not cross '0' this implies a significant
difference between the Langerhans cells in the two areas.
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Chapter 3
Langerhans' cells and local immunity in the normal cervix
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Chapter 3
Introduction
The normal cervix was examined by the methods previously 
described to detect Langerhans' cells. This allowed comparison of 
methods quantitatively and qualitatively, and gave data for 
comparison with the abnormal cervix. Some of the results and 
conclusions from the methods evaluated are presented in the 
preceeding chapter. This chapter describes the morphological 
features and distribution of Langerhans' cells in two areas of the 
cervix, namely the ectocervix and transformation zone. The 
transformation zone of cervix is the area in which neoplastic 
change occurs. One of the aims of this chapter was to establish 
any differences in the Langerhans' cell population between the 
ectocervix and the transformation zone, comparing various methods, 
in the hope of being able to use the Langerhans' cell count in 
the ectocervix as an internal control in later parts of the study. 
The published data suggest that there are no differences between 
the two areas but no author has directly compared the results from 
the ectocervix and the transformation zone of the same patients.
Materials
Specimens were collected initially from patients undergoing 
hysterectomy for reasons other than disease of cervix; none had 
any evidence of malignancy. All had had prior smears within 6 
months which were reported as normal, and subsequent normal 
histology on routine examination and on histology from frozen 
sections (see Appendix Ilia, p. 253).
Punch biopsies of cervix were later used from patients 
undergoing laparoscopic sterilisation. All had normal cervical
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cytology within six months and normal histology on frozen section 
examination. Hospital 'Ethical Committee' approval had been 
granted and informed, written consent was obtained from all 
patients having cervical biopsies taken. Twenty-five cases had 
specimens taken from the transfomation zone; of these a paired 
sample of ectocervix was available in 20 cases. Five patients 
were postmenopausal. Biopsies of vagina and vulva were also 
obtained with written consent from nine patients undergoing 
surgery.
Methods
The methods for mounting the blocks from the hysterectomy 
specimens and punch biopsies have been discussed in chapter 2.
The main staining methods employed were the monoclonal 
antibody technique (using NA 1/34 and Class II antibodies) and 
ATP-ase. ATP-ase staining was performed on 20 micron frozen 
sections and on separated sheets of epithelium from ectocervix and 
transformation zone. S-100 staining was also attempted.
The Langerhans' cell counts were made as described for each 
method in Chapter 2.
Results
Transformation zone and ectocervix
a)NA 1/34
No significant differences were found using the paired T-Test 
to directly compare the Langerhans'cell numbers in the ectocervix 
and transformation zone of each patient for the three denominators 
shown in Table 5.
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Table 5. Paired T-Test comparison of NAl/34 positive Langerhans' 
cell numbers in normal ectocervix (ecto) & transformation zone 
(Tz) counted per 100 basal cells (/100), linear millimetre (/mm) &
Count Area Cases Mean SD SE Diff Corr Siq
ecto 8.2 2.9
/100
Tz
20
8.0 3.4
0.46 0.80 0.66
ecto 17.9 7.6
/mm
Tz
17
15.9 5.9
1.18 0.77 0.11
ecto 13.32 3.11
/area
Tz
20
12.83 3.35
0.61 0.65 0.43
NOTE. Mean & SD of mean are of the individual group cell counts.
SE Diff (standard error of the mean difference), Corr
(correlation) and Sig (significance) relate to the mean difference
between the numbers in each paired analysis. A positive
correlation indicates that pairing decreases the mean difference.
The larger the correlation coefficient the greater the benefit of
pairing.
When the individual biopsies from typical transformation zone 
and ectocervix were taken as two separate groups, no significant 
differences were found with measurements were made per 100 basal 
cells (Table 6) or per unit area (Table 7). The mean number of 
Langerhans' cells and 95% confidence intervals are shown. Results 
of Langerhans' cell counts per 100 basal cells taken from vagina
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and vulva are also included in Table 6. One-way analysis of 
variance shows significant differences between the numbers in 
cervix and the numbers in vagina and vulva (F.ProbCO.OOOl). The 
cervix contains intermediate numbers. Image analyser counts per 
unit area of epithelium are shown in Table 7 and confirm the 
similarities between the normal ectocervix and transformation 
zone.
Table 6. Analysis of variance of NA1/34 positive Langerhans" cell 
counts per 100 basal cells in normal ectocervix (ecto), 
transformation zone (Tz), vulva and vagina._____________________
Area Cases Mean SD Min Max 95% Confidence Intervals
Tz 25 8.0 3.1 3 16 6.7 to 9.2
Ecto 20 8.2 2.9 3 13 6.8 to 9.6
Vagina 9 4.7 1.6 3 8 3.5 to 5.9
Vulva 9 12.6 4.5 6 23 9.1 to 16.0
Table 7. Analysis of variance of NA1/34 positive Langerhans" cell 
counts by image analyser in normal ectocervical (ecto) epithelium 
and transformation zone (Tz),_________________________________
Area Cases Mean SD Min Max 95% Confidence Intervals
TZ 25 12.43 3.30 7.2 18.8 11.07 to 13.80
Ecto 20 13.32 3.11 . 7.9 19.2 11.86 to 14.78
NOTE Tables 6 & 7. Mean & SD are of the cell counts in each group. 
Min and Max are the minimal and maximal counts respectively. The 
95% confidence intervals of the mean cell counts are shown.______
b)ATP-ase
Paired T-Test comparisons of the number of ATP-ase positive
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Langerhans cells per 100 basal cells and per square millimetre 
separated epithelium of normal ectocervix with those of the 
transformation zone (Table 8) show no significant difference in 
numbers between the two areas. This concurs with the results of 
paired analyses using the monoclonal antibody NA 1/34 to 
demonstrate Langerhans' cells (Table 5).
A beneficial effect of pairing the data is again shown with 
positive high correlations decreasing the variability of the mean 
difference.
Table 8. Paired T-Test comparison of ATP-ase positive Langerhans'
cells in normal ectocervix & transformation zone counted per 100
2
basal cells(7100) & per square millimetre ( / m m - ) _____________
Count Area Cases Mean SD SE Diff Corr Siq a
ecto 8.4 3.3
/100 8 0.74 0.78 0.28
Tz 9.2 2.4
ecto 595.0 42.8
/mm2 5 28.07 0.42 0.29
Tz 628.6 67.2
See Note Table 5 p. 99.
Pre and postmenopause
The Langerhans' cell population in the ectocervix and
transformation zone were compared in the pre and postmenopausal 
patients. No significant differences were detected between the 
two areas within each group of patients pairing the data for 
analysis (Table 9). Comparing the results from transformation
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zone and ectocervix of the premenopausal with the post menopausal 
patients there are no significant differences in either area of 
cervix (p=1.00, p=0.66 respectively) between the two groups.
Table 9. Paired T-Test comparison of NAl/34 positive Langerhans' 
cells in ectocervix & transformation zone of pre & postmenopausal 
patients counted per 100 basal cells (/100) . ________________
Group Area Cases Mean SD SE Diff Corr Sig
ecto 8.2 3.2
pre
Tz
15
8.2 3.4
0.53 0.82 1.00
ecto 8.2 2.2
post
Tz
5
7.4 3.6
0.97 0.83 0.46
See Note Table 5 p. 99.
Correlation between methods used
There is good correlation between the numbers of Langerhans' 
cells in the transformation zone stained by the monoclonal 
antibody NA 1/34 and counted per 100 basal cells and with the 
numbers per unit area, the numbers per millimetre of epithelium 
and the numbers of ATP-ase positive Langerhans' cells per 100 
basal cells (r=0.79, 0.82, 0.61 respectively). Similar results are 
obtained when the ectocervix is examined.
Langerhans' cells and other monoclonal antibodies
The numbers of Langerhans' cells identified with MHC class II 
antigens (DA6 147, DA6 231), in sections adjacent to those stained 
with NA 1/34 ranged between 30% and 88% of the counts with NA
page 102
1/34. Lower numbers were recorded with DA6 147 and subjectively 
the staining was less good. The results of MHC class II antigen 
staining in other groups studied are confined to comments relating 
to DA6 231. There were no apparent numerical differences between 
the MHC class II positive Langerhans' cells in the ectocervix and 
transformation zone.
Langerhans' cell morphology
Anti T-6 antigen (NA 1/34) and ATP-ase consistently 
identified dendritic epithelial cells in the basal and lower third 
of normal cervical epithelium. This was not the case for S-100 
(see Chapter 2). The Langerhans' cell bodies were usually clearly 
seen with dendrites extending between adjacent epithelial cells. 
In some areas, dendrites of neighbouring Langerhans' cells 
appeared to meet and apparently form a network that stretched 
between the basal epithelial cells and more superficial layers. 
The dendrites often reached the basement membrane. These features 
were seen best following staining with NA 1/34. The problems 
encountered with other methods have been previously discussed. In 
many sections dendrites were seen with no apparent cell body. Only 
cells with identifiable cell bodies were counted for statistical 
analysis. ATP-ase and MHC class II antigen staining revealed that 
the dendrites occasionally reached capillaries.
The distribution of Langerhans' cells appeared fairly uniform 
between ectocervix and transformation zone, occasionally several 
Langerhans cells were closely related to capillaries of the 
transformation zone. Very few T-6 positive cells were present in 
the stromal mononuclear infiltrate frequently observed in the 
transformation zone.
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Lymphocytic infiltrate
An obvious difference in the lymphocytic infiltrate was 
apparent between the stroma and the epithelium. Cytotoxic T-cells 
were seen to predominate in the epithelium. In the stroma the 
helper subgroup was in the majority. Quantitatively the stromal 
infiltrate is vastly greater. Within the transformation zone the 
cellular infiltrate directly in the vicinity of the squamo- 
columnar junction contains larger numbers of polymorphs and 
occasionally B-cells. In the stroma of the normal cervix the 
lymphocytic infiltrate is found mainly in a relatively narrow band 
immediately below the epithelium of the transformation zone and 
ectocervix (Figure 14b p.161). The infiltrate in the epithelium is 
predominantly in the basal layers. The infiltrate was graded 
semi-quantitatively in all of the cases but apart from the 
clustering around the squamo-columnar junction no difference was 
apparent between ectocervix and transformation zone.
In order to quantify the infiltrate the image analyser was 
used, as previously described, in 20 of the cases with normal 
transformation zone and 15 of those with normal ectocervix. The 
majority of the epithelial infiltrate was of the cytotoxic/ 
suppressor (CD8/T8) variety, both in percentage terms and 
numerically in ratio approximately 4:1 when compared with the 
helper (CD4/T4) cells.
In the stromal infiltrate T4 positive cells predominated in a 
ratio of 2:1. Details of the infiltrate are shown in Table 10. 
Using Scheffe's test for multiple comparisons there are no 
significant differences between the ectocervix and transformation 
zone in the infiltrate of CD3 cells in the epithelium and stroma, 
in the percentage and numbers of helper cells in the epithelium
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and stroma or in the percentage and numbers of cytotoxic cells in 
the epithelium and stroma. No correlation was found between the 
number of Langerhans cells and any component of the stromal or
epithelial infiltrate in either area of the normal cervix.
Table 10. Analysis of variance of T-cell counts per unit area in
epithelium and stroma of normal transformation zone and ectocervix
A) Image analyser counts of T cells in normal transformation zone. 
Marker/Area Cases Mean SD 95% Confidence Intervals
CD 3 epith (N) 20 161.9 68.0 130.2 to 193.8
CD8 epith (N) 20 165.9 75.1 130.7 to 201.0
CD8 epith (%) 20 104.2 26.7 91.7 to 116.8
CD4 epith (N) 20 41.8 22.3 31.4 to 52.3
CD4 epith (%) 20 28.6 16.5 20.9 to 36.6
CD3 stroma (N) 20 343.7 131.4 282.2 to 405.2
CD8 stroma (N) 20 143.6 78.5 106.8 to 180.3
CD8 stroma (%) 20 42.4 15.9 35.9 to 50.0
CD4 stroma IN) 20 255.5 107.3 205.3 to 305.7
CD4 stroma (%) 20 75.4 23.0 64.7 to 86.2
Note. All cell counts are pixel counts of positively stained cells 
CD3 epith=Pan T (Tl) cells in the epithelium 
CD8 epith=Cytotoxic T (T8) cells in the epithelium 
CD4 epith=Helper T (T4) cells in the epithelium 
CD3 stroma=Pan T (Tl) cells in the stroma 
CD8 stroma=Cytotoxic T (T8) cells in the stroma
CD4 stroma=Helper T (T4) cells in the stroma
%= (Number (N) CD4 or CD8 cells X 100)/ (N) CD3 cells)
The SD & 95% confidence intervals of the mean cell counts are
shown.  ___________   — ---------------------------
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B) Image analyser counts of T cells in normal ectocervix.
Marker/Area Cases Mean SD
VXA«
95% Confidence Intervals
CD 3 epith (N) 15 190.9 99.1 136.0 to 245.7
CD 8 epith (N) 15 187.7 84.8 140.7 to 234.7
CD 8 epith (%) 15 103.1 28.5 87.3 to 118.9
CD 4 epith (N) 15 57.4 44.9 32.5 to 82.3
CD 4 epith (%) 15 29.9 15.4 21.3 to 38.4
CD 3 stroma (N) 15 350.6 137.1 274.7 to 426.5
CD 8 stroma (N) 15 133.4 71.9 93.5 to 173.2
CD 8 stroma (%) 15 41.0 19.3 30.3 to 51.7
CD 4 stroma (N) 15 262.9 106.1 204.1 to 321.6
CD 4 stroma (%) 15 79.3 22.8 66.6 to 91.9
Other components of the infiltrate
B-cells (Leu 12) and macrophages (OKMl) were rarely 
encountered outside the region of the squamocolumnar junction. 
Natural killer cells were an infrequent observation. Image 
analyser quantiation of these components was not performed.
The pattern of MHC class I antigen activity was consistent, 
with staining being maximal in the basal one third to half of the 
epithelium.
The MHC class II antigen activity of Langerhans" cells has 
been previously described. No class II staining of the epithelial 
cells was seen although the relation of the Langerhans" cells with 
capillaries was noted.
Comments
Langerhans" cells have previously been described as a 
consistent finding in normal fetal, premenarchial and adult
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cervical epithelium (Morris et al. 1983a). This study shows that 
the numbers of Langerhans cells are similar in pre and post 
menopausal patients. No significant differences are found between 
the ectocervix and transformation zone when different methods of 
identification and different methods of enumeration are used. The 
previously reported data have suggested that this was the case, 
but the numbers of patients studied were very small and contained 
no comparison of staining methods or methods of enumeration. No 
study has presented internal comparisons between ectocervix and 
transformation zone.
The results obtained from this analysis confirm that there is 
large individual variation in the numbers of Langerhans" cells in 
the normal cervix, a five fold range being noted for both NA 1/34 
and ATP-ase. This is considerably less than the variation recorded 
with other methods, especially S-100 (McArdle & Muller 1986; Tay 
et al. 1987a). The inconsistency of S-100 staining has been 
previously mentioned (see Chapter 2, p. 81).
The results presented in this chapter agree with others that 
Langerhans"cells are identified in approximately equal numbers in 
cervix using ATP-ase and anti T-6 antigens with around 50-60% of 
these expressing MHC class II antigens (Tay et al. 1987a).
The Langerhans" cell density of cervix is approximately half 
that of normal skin. Using a similar monoclonal antibody technique 
other investigators, working in the same laboratory, report the 
normal mean Langerhans" cell density as between 11 and 31 cells 
per 200 basal cells depending on the body site (Ashworth et al. 
1986). Rowden (1981) reported that the mean density of ATP-ase 
positive Langerhans" cells per square millimetre of skin was 460 
to 1000 depending on the site of the biopsy, roughly 1.5 times the
page 107
number recorded in epithelial sheets in this study. The 
observation that the Langerhans" cell density of cervix is around 
50-70% of that of skin is a useful comparison when other 
Langerhans cell markers are compared. The cervix does not show 
the age dependent decrease in Langerhans" cell numbers seen in 
skin, presumably because of the lack of effects of ultraviolet 
radiation on the cervix.
Although neither the T-6 antigen nor membrane ATP-ase 
activity of Langerhans" cells have any functional significance, 
there is reasonably good evidence that actual numbers of 
Langerhans" cells are important when immunological responses are 
considered. This evidence has been presented in the introduction 
and relates mainly to the Langerhans" cells required to produce an 
adequate response to contact allergens.
The good correlation between the numbers of Langerhans" cells 
per 100 basal cells and other methods of quantitation is a 
reassuring finding, as is the demonstration that cervix contains 
50-70% of the numbers of Langerhans" cells found in skin using 
different methods for their identification. The good correlation 
between the number of Langerhans" cells per 100 basal cells and 
the number per linear millimetre in the transformation zone was 
not unexpected, despite the reservations expressed in the previous 
chapter, since the counts made per linear millimetre were
performed in areas where the basement membrane was least
undulating, usually between cervical crypts. The large 
hysterectomy specimens permitted easy measurement of the linear 
millimetre which would not have been consistently possible on the 
smaller punch biopsies. One hundred basal cells was taken as the 
denominator for quantification in the later parts of the study.
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This measurement was the denominator used by Edwards & Morris 
(1985) although they reported higher numbers than found in this 
study in the normal cervix. Additional support for the 
observations made in this study was obtained by image analyser 
quantification.
The comparable distribution of Langerhans" cells between 
ectocervix and transformation zone in individual patients, as 
shown by paired data analysis, is particularly important since it 
allows the inclusion of internal controls when the abnormal cervix 
is examined. This reduces the effects of the large range in 
Langerhans" cell numbers detected by all methods, with the nett 
effect of providing a larger control population than would 
otherwise have been possible. Further support for the use of 
internal controls is given in the following chapter.
It is difficult to compare the results of the lymphocytic 
infiltrate reported in different studies, largely because of the 
many different methods employed and lack of quantitative 
statistical analysis. Most authors seem to agree that in the 
epithelium cytotoxic cells predominate with helpers predominant in 
the stroma. There is no evidence from this study to suggest that 
the transformation zone is an area of enhanced immunological 
activity as proposed by Edwards & Morris (1985).
Summary
Langerhans" cells are distributed fairly regularly in the 
cervical epithelium in similar numbers in the normal ectocervix 
and transformation zone. Substantial differences in numbers are 
obvious between patients but the number in the ectocervix is a 
useful internal control for the transformation zone. Anti T-6
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monoclonal antibody demonstrates the largest numbers of 
Langerhans cells, although their relation with other cells in the 
epithelium and with capillaries is better seen with anti-MHC class 
II antibodies. The numbers of Langerhans" cells in cervix are 
approximately half that found in skin when several methods are 
compared. . Quantitation per 100 basal cells is a reliable method 
that correlates well with other methods.
The lymphocytic infiltrate is also similar in the ectocervix 
and the transformation zone, with cytotoxic T-cells predominating 
in the epithelium and helper cells in the stroma. B-cells, natural 
killer cells and macrophages are rarely present in significant 
numbers. There is no evidence to support a previous comment that 
the normal transformation zone is a region of enhanced 
immunological activity.
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Chapter 4
Langerhans" cells and the local immune response to cervical 
intraepithelial neoplasia
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Chapter 4
Introduction
This chapter examines the relationship between Langerhans" 
cell numbers and CIN. Internal control biopsies of ectocervix have 
been used, where possible, to allow comparison of Langerhans" cell 
numbers in normal and abnormal cervical tissue from the same 
patient. The methods used are those established as most 
appropriate from studies performed in Chapter 2.
Patients
One hundred and seventy-two patients attending the Western 
Infirmary for laser ablation as treatment of CIN were studied. All 
were under the care of Dr A B MacLean or Dr J W Cordiner.
The Western Infirmary serves as a referral centre for 
patients with CIN, amenable to local ablative therapy, from large 
areas of the west of Scotland. Not all the routine histology from 
these 172 patients was reported in the Western Infirmary, but the 
histological diagnosis was available in all instances. The 
histology taken from frozen sections was reviewed by Dr R A 
Burnett, Department of Pathology, Western Infirmary and his 
interpretation was used if there was any discrepancy with the
referral histology.
Colposcopically guided laser ablation was performed on all 
patients. Before the procedure, biopsies were taken from abnormal 
aceto-white areas of the transformation zone and from normal
adjacent ectocervix.
The names of the patients were entered chronologically in the 
"Dermatology Research Day Book" and given an identifying number.
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Patient details and results were entered using this number on 
record sheets, later sent to Glasgow University Department of 
Computing for processing into files which were used for
statistical analysis. Patient details including the histological 
diagnosis are shown in Appendix Illb (p. 254).
Biopsies were also taken from the previously lasered area in 
23 of the patients at routine follow-up. These were taken from the 
treated area identified colposcopically by changes in the vascular 
patterns described by MacLean (1984a).
Methods
The paired biopsies were mounted in OCT and orientated 
optimally as previously described, on a microtome chuck cooled in 
carbon dioxide ice. Both biopsies were mounted together on one 
chuck to allow simultaneous cutting (Figure 1 p. 73) and staining. 
Initial sections from each block were stained immediately with 
methylene blue to confirm the presence of orthagonally sectioned 
epithelium in both biopsies. Twenty serial sections were then cut 
where possible. Every fifth section was stained with haematoxylin 
and eosin for comparison with the previously reported routine 
histology. The sections not stained with haematoxylin and eosin 
were stored at -20°C for immunohistochemical staining. This was 
performed within one week of collection of the biopsies. The 
slides not stained initially were kept at -20°C as "extras". The 
biopsies were also stored in labelled numbered boxes at -20°C 
after they had been cut from the microtome chucks.
The antibodies, methods of staining used and methods of 
assessment have been discussed previously in Chapter 1. 
Statistical analysis was performed using packages available with
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SPSS-X.
Results
Results of biopsies from 142 patients with histological 
evidence of CIN on frozen section were available for statistical 
analysis. Biopsies from another 30 patients were collected but the 
frozen section histology from these showed no apparent abnormal 
epithelium, poor preservation or fragments too small for 
interpretation. Eighty-seven patients had evidence of co-existant 
HPV infection on well established histological criteria (Meisels 
et al. 1981; Fletcher 1983). Fifty-five patients had CIN with no 
apparent HPV infection. The mean ages of these two groups were 
28.0 and 29.9 respectively, the viral group being significantly 
younger (p<0.05).
The majority of patients had CIN III (90 patients), being 
equally split between pure CIN and CIN with viral infection. 
Thirty-four patients were treated for CIN II with virus and 10 for 
CIN II only. Eight cases had CIN I, all showed histological 
features of HPV infection. A paired normal internal control biopsy 
of ectocervix was available for comparison in 136 of the 142 
patients.
a)Paired data
Analysis of the data on Langerhans" cell numbers from the 
patients in whom paired biopsies were taken was performed in 
several ways.
Firstly, the difference (normal - abnormal) and the 
percentage difference ((normal - abnormal X 100 )/ normal) in 
Langerhans" cell numbers between the biopsies were calculated. 
One-way analysis of variance showed no statistically significant
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difference with respect to the histological grade of CIN in either 
those patients with or those without evidence of HPV infection 
(Tables 11 to 14).
Table 11. Analysis of variance of the difference in Langerhans' 
cell counts per 100 basal cells between paired biopsies of normal 
ectocervix and CIN with HPV.
Grade Cases Mean SD Min Max 95% Confidence Interval
CIN I+HPV 7 2.3 3.7 -4 6 -1.2 to 5.7
CIN II+HPV 33 3.4 4.1 -10 10 2.0 to 4.9
CIN III+HPV 44 4.0 4.0 -6 16 2.8 to 5.2
Total 84 3.7 4.0 -10 16 2.8 to 4.5
F.Prob=0.53
Note. Mean=mean difference (normal-abnormal) in Langerhans' cell
count between the paired biopsies. The minimal and maximal
differences are indicated with the 95% confidence intervals for
the mean difference. F.Prob=probability of a difference between
groups, p >0.05 implies no significant difference between groups.
Table 12. Analysis of variance of the difference in Langerhans' 
cell counts per 100 basal cells between paired biopsies of normal 
ectocervix and CIN without HPV._____________________________
Grade Cases Mean SD Min Max 95% Confidence Intervals
CIN I 0
CIN II 10 -2.1 3.9 -10 3 -4.9 to 0.7
CIN III 42 -1.2 5.9 -11 11 -3.1 to 0.5
Total 52 -1.4 5.5 -11 11 -2.9 to 0.1
o V O 68
See Note Table 11. _ .
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Table 13. Analysis of variance of percentage difference (((normal- 
abnormal)X100)/normal) in Langerhans' cells per 100 basal cells 
between paired biopsies of ectocervix and CIN with HPV.__________
Grade Cases Mean SD Min Max 95% Confidence Interval
CIN I+HPV 7 29.0 66.4 -100 83.3 -32.4 to 90.4
CIN II+HPV 33 36.7 47.9 -125 87.5 19.7 to 53.7
CIN III+HPV 44 45.8 37.5 -60 90.9 34.4 to 57.2
Total 84 40.8 44.3 -125 90.9 31.2 to 50.4
F.Prob=0.52
See Note Table 11 p.115.
Table 14. Analysis of variance of percentage difference (((normal- 
abnormal )X100) /normal) in Langerhans' cells per 100 basal cells 
between paired biopsies of ectocervix and CIN without HPV._______
Grade Cases Mean SD Min Max 95% Confidence Intervals
CIN I 0
CIN II 10 --31.4 56.0 -120 50 -71.4 to 8.6
CIN III 42 -27.4 85.4 -275 88.9 -54.0 to -0.8
Total 52 --28.2 80.1 -275 88.9 -50.5 to -5.9
F.Prob=0.88
See Note Table 11 p.115.
In the above tables if the 95% confidence intervals of the 
mean differences do not cross "0" this implies a significant 
difference between the Langerhans' cell counts in the normal and 
abnormal biopsies. Positive values imply larger numbers in 
ectocervix. Negative values indicate larger numbers in the 
biopsies of abnormal cervix. Tables 11 to 14 thus show that:
1) there is no variation in the difference in Langerhans cells
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between control and CIN tissue (irrespective of the presence of 
HPV) dependent on the grade of CIN (F.Prob >0.05),
2) the numbers of Langerhans' cells are significantly greater in 
CIN without HPV (negative difference best seen in percentage data, 
Table 14, see below) and significantly less in CIN with virus 
(positive difference) than in internal control biopsies (95% Cl of 
'totals' do not cross 'O', see p. 95),
3) there are highly significant differences, (p<0.001), comparing 
the two calculated variables in the group with histological 
evidence of viral infection with the group showing CIN only 
(comparing Table 11 with 12 and 13 with 14).
As the number of Langerhans' cells in control cervix are 
small, additional use of the percentage differences (Tables 13 & 
14) for analysis increases the sensitivity that small changes in 
Langerhans' cell numbers between control and abnormal tissue will 
detected at significant levels (see Tables 12 & 14).
Since the grade of CIN does not influence the numerical or 
percentage differences in Langerhans' cells, the paired T-test 
was used on the pooled data from each group to establish the 
significance of the difference in Langerhans' cell numbers in the 
paired biopsies (Tables 15 & 16). Results from lesional versus
post-laser areas are also included.
The significant increase in Langerhans' cells in the CIN only 
lesions was confirmed using counts per 100 basal cells (p=0.033) 
and image analyser counts (p=0.019). Similar analysis of paired 
data in the group with histological evidence of viral infection 
showed a highly significant reduction in Langerhans' cells in 
lesional epithelium per 100 basal cells (pCO.001) and per unit 
area (p<0.001).
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Table 15. Paired T-Test comparison of Langerhans' cells in CIN & 
HPV with ectocervix and post laser epithelium counted per 100 
basal cells (/100) and with image analyser (mrA.
Count Area Cases Mean SD Sig
ecto 8.4 3.1
/100 84 CIN+HPV<ecto p<0.001
CIN+HPV 4.7 3.6
ecto 11.2 4.2
/mm2 34 CIN+HFV<ecto p<0.001
CIN+HPV 5.4 4.6
post laser 8.1 2.5
/100 13 CIN+HFV<post laser p=0.03
CIN+HPV 4.7 4.8
Table 16. Paired T-Test comparison of Langerhans' cells in CIN
without HPV with ectocervix and with post laser epithelium counted
2
per 100 basal cells and with image analyser (/mm-)._____________
Count Area Cases Mean SD Sig
ecto 7.6 2.5
/100 52 CIN>ecto p=0.033
CIN 9.0 5.4
ecto 10.7 4.1
/mm2 24 CIN>ecto p=0.019
CIN 13.9 6.4
post laser 8.1 2.7
/100 10 CIN>post laser p=0.07
CIN 10.5 5.2
Note. Tables 15 & 16 Mean and SD (of mean) refer to cell counts
in the individual groups. _
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Direct comparisons of the Langerhans' cell numbers in 
abnormal epithelium with those of the post laser areas in the two 
histological groups again showed significantly lesser numbers are 
present in lesions with CIN and virus (p<0.03). There was no 
significant difference in Langerhans' cell numbers seen in the 
biopsies with CIN only using the treated area as a control.
Comparison of the numbers in ectocervix with post laser
epithelium showed no significant difference in either the patients 
with or without histological evidence of HFV (p=0.084 and p=0.228 
respectively).
b) Individual groups
In addition to the paired results presented above, 
Langerhans' cell counts in the control ectocervix, abnormal and
post laser cervix were compared with external control groups. Once
again one-way analysis of variance no difference in Langerhans' 
cells counted per 100 basal cells between the various grades of 
CIN within the two histological groups (Tables 17 & 19). The total 
number of cases with CIN only and with CIN plus virus were
therefore pooled to give 87 and 55 cases respectively. This was 
true for the control biopsies of ectocervix (Tables 18 & 20)
obtained within each group (and also for the small number of post 
laser biopsies). Similar results were obtained for Langerhans' 
cell counts made per unit area of cervical epithelium. The 
cumulative totals of the cases examined using the image analyser 
and the results of analysis of variance are shown at the bottom of 
the relevant table. (See Figures 10 & 11, p. 149, respectively for 
exairples of Langerhans' cells in CIN with and without HFV.)
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Table 17. Analysis of variance of Langerhans' cell counts per 100 
basal cells and by image analyser (/mm^ ) in CIN with HFV.________
Grade Cases Mean SD Min Max 95% Confidence Interval
CIN I+HFV 8 3.7 3.1 1 9 1.2 to 6.3
CIN II+HPV 34 5.3 3.9 1 18 3.9 to 6.6
CIN III+HFV 45 4.2 3.3 1 16 3.2 to 5.2
Total 87 4.6 3.5 1 18 3.9 to 5.4
F.prob=■0.33
Total(/mm^) 35 5.3 4.5 0.9 22.1 3.7 to 6.8
F.prob=0.16
Table 18. Analysis of variance of Langerhans' cell counts per 100
2
basal cells and by image analyser (/mm ) in the ectocervix of
patients with CIN and HFV.___________________________
Grade______ Cases Mean SD Min Max 95% Confidence Interval
CIN I+HFV 7 6.3 1.9 4 9 4.5 to 8.0
CIN II+HFV 33 8.8 2.8 4 15 7.8 to 9.8
CIN 11 I+HFV 44 8.4 3.3 4 21 7.4 to 9.4
Total 84 8.4 3.1 4 21 7.7 to 9.0
 ____________________ F.prob=0.14______________________ ___
Total/mm2 34 11.2 4.3 4.4 20.3 9.7 to 12.7
____________   F.prob=0.06__________
Note Tables 17 & 18. Mean, SD (of mean) & 95% confidence intervals
of the mean refer to cell counts in each group and the maximal and
minimal values in each are shown. F.prob indicates the probability
of a difference between groups, equal. Only the totals of the data
2
are shown for image analyser counts (Total/mm-).________________
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Table 19. Langerhans' cells per 100 basal cells and per unit area 
2
(/mm-) in CIN without HPV.
Grade Cases Mean SD Min Max 95% Confidence Intervals
CIN I 0
CIN II 10 8.6 4.4 3 19 5.4 to 11.7
CIN III 45 9.1 5.6 1 22 7.4 to 10.8
Total 55 9.0 5.4 1 22 
F.prob=0.78
7.6 to 10.5
Total/mm 26 14.0 6.1 2.5 29.4 
F.prob=0.19
11.5 to 16.5
See Note Tables 17 & 18 p. 120.
Table 20. Langerhans cells per 100 basal cells and per unit area
2
(/nun--) in the ectocervix of patients with CIN & no HFV.
Cases Mean SD Min Max 95% Confidence Intervals
CIN I 0
CIN II 10 6.5 1.2 5 9 5.7 to 7.3
CIN III 42 7.8 2.7 4 15 7.0 to 8.6
Total 52 7.6 2.5 4 15 6.9 to 8.2
F.prob=0.14
2
Total/mm 24 10.7 4.1 3.9 22.6 9.0 to 12.4
F.prob=0.53
See Notes Table 17 & 18 p. 120.
The results from the ectocervix and transformation zone of 
the normal cervices examined have been presented in Chapter 3.
Analysis of variance on the numbers of Langerhans' cells
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between normal transformation zone (mean 8.0; 95% Cl 6.7 to
9.2)and abnormal transformation zone from both types of CIN showed 
significant differences between the sample means (F.prob<0.0001). 
Using Scheffe's correction for multiple comparisons at the 5% 
level, the CIN only lesions showed no significant difference in 
the Langerhans' cell count when compared with normal 
transformation zone. Those with histological evidence of HPV 
infection show a highly significant reduction in numbers when 
compared with normal transformation zone• and with the lesions 
showing no apparent viral features.
No significant differences in Langerhans' cell numbers in 
ectocervix were detected comparing the patients with pure CIN, CIN 
plus virus, post laser cervix or normal ectocervix.
The Langerhans' cell count in the biopsies of histologically 
mixed lesions was significantly less when compared with the 
numbers in biopsies of ectocervix (normal ectocervix, post laser 
cervix and control ectocervix).
Direct comparison of CIN with and without virus, as expected 
from the above results, demonstrated a highly significant 
reduction in numbers (p<0.001) of Langerhans' cells in the lesions 
of the group with viral features.
The findings were similar using the Langerhans' cell counts 
per unit area of cervical epithelium.
c)Langerhans' cell morphology in CIN
The morphology of the Langerhans' cells appeared altered in 
the abnormal epithelium irrespective of the type of lesion, the 
cell bodies remained obvious but the dendrites were stunted and 
generally reduced in number. Their distribution in the abnormal
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epithelium was little altered compared with normal epithelium, 
being predominantly situated in the basal / middle layers with the 
shortened dendrites extending from the cell body to the more 
superficical and basal layers (see Figure 11 p. 149). They tended 
to be related to capillaries extending into the epithelium as in 
the normal cervix but did not appear to be particularly related to 
any mononuclear infiltrate that was present. Very few T-6 positive 
cells were located in the sub-epithelial stroma but they were 
occasionally seen in the mononuclear infiltrates.
d) Lymphocytic infiltrate
On semi-quantitative asssessment of the epithelial and 
stromal infiltrate with the Pan T-cell marker, UCHTl, no 
particular relationship between the infiltrate and degree of CIN 
was obvious for either the group with evidence of viral infection 
or the group without. There did, however, appear to be a fairly 
consistent reduction in the epithelial infiltrate where there was 
concomitant evidence of HFV infection. Image analysis methods were 
pursued to investigate this further. Comparisons have been drawn 
from the results obtained from examination of the typical 
transformation zone (see Chapter 3) and abnormal transformation 
zone in both histological types of CIN. The numerical and 
percentage assessment of the infiltrate and its components have 
been described in Chapter 2. The results of image analyser 
quantification of the infltrate in CIN are shown in Table 21.
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Table 21. Analysis of variance of T cell counts per unit area in 
the epithelium and stroma in CIN with (a) and without (b) 
histological evidence of HFV infection.
Marker/Area Cases Mean SD 95% Confidence Interval
CD 3 epith (N) 34 189.0 172.5 128.8 to 249.2
CD 8 epith (N) 34 158.0 122.7 115.2 to 200.8
CD 8 epith (%) 34 86.5 16.5 80.8 to 92.3
CD 4 epith (N) 34 40.1 59.3 19.4 to 60.8
CD 4 epith (%) 34 19.1 4.4 15.2 to 23.1
CD 3 stroma (N) 34 660.6 425.6 512.1 to 809.1
CD 8 stroma (N) 34 257.1 185.5 192.3 to 321.8
CD 8 stroma (%) 34 38.1 4.2 34.2 to 42.0
CD 4 stroma (N) 34 462.4 291.7 360.7 to 564.2
CD 4 stroma (%) 34 70.2 12.2 66.0 to 74.5
b) Lymphocytic infiltrate by image analyser in CIN only.
Marker/Area Cases Mean SD 95% Confidence Interval
CD 3 epith (N) 29 227.6 152.1 169.7 to 285.4
CD 8 epith (N) 29 195.1 130.7 145.4 to 244.8
CD 8 epith (%) 29 86.2 12.7 81.4 to 91.1
CD 4 epith (N) 29 38.3 34.3 25.3 to 51.3
CD 4 epith (%) 29 19.3 12.7 14.5 to 24.1
CD 3 stroma (N) 29 638.2 279.8 531.8 to 744.6
CD 8 stroma (N) 29 234.5 138.7 181.7 to 287.2
CD 8 stroma (%) 29 37.5 14.4 32.1 to 43.0
CD 4 stroma (N) 29 404.6 230.7 316.8 to 492.3
CD 4 stroma (%) 29 63.2 25.7 53.4 to 73.0
See Note Table 10 p. 105._______________ _ ___ ____________ ____
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Figure 7.
Uniform epithelial cell 
staining with MHC class II 
antibody.
The cells of the 
epithelium (e) are fairly 
uniformly stained with 
DA6 231 in a lesion 
showing CIN with features 
of HFV infection 
(b = basement membrane; 
s = stroma).
Total magnification X 725.
Figure 8.
Pericellular MHC class II 
staining.
Pericellular distribution 
■of DA6 231 is seen in the 
epithelium.
Total magnification X1450.
Multiple comparison of means with Scheffe^s correction at the 
5% level showed no significant differences in any of the 
components of the lymphocytic infiltrate comparing the CIN lesions 
with those showing CIN and HFV. The stromal infiltrate was 
significantly greater in both types of CIN when compared with the 
typical transformation zone. In the epithelium the percentage of 
cytotoxic and helper cells were significantly less in both 
varieties of CIN lesions compared with the typical transformation 
zone. Numerically the stromal infiltrate of helper T-cells was 
greater in both types of CIN than in the typical transformation 
zone. Cytotoxic T-cells were greater in the stroma comparing
normal with virus containing lesions only.
e) Epithelial cell MHC class II expression
Two patterns of epithelial MHC class II antibody staining
were obvious in the abnormal transformation zone, uniform cellular 
staining (Figure 7) and pericellular staining (Figure 8). MHC
class II antibody staining of keratinocytes was found in 78.2% 
(43/55) of cases with CIN and 60.9% (53/87) of combined lesions. 
Pericellular staining was most obvious in the lesions showing 
viral features. As in the biopsies of normal cervix, class II 
antigens were consistently demonstrated on vascular endothelium.
The components of the lymphocytic infiltrate in the lesions 
with and without epithelial cell MHC class II antigen expression 
were compared to highlight whether the epithelial cell expression 
of these antigens could be influencing the lymphocytic response. 
There was no significant difference in the numbers of Langerhans 
cells in the epithelial cell MHC class II positive and negative 
lesions in either CIN with or without evidence of CIN.
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In the lesions showing CIN only there was no significant 
difference found in any component of the lymphocytic infiltrate in 
the stroma or epithelium, comparing the epithelial cell MHC class 
II positive with the negative biopsies.
In the biopsies with CIN and histological evidence of HPV 
infection all of the components of the infiltrate measured 
numerically were significantly reduced in the epithelium and 
stroma of the lesions lacking epithelial class II antigen 
positivity (p<0.05). These are shown in Table 22. There were no 
significant alterations in the percentage composition of the 
infiltrate in either the epithelium or the stroma.
The relationship between class II positivity on the
epithelial cells, the number of Langerhans' cells and the
lymphocytic infiltrate was further explored by examining the 
correlation between the number of Langerhans' cells and the
infiltrate in the epithelial cell class II positive and negative 
lesions.
Where CIN only was present there was no significant 
correlation between the number of Langerhans' cells and any
component of the infiltrate in either the epithelial cell class II 
positve or negative lesions.
In the lesions showing CIN and viral features, significant 
positive correlations were found between the number of Langerhans' 
cells and the numbers of epithelial T—cells in the lesions with no 
concomitant class II positive keratinocytes (Table 23). There was 
no significant association between the Langerhans cells and the 
components of the epithelial infiltrate when calculated as
percentages.
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Table 22. Analysis of variance of T cell counts per unit area in 
CIN with HFV, in 'the presence and absence of MBC class II .antigen 
ejgpression on transformed epithelial cells. ________________
! Marker/Area Class II ■cases Mean 95%. 'Confidence Interval
pos 18 260.1 155.0 to 385.1
CD 3 epith (N)
1 neg 14 112.6 87.0 to 138.3 |
pos 18 838.9 597.4 to 1080.4
CD 3 stroma (N)
neg 14 453.7 341.2 to 566.2
pos 18 220.7 151.6 to 289.7
CDS epith (11)
neg 14 91.4 70.8 to 112.0
pos 18 325.6 219.0 to 432.2
CD 8 stroina(N)
neg 14 186.5 125.8 to 247.3
pos 18 58.3 20.1 to 96.5
CD 4 epith (!)
neg 14 18.0 10.9 to 25.2
pos 18 586.3 426.9 to 745.7
CD 4 stroma(N)
neg 14 316.3 222.3 to 410.4
See Note Table 10 p. 105.
pos=lesions with tBC class II positive epithelial cells
iseq-lesifflis without KBC class II positive epithelial cells
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Table 23. Correlation (Pearson Corr) between Langerhans' cells 
(/100 basal cells) and epithelial T cell counts per unit area in 
CIN+HFV in absence of MHC class II expressing epithelial cells.
Marker/Area Cases Pearson Corr. Significance Level
CD 3 epith (N) 14 0.665 p=0.009
CD 8 epith (N) 14 0.559 p=0.038
CD 4 epith (N) 14 0.849 PC0.001
See Note Table &
oi—1 105.
In the biopsies showing combined CIN and viral features the 
significant correlations between the number of Langerhans' cells 
and the epithelial infiltrate are lost when there is concomitant 
class II staining of the epithelial cells.
The suggestion of a link between reduced Langerhans' cell 
numbers, epithelial cell class II antigen expression and the 
lymphocytic infiltrate was further examined by looking at the 
latter two variables in all the biopsies showing an atypical 
transformation zone and less than seven Langerhans' cells per 100 
basal cells ie. comparing the lymphocytic infiltrate in the 
presence and absence of class II antigen expression in all cases 
(CIN only and CIN+HFV) with low numbers of Langerhans' cells.
No differences were found in the percentage composition of 
the stromal infiltrate. The numerical composition of the 
infiltrate in the epithelium and stroma was significantly reduced 
in the lesions not expressing MHC class II antigens on the 
epithelial cells (Table 24). The percentage of helper cells was 
also significantly reduced (p=0.012).
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Table 24. Comparison of T cell counts per unit area in lesions 
with and without epithelial expression of MHC class II antigens in 
CIN & CIN+HFV with under 7 Langerhans" cells per 100 basal cells.
Marker/area Class II Cases Mean 95% Confidence Interval
pos 26 247.4 165.4 to 329.5
CD 3 epith(N) sig p=0.003
neg 16 120.7 86.4 to 154.9
pos 26 742.5 654.0 to 920.9
CD 3 stroma(N) sig p=0.002
neg 16 424.3 308.1 to 540.5
pos 26 201.0 143.9 to 258.2
CD 8 epith (N) sig p=0.002
neg 16 101.6 71.9 to 133.4
pos 26 274.0 196.4 to 351.7
CD 8 stroma(N) sig p=0.025
neg 16 179.6 121.1 to 238.0
pos 26 54.9 27.5 to 82.3
CD 4 epith (N) sig p=0.004
neg 16 15.1 10.6 to 19.6
pos 26 504.3 393.7 to 615.0
CD 4 stroma(N) sig p=0.003
neg 16 180.3 200.6 to 392.8
See Notes Table 10 p. 105 & Table 22 p. 127.
Significance of the differences in mean T cell counts between MHC
class II positive and negative lesions are shown.
f) Epithelial cell MHC class I antigen expression
Lesions with pure CIN more frequently demonstrated increased
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Figure 9.
MHC class I staining in CIN.
W6/32 positive cells occupy the complete epithelium (e). The 
stroma is shown (s).
Total magnification X 725.
epithelial cell labelling with anti-class I antibody. This 
increased labelling was apparent throughout most of the epithelial 
thickness (Figure 9). This staining was predominantly cytoplasmic 
and pericellular. Where there was histololgical evidence of viral 
infection the pattern of MHC class I antigen expression was more 
varied. The staining frequently extended throughout the epithelium 
but especially in the areas showing marked features of viral 
infection the pattern was patchy and the staining tended to be 
more pericellular than cytoplasmic.
g)B-cells, macrophages and natural killer cells
No differences in B-cells, macrophages or natural killer 
cells were apparent in the abnormal epithelium when compared 
subjectively with the normal cervix. B-cells were an occasional 
but inconsistent feature of the infiltrate. Natural killer cells 
were very rarely found and macrophages were generally present in 
small numbers. None of these other cells showed any apparent 
relation to the presence or absence of virus or to the degree of 
intraepithelial neoplasia.
Comments
The number of Langerhans' cells in CIN appears to be 
influenced by the presence or absence of viral infection. No other 
study has presented quantitative data comparing these two 
histological varieties of CIN. There is no relationship between 
the numbers of Langerhans' cells and grade of CIN contrary to the
claims of Caorsi & Figueroa (1986).
The reduction in the Langerhans' cell population in CIN 
showing viral features was confirmed in this study using the
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sensitive and specific Langerhans' cell monoclonal antibody (NA 
1/34) in much larger number of cases than previously reported (Tay 
et al. 1987a). The reduction in numbers is significant when 
comparison is made with internal control biopsies and with normal 
transformation zone.
In CIN with no evidence of viral infection the Langerhans' 
cells are increased when compared with paired internal controls, 
although when compared with external control groups this 
significance is lost. The studies reviewed in Chapter 1 which have 
suggested similar results in this group of patients have either 
reported small numbers of cases, included poor control data or had 
no quantification at all (Morris et al. 1983b; Caorsi & Figueroa 
1984, 1986; MacLean 1984b).
The results of this study emphasise the value of internal 
controls for quantitative analysis especially where CIN without 
viral infection is being studied. The large quantitative changes 
in Langerhans' cells are obvious in combined lesions even using 
external controls.
The use of internal control biopsies adds another dimension 
to the analysis of Langerhans' cells in cervix. The results from 
the previous chapter suggest that the ectocervix is an appropriate 
control for the normal transformation zone. It is possible that 
colposcopically and histologically normal adjacent transformation 
zone may have been a valid internal control. However, the number 
of cases where paired data would have been available would then 
have been substantially less as in many instances the abnormal 
acetowhite epithelium involves the complete transformation zone.
The use of internal control tissue also makes allowance for 
other factors iirplicated in the natural history of cervical
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neoplasia such as smoking, number of sexual partners and 
contraceptive habits. In the study of the local immune response in 
the cervix the value of this becomes apparent when the 
immunosuppressant action of semen (James & Hargreave 1984), 
smoking (Miller et al. 1982) and the oral contraceptive pill 
(Hagen & Froland 1972; Barnes et al. 1974) are considered. 
Although the association of these cofactors with immunosuppression 
is mainly on in vitro systemic T-cell function, preliminary data 
from Dr Simon Barton (personal communication), Royal Northern 
Hospital, London, suggests that smoking per se reduces the 
Langerhans' cell numbers in the cervix. Hughes, Norval & Howie 
(1988), however, found no difference in the number of Langerhans' 
cells in CIN in smokers compared with non-smokers. An increase was 
noted in pill users versus non-pill users. Although examination of 
control data was limited in this latter study these findings 
require clarification, particularly on the effects of smoking and 
pill use in the normal cervix. They further emphasise the need for 
internal control biopsies in such studies.
The implication from the other studies reporting reduction 
in Langerhans' cells in CIN is that the local immune response is 
impaired where there is evidence of viral infection secondary to 
the reduction in Langerhans' cell numbers. However, the consistent 
finding of reduced numbers of Langerhans' cells in CIN with viral 
infection is suggestive that local "immunological failure" in the 
cervix does not follow every reduction in Langerhans' cells since 
only the minority of these lesions actually progress. It is 
possible there is a critical level of reduction or absolute level 
at which the antigen presenting capacity of the Langerhans cell 
network begins to be compromised. Such a mechanism would then
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allow escape of neoantigens from immunological surveillance. They 
would, in the intact host, be detected and effectively eliminated 
via the subsequent T-cell response. This could explain why human 
papillomavirus, even if subsequently shown not to be the actual 
aetiological agent, may have at least a role as a cofactor in the 
development of cervical neoplasia. The possibility that low 
numbers of Langerhans' cells are related to the presence of human 
papillomavirus DNA sequences is investigated in Chapter 5.
The number of Langerhans' cells present in squamous 
epithelium has been shown to be a factor in the adequate 
presentation of antigens to the immune system (Ptak et al. 1980? 
Toews et al. 1980b; Rheins & Nordlund 1986). The increased number 
of Langerhans' cells seen in CIN with no apparent viral infection 
has been interpreted as a specific immunological response to the 
neoplastic process. However, the results shown in Tables 12 and 14 
indicate that reductions in Langerhans' cells also occur in cases 
of intraepithelial neoplasia with no apparent viral infection. If 
significant reductions in Langerhans' cells are required, perhaps 
to a critical threshold, to cause immuno-compromise this would 
explain why fewer virus negative lesions progress than virus 
positive lesions. It is not possible from this form of study to 
determine whether a particular level of reduction or critical 
threshold number of Langerhans cells is of importance in the 
progression of lesions to higher degrees of intraepithelial 
neplasia and possibly to invasion. As explained in the 
introduction this short-coming relates to effects of biopsy itself 
on the natural history of CIN (Rawson & Knoblich 1957; Buckley et 
al. 1982), biopsy being required for Langerhans' cell enumeration 
and for initial diagnosis.
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The results presented in Tables 22, 23 and 24 suggest that, 
in the absence of other possible antigen presenting cells, low 
numbers of Langerhans' cells are positively correlated with 
reduced epithelial lymphocytes. At higher numbers this association 
is lost and this perhaps indicates that a threshold number of 
Langerhans' cells is important for effective immune surveillance.
The assumption has been made above that the decrease in 
Langerhans' cells in virus containing lesions is real and others 
have suggested why this may be so. However, the reduction may only 
be apparent, with the presence of viral infection inducing changes 
in the surface antigenic markers of the Langerhans' cell. Although 
surface T-6 has no functional significance it is considered one of 
the most sensitive markers of Langerhans' cells (Harrist et al. 
1983; MacKie & Turbitt 1983).
No consideration was given specifically to the numbers of 
class II antigen positive Langerhans' cells in the lesions in view 
of the large percentage that showed class II antigen staining of 
the epithelial cells. This epithelial cell staining effectively 
masks the class II activity of the Langerhans' cells.
Although Langerhans' cells act in the afferent antigen 
presenting limb of the local immune system, the presence of viral 
and class II antigens on the Langerhans' cells may be one
explanation of the reduced Langerhans' cell numbers seen in the 
virus containing lesions since they may also be the targets for 
the efferent T-cell response. The electron microscopic studies 
performed by Silberberg-Sinakin et al. (1977) indicated that
Langerhans' could be damaged by immunological reactions and that
numbers were reduced following the initial phase of the contact 
sensitivity reaction (Silberberg-Sinakin & Thorbecke 1980).
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The finding that epithelial cells in CIN express class II 
antigens is an interesting observation that has been noted by 
others (Morris et al. 1983b, 1983c; Hughes et al. 1988). The
results presented in this chapter reveal that the epithelial cells 
in the majority of CIN lesions exhibit this phenomenon (78.2% of 
lesions with no apparent viral infection and 60.9% of cases with 
histological evidence of viral infection). The data from the 
Edinburgh group (Hughes et al. 1988) indicated this staining 
occured only in the minority of lesions they examined. Class II 
antigens are known to be expressed on epithelial cells in other 
circumstances (Lampert, Suitters & Chisholm 1981; Mason, Dallman & 
Barclay 1981; Terui et al. 1987). Class II expressing epithelial 
cells may have an antigen presenting role (Barclay & Mason 1982) 
but in addition, may also influence the cytotoxic T-cell response 
(Sollinger & Bach 1976). These new antigens appear to be 
synthesised by the epithelial cells (Breathnach & Katz 1983) and 
not to be the result of transfer from Langerhans' cells, 
lymphocytes or from endothelial cells (Morhenn, Charron & Engleman
1982). The stimulus to their induction in other areas has been 
shown to be dependent on the production of gamma interferon from 
T-cells (Pober et al. 1983; Wong et al. 1982). This has been 
confirmed for keratinocytes in culture (Wikner et al. 1986). The 
relation between squamous epithelial cells, HLA/DR expression and 
lymphocytes and interferon production has been discussed by 
Nickoloff et al. (1986) and Breathnach & Katz (1986) and reviewed 
in Chapter 1.
The results presented in relation to the lymphocytic 
infiltrate and the presence or absence of class II antigen 
expression on the epithelial cells in the two histological
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sub-types of CIN studied indicate that at low Langerhans' cell 
numbers the presence of class II epithelial antigens significantly 
influences the quantitative infiltrate in both the epithelium and 
stroma (Tables 22 & 24) without significantly changing its
proportions in either area. Combining these observations with the 
significant correlations between the Langerhans' cell numbers and 
the epithelial infiltrate at low Langerhans' cell numbers in the 
absence of class II antigens on the epithelial cells (Table 23) 
suggests that there is an optimal threshold, or level, of antigen 
presenting capacity in the squamous epithelium of the cervix, 
below which the immune response may become defective. Both 
Langerhans' cells and the class II positive keratinocytes 
contribute to this threshold. This emphasises that the epithelial 
cells are likely to have more than merely a passive role in local 
immunity in the cervix.
It is possible that the epithelial cells with their class II 
antigens are more important than Langerhans' cells in determining 
the immune response in abnormal cervical epithelium. They vastly 
exceed Langerhans' cells in number, and the results presented in 
Tables 22 and 24 indicate that the Langerhans' cells appear to 
influence only the epithelial infiltrate while class II epithelial 
cell positivity is significantly associated with an increase in 
the epithelial and stromal infiltrate. When the origin of the 
stimulus to the production of class II antigens on the epithelial 
cells is considered, this reinforces the notion of 'cervical 
lymphoid tissue'as a very complex entity dependent on the 
interaction of many cell types and soluble factors.
In the earlier studies no account has been taken of the 
influence of epithelial cell class II antigens on the lymphocytic
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infiltrate. Tay et al. (1987b) demonstrated significant reductions 
in the epithelial helper cells of patients with CIN/HPV, and HFV 
infection compared with normal patients. The findings described in 
this chapter and in Chapter 3 (Tables 21 & 10) suggest a reduction 
occurs only in the percentage helper cells in CIN. In addition the 
percentage of epithelial cytotoxic cells is reduced compared with 
normal transformation zone while the total stromal infiltrate is 
increased. In general terms no great differences in the 
lymphocytic infiltrate are found comparing CIN only with CIN/ HFV. 
However, the results do indicate that analysis of the infiltrate 
is not complete without consideration of those lesions with and 
without class II antigens on the epithelial cells.
The findings in relation to class II antigen expression on 
epithelial cells may explain the results of others in HFV lesions 
with no CIN. Several authors have noted significantly reduced 
Langerhans' cells in such lesions (Morris et al. 1983b; McArdle & 
Muller 1986; Tay et al. 1987a). Morris et al. (1983c) noted class 
II antigen expression on the epithelial cells in all of the viral 
only lesions they examined. Similar results were noted in the 
earlier paper from the same group (Morris et al. 1983b). It is 
possible that the antigen presenting capacity is not dramatically 
impaired in these lesions and that this contributes to the very 
low malignant potential of pure HFV infection.
This discussion has concentrated on some of the possible 
factors influencing the afferent immune response. The finding that 
most lesions demonstrate increased class I antigens suggests that 
the afferent limb may be the limiting factor in cervical 
neoplasia. The efferent immune response may have been impaired if 
there was loss of class I activity on the epithelial cells
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preventing recognition by the effector cytotoxic cells. Breathnach 
& Katz (1986) presented evidence suggesting that although the 
cytotoxic T-cell response to allogenic cells involved recognition 
of class I antigens, the response was augmented greatly by the 
additional presence of class II antigens. Thus in the majority of 
cases of CIN the epithelial cells may be dictating the afferent 
and efferent T-cell response. The results presented for both MHC 
class I and II activity are in-situ observations. The possibility 
that the actual antigens they define are of no functional or 
qualitative significance cannot be excluded in studies such as 
this.
There is no evidence in the large number of cases examined by 
these in-situ methods that the actual numbers of macrophages or 
natural killer cells have any role in cervical neoplasia contrary 
to the findings of Tay et al. (1987; 1987c). However, systemic 
natural killer cell activity has been reported to be significantly 
impaired in patients with CIN III. Return to normal activity has 
been described with alpha-Interferon and used to support possible 
treatment of CIN by this novel method (Seltzer, Doyle & Kaddish
1983).
Summary
The number of Langerhans' cells in cervical epithelium in CIN 
is related to the presence or absence of histological features of 
viral infection. The changes are best seen when internal control 
biopsies of ectocervix are paired with biopsies from lesions for 
analysis. In the presence of histological evidence of viral 
infection the Langerhans' cells are significantly reduced, while 
in the group without viral features the Langerhans' cells are
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significantly increased. The changes are independent of the grade 
of CIN in each group. Following laser treatment the numbers of 
Langerhans' cells return to normal levels.
Quantitative assessment of the lymhocytic infiltrate reveals 
differences dependent on the number of Langerhans' cells and on 
the presence or absence class II antigens on the epithelial cells. 
It is suggested that Langerhans' cells and epithelial cells 
expressing MHC class II antigens are linked together in
determining the 'antigen presenting capacity' of the epithelium in
CIN.
The afferent limb of the immune system appears to be the
limiting factor in determining the response, with MHC class I
antigens generally being increased. Natural killer cells, 
macrophages and B cells appear unimportant.
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Chapter 5
Langerhans' cells and HFV subtypes in CIN
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Chapter 5
Introduction
Pure virus infection of the cervix has not been considered in 
this thesis, as the malignant potential of typical condylomatous 
change is very low with high rates of spontaneous regression. This 
is in contrast to the lesions which show atypical mitoses in 
conjunction with histological features of viral infection (Crum et 
al. 1984). The previous chapter deals with Langerhans' cells in 
CIN and in CIN with associated histological features of wart 
virus infection. These features have been extensively reported 
(Morin et al. 1981; Fletcher 1983; Dyson, Walker & Singer 1984) 
but essentially consist of koilocytosis, multinucleation and
disordered keratinisation. In addition to histological features of 
HPV infection, diagnosis may be made from the features in cervical 
smears (Meisels et al. 1981).
The presence of koilocytosis on histological examination has 
almost become the pathognomonic feature of HPV infection (Dyson et 
al. 1984). Alone it is a poor indicator of wart virus infection
(Winkler et al. 1984; MacLeod 1986; Kirkup et al. 1982). The 
picture is further complicated as the individual threshold for 
reporting the presence of viral infection varies between
individual pathologists and cytologists. This has been the subject 
of a recent investigation, as yet unreported, amongst Scottish 
pathologists. The histological interpretation becomes more clouded 
as the frequency of koilocytosis decreases with increasing degrees 
of CIN (Pilotti et al. 1981). The poor correlation between
koilocytes and HPV infection becomes evident when other methods of 
diagnosing HPV are taken in to account.
Antibodies raised to a group antigen common to all
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papillomaviruses, present in the coat protein, allows 
immunohistochemical detection of papillomavirus infection. This 
serum, broadly reactive to the common capsid antigen, has been 
used by many investigators for identification of papillomavirus in 
'fixed'’ tissue sections (Jenson et al. 1980; Woodruff et al. 1980; 
Morin et al. 1981; Kurman et al. 1981; Ferenczy, Braun & Shah 
1981; Dyson et al. 1984). Fletcher (1983) reported koilocytotic 
atypia in 60% of biopsies showing CIN, whereas Walker et al. 
(1983) found only 18.3% of biopsies with CIN had demonstrable 
viral antigen. Others have reported histological evidence of HFV 
in 44.6% of cases with CIN (Grunebaum et al. 1983) and levels over 
90% have been reported (Reid et al. 1982). HPV antigen positivity 
has been shown in 22% of biopsies in cases studied from the west 
of Scotland with CIN (Murdoch et al. 1988).
Following the demonstration by Hills & Laverty (1979) of 
viral inclusion bodies in koilocytes using electron microscopy, 
Ferenczy et al. (1981) showed the apparent value of immuno- 
staining for viral antigen. All cases with viral inclusions 
demonstrated viral antigens. However, a further 23% of cases 
showed antigen positivity only. Simliar findings were presented by 
Sillman et al. (1984).
The most sensitive method identifying HPV presence is by 
using a labelled probe to identify homologous sequences of viral 
DNA (Coleman & Richman 1985; Jenkins, Tay & Dyson 1986). McCance 
et al. (1983) presented results comparing histology, antigen 
staining and DNA/DNA hybridisation studies. Nineteen women had 
histological features of CIN (15 also with features of virus 
infection) of these, six demonstrated viral antigens and 12 (63%) 
contained HPV genome sequences. Not all the lesions expressing
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antigen contained viral genomes. DNA hybridisation permits 
identification of viral subtypes dependent on the homology between 
known strains. It is reported that HPV 6 and 11 are present in up 
to 30% of CIN, whereas HPV 16 is reportedly present in 66% of CIN 
(Singer & McCance 1985). The prevalence of HPV 16 increases with 
increasing degrees of intraepithelial neoplasia, 77% of CIN III 
containing HPV 16 (McCance et al. 1985). There is a geographic 
variation in the prevalence of the HPV and its subtypes. Taking 
data from the west of Scotland, Millan et al. (1986) found 40% of 
pure CIN lesions and 73% of those with combined features had 
demonstrable HPV DNA. HPV 16 was present in 44% of all CIN (II
and III). They also reported HPV 18 in 19% of lesions showing CIN
(in the United Kingdom HPV 18 had previously only been reported in 
carcinoma). Murdoch et al. (1988) showed similar results with HPV
16 in 63% and HPV 18 in 15% of biopsies with CIN.
The very high prevalence of HPV 16 (McCance et al. 1985) in
squamous cancer of cervix, and its association with abnormal
mitoses (Crum et al. 1984), prompted suggestions that HPV 16 and
18 were the types most likely to progress to malignancy. The 
consistent presence of HPV genomes in some preinvasive lesions and 
in most squamous cell carcinomas of cervix also lead to some
authorities suggesting that HPV causes cervical neoplasia (zur 
Hausen 1982; Gissman et al. 1983; Crum et al. 1984; Singer et al.
1984).
The findings described in the previous chapter together with 
the publications noting a link between the histological diagnosis 
of associated HPV infection in CIN and a reduction in Langerhans' 
cell numbers prompted the investigation of the possibility of a 
specific relationship between reduction in Langerhans' cell
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numbers and particular HPV subtypes. The distribution of 
Langerhans' cell in CIN with and without HPV 16 and 18 infection 
was investigated to test the hypothesis that specific HPV subtypes 
are associated with reduced Langerhans' cells.
Patients
Tissue was obtained from 23 patients attending for treatment 
of histologically proven CIN. They form a subgroup of the patients 
examined in the previous chapter (Appendix Illb, p. 254).
Methods
Paired biopsies of normal ectocervix and abnormal 
transformation zone were taken under colposcopic control from 
each patient. Separate biopsy forceps were used to avoid cross 
contamination. The two biopsies were halved, part being used for 
immunohistochemical studies and part for HPV probing. A biopsy 
taken for histopathology was available for comparison.
1) Iirmunohistochemical studies
The methods, antibodies and counting of Langerhans' cells 
were as described in Chapter 2.
2) DNA-DNA hybridisation
The DNA hybridisation was performed by Dr J B Murdoch in the 
Department of Virology, Western Infirmary under the supervision of 
Dr Joan Macnab. Dr Murdoch was the recipient of a Wellcome 
Research Training Fellowship.
HPV 16 deoxyribonucleic acid (DNA) cloned to the BamHl site 
of pBR322 and HPV 18 cloned to the ECORI site of pBR322 were 
kindly donated by Professor Harald zur Hausen, Dr Lutz Gissman and
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collegues. HPV DNA was released from the vectors by the
appropriate restriction endonuclease digestion and purified twice 
by electroelution after agarose gel electrophoresis.
Biopsies stored at -20° C were chopped finely with a sterile 
blade and the DNA was extracted in 0.4% sodium dodecyl sulphate, 
O.lM sodium chloride, 0.01M edetic acid (disodium salt), 0.05M 
trometamol (TRIS) hydrochloric acid pH 8.0, 200 mg / 1 proteinase 
K (Boehringer). The sample DNA was then extracted with phenol and 
chloroform before ethanol precipitation. Thereafter the samples 
were treated with 100 mg / 1 ribonuclease A. Sample DNA was
quantified against a known standard lambda DNA (Gibco, Paisley,
Scotland). Three microgrammes of each sample together with 
appropriate HPV reconstructions containing equivalent amounts of 
mammalian DNA were transferred through a Minifold 11 slot blot 
apparatus (Schleicher & Schuell) onto the reprobable nylon 
membrane Genescreen Plus (New England Nuclear) which had been 
pre - soaked in 10 X SCC (1 X SCC is 0.15M sodium chloride and 
0.015M sodium citrate). The membrane was then treated with a
denaturing solution containing 0.4M sodium hydroxide and 0.6M 
sodium chloride for 20 minutes and transferred to a neutralising 
solution containing 0.5M TRIS pH7.0 and 1M sodium chloride for 20 
minutes before drying at 37°C for 40 minutes. Purified probes were 
radiolabelled with alpha-phosphorus-32-deoxyadenosine triphosphate 
and alpha-phosphorus-32-deoxythymidine triphoshate to a specific
Q
activity in excess of 1 X 10 counts per minute per microgramme of 
DNA. The membrane was prehybridised at 42°C in 50% formamide 
(Fluka), 10% Dextran sulphate , 1% sodium dodecyl sulphate and 1M 
sodium chloride for 30 minutes. The probes plus 100 mg / 1 
denatured salmon sperm DNA (Sigma) and 0.5 microgrammes cold
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denatured pBR322 were treated with 1M sodium hydroxide for 20 
minutes at room temperature before neutralising with 1M 
hydrochloric acid. This solution was then added to the 
prehybridisation mix and the samples hybridised at 42°C for 18 
hours. Cold pBR322 is added to block hybridisation of any residual 
radiolabelled pBR322 in the purified probe to the sample DNA. 
Thereafter the membrane was washed in 2 X SCC, 0.1% sodium dodecyl 
sulphate at 68° C (stringent conditions) and autoradiographed 
using intensifying screens on X-Omat film (Kodak).
Results
HPV copy numbers per cell and Langerhans' cell numbers from 
the normal and abnormal biopsies are shown in Table 25. The level 
of genome expression has been based on densitometry compared with 
known copy number reconstructions. Under 10 copies per cell of HPV 
DNA has been taken as a negative result (Murdoch et al. 1987). 
Low, moderate and high levels of expression have been taken to 
represent 10-50, 51-100 and over 100 copies per cell respectively.
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Table 25. Langerhans' cells and HPV subtypes in CIN.
HPV genome Langerhans' cells
Patient 16 18 (/100 basal cells)
______________ (copies/cell)____________________
6007 10-50 <10 7 15
6044 10-50 <10 4 15
6050 10-50 <10 8 4
6054 10-50 <10 11 5
6098 <10 <10 10 13
6121 <10 <10 6 9
6206 <10 <10 6 10
6229 <10 10-50 11 5
6249 10-50 <10 6 6
6267 <10 51-100 14 10
6272 <10 10-50 6 4
6276 <10 >100 12 7
6277 <10 10-50 14 11
6278 <10 51-100 12 6
6281 <10 10-50 7 5
6284 <10 <10 11 21
6285 <10 10-50 8 5
6288 51-100 <10 7 5
6289 <10 <10 11 14
6296 51-100 <10 5 4
6300 <10 <10 9 8
6302 10-50 <10 9 12
6305 51-100 <10 10 6
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The vast majority of HPV DNA positive lesions (11/17) showed 
low levels of genome expression.
Groups were defined according to the presence and level of 
HPV 16 and 18 genome copies per cell. Statistical analysis was 
performed on the difference (normal - abnormal) and percentage 
difference (((normal - abnormal)/ normal) X 100) in Langerhans' 
cells in the paired biopsies. The median difference and percentage 
differences are shown with 95% confidence intervals in view of the 
relatively small numbers involved. Non - parametric testing was 
also performed using the Wilcoxon matched-pairs signed-ranks test.
HPV 18 > 10 copies per cell is significantly associated with
decreased Langerhans' cell numbers (Tables 26 & 27). Inspection of 
the results in Table 25 suggests that HPV 16 in higher copy
numbers per cell (>50) may be producing a similar effect (positive 
differences in all cases) although the numbers of observations are 
too small to allow valid analysis.
Any correlation between copies of HPV 18 genome per cell and 
reduction in Langerhans cells is difficult to evaluate because of 
the small number of cases with over 50 copies of viral genome per 
cell.
A significant increase in Langerhans' cell numbers was
detected where no virus was present when the normal internal 
control was compared with the abnormal biopsy (Table 27).
The age range was 19 to 37 in patients with HPV type 16, 23 
to 36 with type 18 and 27 to 40 in the absence of viral genomes.
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Figure 10.
Langerhans" cells in CIN 
with HPV - HPV 18 
positive.
No Langerhans" cells are 
seen in the epithelium (e) 
or stroma (s) in this 
field; a few were seen in 
other areas of the lesion 
stained with NA 1/34.
Total magnification X 725.
Figure 11.
Langerhans" cells in CIN -
HPV 16 and 18 negative. 
Increased numbers of 
Langerhans" cells, stained 
with NA 1/34, are seen in 
the epithelium (e). Their 
dendrites are stunted but 
they are still mainly 
found in the lower 
epithelium. (S=stroma) 
Total magnification X 725.
Table 26. Relationship between density of HPV 16 and 18 genome 
expression in CIN and Langerhans" cells per 100 basal cells._____
Copy No N Median Wilcoxon
^
95% Confidence Intervals
/cell % (n-ab/n) Numbers(n-ab)
HPV 16 10-50 6 -2.0 p > 0.05 -9.5 to 5.0
-32.1 p > 0.05 -194.6 to 52.3
HPV 18 10-50 5 3.0 p = 0.031 2.0 to 6.0
33.3 p = 0.031 21.4 to 54.6
Note. Median=median difference (normal-abnormal) in Langerhans"
cell numbers. 95% Cl for median & % difference are shown with
Wilcoxon matched-pairs signed-ranks test of significance.
Table 27. HPV 16 and 18 positive and negative biopsies in relation 
to cervical Langerhans' cells per 100 basal cells.
N Median Wilcoxon 95% Confidence Intervals 
% (n-ab/n) Numbers(n-ab)
HPV 16 pos 9 0.5 P > 0.05 -5.5 to 4.0
3.3 P > 0.05 -123.2 to 41.6
HPV 18 pos 8 4.0 P = 0.007 2.5 to 5.5
36.6 P = 0.007 27.4 to 48.1
No HPV 6 -3.0 P = 0.03 -7.0 to -1.0
-40.0 P = 0.03 -78.9 to -8.1
See Note Table 26.
The Langerhans" cell morphology was altered in the biopsies 
with HPV 16, 18 and in pure CIN. The main changes were, as 
previously described, to the dendrites with these becoming 
stunted. Cell bodies appeared unaltered (Figures 10 & 11).
Using Scheffes" correction, at the 5% level, for multiple
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comparisons no significant differences were noted in any component 
of the lymphocytic infiltrate between the HPV 16 and 18 positive 
lesions and HPV negative lesions.
The small numbers and consequent large confidence intervals 
precluded any more detailed analysis of the pattern of epithelial 
cell expression of MHC class II antigens and the lymphocytic 
infiltrate.
Comments
DNA-DNA hybridisaton is the most sensitive and specific way 
of detecting the presence of HPV infection. Slot blot detection of 
HPV genomes does have some limitations when compared with the 
"gold standard" Southern blot technique. Murdoch et al. (1987) 
have shown that slot blot analysis offers low specificity if HPV 
DNA is present at low copy number but at high copy number (over 10 
copies per cell) it is both sensitive and specific. A further 
limitation of the technique is that it is impossible to 
differentiate between combined HPV 16 and 18 infection.
The results presented in this chapter show that Langerhans" 
cells are specifically decreased in the presence of HPV 18 even in 
low copy numbers and in the presence of HPV 16 at higher copy 
numbers. The depletion of Langerhans" cells may be a function of 
both HPV subtype and copy number. The question of whether there is 
a critical threshold copy number cannot be answered by slot blot 
hybridisation as this method cannot distinguish between samples 
with very low copy numbers (<10 copies per cell) and negative 
samples. It may be that a progressive immunological failure in the 
afferent limb of the T-cell response results frcm increased HPV 
presence. Alternatively, local immunodeficiency may preceed HPV
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infection facilitating the infection and subsequent cell 
transformation by viral gene products (Schneider-Gadicke & 
Schwartz 1986). No attempt was made to detect possible integration 
of the viral genome. The presence of preinvasive lesions which do 
not manifest HPV genomes emphasises that HPV is not likely to be 
the sole agent and many cofactors are implicated. They may not all 
involve depletion of Langerhans' cells.
Although the implication above is that Langerhans' cells are 
reduced secondary to HPV infection, reduction in Langerhans' cells 
may be permissive to HPV infection. Similar problems relate to the 
study of HPV infection, genital tract neoplasia and systemic 
T-cell function, with some authors suggesting that underlying 
immunocompromise is a factor (Seski et al. 1977; Seski et al. 
1978; Carson et al. 1986). Separating the 'horse from the cart' in 
longitudinal studies of local immunity would be impossible because 
of the previously mentioned effects of biopsy.
Another method of pursuing the possible relationship of 
Langerhans" cells to the development of wart virus infection and 
cervical neoplasia is to examine populations at high risk of such 
changes. The following chapter deals with Langerhans" cells and 
the in-situ local immune response in immunosuppressed renal 
transplant patients. Examination of immune compromised women in 
renal failure and in pregnancy follow in Chapters 7 and 8.
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Chapter 6
Langerhans" cells and local immunity in the cervix of renal 
transplant recipients
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Chapter 6
Introduction
Immunosuppressed renal transplant recipients are at increased 
risk of neoplasia. Hoover & Fraumeni (1973) reported this risk to 
be of the order of 35 times for lymphomata and of the order of 350 
times for reticulum cell sarcoma. Skin and lip cancers were also 
increased by a factor of four. In the female population they 
studied there were five cases with CIS. Porreco et al. (1975) 
found gynaecological malignancies in 21 of 224 female patients who 
developed tumours after transplantation. Cervical neoplasia was 
present in 18 patients, with two lesions being invasive 
carcinomata. They calculated the increased risk of cervical 
intraepithelial "carcinoma" in this group compared with aged 
matched controls to be 14 fold. Abnormal cytology on routine smear 
examination was the commonest presentation. All patients had 
received azathioprine and prednisolone in their immunosuppressant 
regimes. It was postulated that "immunologic surveillance" may be 
impaired, that oncogenic viruses may be potentiated or that the 
immunosuppressive regimes themselves may act as cofactors in 
tumour development.
The high prevalence of cervical disease (39 Of 529 tumours) 
was emphasised in a later paper (Penn 1978). Penn (1986) also 
found carcinoma of cervix was present in 1.8% of the females (14 
of 777) in a series of 2150 patients with anogenital carcinomas. A 
field change was reported in some women with lesions in the 
squamous epithelium of the vulva, vagina and cervix.
In general the incidence of neoplasia appears to increase 
with length of time since transplantation (Penn 1978). In the
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latest paper by Penn (1986) he noted that the genital tumours in 
females tended to occur later than the other tumours (88 versus 56 
months) and at much younger ages than the same tumours in the 
general population.
The relationship between wart virus infection in the female 
genital tract and immunosuppression has been examined in two 
studies (Schneider et al. 1983; Sillman et al. 1984). Schneider et 
al. (1983) used koilocytosis as being diagnostic of wart virus 
infection and retrospectively reviewed all cervical material taken 
from 132 patients identified as at risk of cervical neoplasia, 
from a total of 472 transplant recipients over a 17 year period at 
the Medical College of Virginia. Eleven patients had histological 
evidence of wart virus infection with 5 also having intraepitheial 
disease (4.5%). One invasive squamous tumour was identified. The 
average duration between transplant and the diagnosis of neoplasia 
was 38 months. The 8.8% prevalence of cervical condyloma 
represents a 5.5 times increase compared with that detected in a 
routine screening programme (Morin et al. 1981). Schneider et al. 
(1983) proposed that immunosuppression be added to the list of 
factors associated with development of cervical neoplasia.
Sillman et al. (1984) studied the problem from another 
perspective. Twenty women with genital neoplasia on 
immunosuppressants (predominantly prednisolone for lupus 
erythematosis) were examined. Colposcopy with directed biopsy was 
performed in 19 of these patients. Histological examination showed 
koilocytosis in all the patients. Multifocal intraepithelial 
disease was also noted in 11 of the 20 patients. Confirmatory 
evidence of papillomavirus presence was obtained from electron 
microscopic and immunohistological studies (in 50% and 60% of
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cases respectively). T-cell functions were also studied in the 
peripheral blood of 10 patients using the blastogenic response to 
phytohaemaglutinin (PHA) and pokeweed mitogen (PWM) as the means 
of assessment. An impaired T-cell response was found in nine of 
the patients. In addition examination of the circulating B-cell 
and T-cell subsets, using rosetting and immunofluorescence 
techniques, showed a decreased helper/suppressor ratio in nine 
patients. They also mentioned that those with the most aggressive 
neoplasia on follow up had the greatest depression of cellular 
immunity.
Despite the reports noting an increased prevalence of CIN and 
cervical carcinoma in renal transplant recipients, there are few 
studies where the at-risk patients have been systematically 
screened following the advice of Porreco et al. (1975):-
"all such patients require gynecologic examination 
before commencement of treatment and at regular 
intervals thereafter so that malignancies may be 
diagnosed at an early stage and treated effectively"
Considering the recommendations of Porreco et al. (1975) it 
seemed appropriate that this group of patients be screened looking 
for evidence of papillomavirus infection and cervical neoplasia. A 
previous study from the Western Infirmary, Glasgow by Cordiner et 
al. (1986) found five patients, screened colposcopically and 
cytologically, with CIN. No further screening had been conducted 
since that study. The local immune system of the cervix was also 
examined to detect any changes that could predispose to these 
changes, particulary considering the recent introduction of 
cyclosporin A to the immunosuppressant regime and its effects on
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the T-cell subsets (Hess, Colombami & Esa 1986).
Recruitment of patients
Forty patients attending the renal transplant clinic at the 
Western Infirmary, Glasgow under the care of DrJ D Briggs and Dr M 
A Watson were asked for consent to a biopsy of cervix being taken 
during colposcopic examination. The study had Ethical Committee 
approval. All patients had had renal transplantation performed a 
minimum of six months before the examination and were taking 
systemic immunosuppressant therapy.
Two of the patients approached declined to participate.
Materials and methods
A cervical smear was taken in the usual manner before 
colposcopic examination. Punch biopsies of cervix were taken from 
areas identified as normal transformation zone from all patients 
who showed no evidence of aceto-white epithelium after the
application of 5% acetic acid. In those with abnormal aceto-white
epithelium two biopsies were taken from the abnormal area and 
where possible one from adjacent normal ectocervix. One of the 
biopsies taken from the colposcopically abnormal area was
submitted for routine histological examination and used for 
comparison with frozen section histology. The other was used for 
immunohistochemical studies and processed and stained with the 
panel of antibodies described in Chapter 2.
Colposcopic examination of the vulva was also performed. The 
patients recruited also had a full dermatological examination by 
Dr D Tillman, Department of Dermatology, Western Infirmary,
Glasgow. He examined the group looking especially for any evidence
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Figure 12.
Colpophotograph of genital warts in a renal transplant recipient.
Multiple warts are seen on the cervix (c) and on the vagina (v).
of cutaneous pre-neoplastic, neoplastic and viral lesions.
Results
1) Patients
Patient details are shown in Appendix IIIc (p. 257). Twenty 
patients were receiving cyclosporin and prednisolone and 14 were 
receiving azathioprine and prednisolone at the time of the study. 
Three were on prednisolone only and one patient was on 
azathioprine and cyclosporin. The mean duration since transplant 
was 44 months (range 6-200 months). The mean age of the patients 
was 38.3 years (range 23-62). One patient had been included in the 
previous study by Cordiner et al. (1980).
2) Cytology
Dyskaryotic smears were reported in three patients. A further 
four patients had smears with features suggestive of viral 
infection only. Evidence of monilia was found in eight smears and 
trichomonas vaginalis infection in two.
Eleven of the patients had never had a previous smear and a 
further nine patients had not had a smear within five years.
3) Colposcopy
Aceto-white epithelium was identified in 14 patients. A 
colpo-photograph of multiple warts on the cervix and vagina of one 
patient is shown in Figure 12. Vulval warts were observed in two 
patients.
4) Histology
The results of histology from the biopsies taken from the 
aceto-white epithelium showed CIN I in two patients, CIN II in 
three and CIN III in one patient. All had histological associated 
features of wart virus infection. A further six patients had
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histological evidence of HPV infection only. The remaining two 
biopsies were negative.
5) Skin survey
Cutaneous warts were found in 65% of the patients examined. 
No cases with cutaneous neooplasia were detected.
6) Iirmunohistochemical studies
As mentioned above the transplant population do not receive a 
uniform immunosuppression regime. There are essentially two 
groups, one receiving azathioprine and prednisolone and the other 
receiving cyclosporin A and prednisolone. The mean and 95% 
confidence intervals for the numbers of Langerhans' cells per 100 
basal cells and per unit area of the typical transformation zone 
are shown in Table 28 in association with the immunosuppressant 
regime used.
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Table 28. Analysis of variance of Langerhans' cells per 100 basal 
cells and per unit area of cervical epithelium in the typical 
transformation zone of patients following renal transplantation. 
a) per 100 basal cells________________________
Regime Cases Mean SD 95% Confidence Interval
Cyclo 17 4.1 2.7 2.7 to 5.5
Aza 9 3.9 2.4 2.1 to 5.7
Total 28 4.1 2.7 3.1 to 5.2
(inc. 2 Pred only)
b) per unit area________________________________
Regime Cases Mean SD 95% Confidence Interval
Cyclo 17 4.36 5.61 1.37 to 7.34
Aza 9 6.50 4.45 2.78 to 10.47
Total 28 4.87 5.12 5.30 to 8.19
(inc. 2 Pred only)
Note. Cyclo=Cyclosporin/Prednisolone 
Aza =Azathioprine/Prednisolone
Totals include 2 patients on Prednisolone (Pred) only 
_____ Mean, SD & 95% Cl of mean for each group are shown.________
Using Scheffe's test for multiple comparisons, at the 5% 
level, the Langerhans' cells in both groups are significantly less 
than the numbers seen in normal transformation zone (mean 8.0 & 
12.43; 95% Cl 6.7-9.2 & 11.07-31.80 respectively for counts per
100 basal cells and by image analyser, Tables 6 & 7 p. 100). There 
is no significant difference in Langerhans cells comparing the 
azathioprine with the cyclosporin group.
In addition to the decrease in Langerhans' cells, the other
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Figure 13.
Langerhans' cells in the typical transformation zone of a renal 
transplant recipient.
The Langerhans' cells in the epithelium (e) are reduced in 
number; two cell bodies are indicated, stained with NA 1/34, 
close to a capillary (c).
Total magnification X 362.
main difference was a significant decrease in the helper T-cell 
infiltrate in percentage and numerical terms in the stroma and 
epithelium of the transformation zone of both groups of transplant 
patients compared with the results obtained from the normal
patients presented in Chapter 3 (Table 10 p.105). Details are
shown, in Table 29, of the mean, SD and 95% confidence intervals 
for the relevant variables. Scheffe's correction at the 5% level 
was used to make the multiple comparisons. No difference in 
percentage or number of helper cells was detected comparing the 
group on cyclosporin with the group on azathioprine.
Photomicrographs of the Langerhans" cells and helper T-cell
infiltrate in the transformation zone in one of these patients are 
shown in Figures 13 & 14a and comparisons with normal cervix in 
Figures 2 & 14b.
Table 29. Comparison of Helper T-cell (CD 4) infiltrate in typical 
transformation zone of patients on two immunosuppressant regimes 
fpillowing renal transplantation.____________________________
■ Area/Marker Regime Cases Mean SD 95% Confidence Interval
CD 4 epith (% Cyclo 15 12.7 11.2 6.5 to 19.0
CD 4 epith (% Aza 8 9.0 9.4 1.1 to 16.7
CD 4 stroma(% Cyclo 15 51.3 23.5 38.3 to 64.3
CD 4 stroma(% Aza 8 43.7 21.9 25.4 to 62.1
CD 4 epith (N Cyclo 15 16.3 11.5 10.0 to 22.7
CD 4 epith (N Aza 8 9.9 12.3 -0.4 to 20.2
CD 4 stroma(N Cyclo 15 162.4 94.1 110.3 to 214.6
CD 4 stroma(N Aza 8 131.6 115.2 35.3 to 227.9
See also Note Table 10 p. 105. %=((No. of positive cells X 100)
/total infiltrate (CD 3)). Cyclo=cyclosporin/prednisolone
Aza=azathioprine/prednisolone
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Figure 14a.
Helper T-cells in the 
typical transformation 
zone of a renal transplant 
recipient.
The epithelium (e) and 
narrow subepithelial band 
(see Figure 14b) are shown 
with markedly reduced 
numbers of Leu 3a positive 
cells in the stroma (s). 
Total magnification X 725.
Figure 14b.
Helper T-cell infiltrate 
in normal transformation 
zone.
Leu 3a positive cells are 
seen in the epithelium (e) 
and especially in the 
narrow band indicated 
immediately below the 
basement memrane (b)(see 
Figure 14a).
Total magnification X 362.
Despite the changes in the helper T-cell infiltrate there was 
no significant differences in the percentage or numbers of 
cytotoxic T-cells comparing the two transplant groups and the 
non-compromised patients (Chapter 3). There were no differences in 
any other component of the infiltrate comparing the patients on 
cyclosporin with those on azathioprine. The quantitative analysis 
of the infiltrate in the normal transformation zone from the whole 
group (including two patients on prednisolone alone) are shown in 
Table 30. Graphical comparison of the results presented in Tables 
10 & 30 is shown in Appendix IV.
Table 30. Analysis of variance of T cell counts per unit area in 
the typical transformation zone of renal transplant recipients.
Marker/Area Cases Mean SD 95% Confidence Intervals
CD 3 epith (N) 25 139.0 76.9 107.2 to 170.7
CD 8 epith (N) 25 142.4 106.9 98.3 to 186.6
CD 8 epith (%) 25 99.6 21.9 90.6 to 108.7
CD 4 epith (N) 25 14.3 11.6 9.6 to 19.1
CD 4 epith (%) 25 11.2 10.2 7.0 to 15.4
CD 3 stroma (N) 25 300.6 135.6 244.6 to 356.5
CD 8 stroma (N) 25 180.2 102.1 138.0 to 222.3
CD 8 stroma (%) 25 60.2 17.7 52.9 to 67.5
CD 4 stroma (N) 25 149.6 100.5 108.1 to 191.1
CD 4 stroma (%) 25 47.8 23.2 38.2 to 57.3
See Note Table 10 p . 105.
The number of renal transplant recipients with CIN were small 
but represent over 15% of the patients screened. There was no
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significant difference in the numbers of Langerhans" cells or in 
any component of the lymphocytic infiltrate between this group and 
those with CIN and histological features of HPV infection 
presented in Chapter 4. Four of the six patients were receiving 
azathioprine and prednisolone and one cyclosporin and 
prednisolone. Fisher's exact probability test showed no 
significant difference (p=0.079) between the azathioprine patients 
(4/14) and the cyclosporin patients (1/20). The remaining patient 
was receiving both cyclosporin and azathioprine.
Comments
Prednisolone forms the basis of the immunosuppressant regimes 
post transplantation being combined with either cyclosporin or 
azathioprine.
Prednisolone itself has been shown to decrease Langerhans" 
cell density. This is seen following topical application to the 
skin (Breathnach & Katz 1986; Halliday, Knight & Muller 1986) 
rather than after systemic use (Belsito et al. 1982). Prednisolone 
has also been shown to decrease Langerhans" cell surface markers 
and impair function by decreasing class II surface antigens 
(Belsito et al. 1982; Berman et al. 1983; Aberer et al. 1984). The 
surface T-6 antigens appear not to be affected (Berman et al. 
1983). The effects of other immunosuppressants, including 
azathioprine and cyclosporin, applied topically and administered 
systemically to mice showed similar effects (Halliday et al. 
1986) when ATP-ase is used as the Langerhans cell marker. The 
suggestion is that reduction in Langerhans" cells results from the 
marrow supressant effects of the various agents.
Sontheimer et al. (1984) presented evidence from a small
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number of cases that showed the Langerhans' cell population was 
significantly reduced in skin of patients following renal 
transplantation and maintained on prednisolone and azathioprine 
compared with matched controls. They also found the antigen- 
presenting capacity of the Langerhans cell was excessively 
reduced when compared to the mononuclear cells of the peripheral 
blood. The changes were most marked on the Langerhansx cells from 
sun exposed areas where pre-malignant and squamous epithelial 
tumours develop most commonly in this group of patients.
The introduction of cyclosporin to the immunosuppressant 
regime followed reports that its use resulted in less graft 
rejection and less myelotoxicity than azathioprine (Hess et al. 
1986). Its main disadvantage is its effect on T-cells especially 
decreasing helper T-cell function (Hess et al. 1986). The dual 
effect of a cyclosporin and prednisolone regime may theoretically 
result in a greater propensity to neoplastic transformation or 
viral infection because both the antigen presenting cell and its 
receptor T-cell are reduced in number and in function. The 
possibility of promoting neoplastic change reflects one of the 
worries in long term use of cyclosporin. No previously published 
study has reported any cases of CIN in patients receiving 
cyclosporin. The findings of this study do not substantiate this 
theory, indeed comparing the observed and expected cases in the 
azathioprine and cyclosporin groups showed greater numbers of 
patients in the azathioprine group. This is not wholly unexpected 
since the number of malignancies increases with time from 
transplantation and cyclosporin is usually given for six months 
during the first year. It is reassuring that cyclosporin does not 
appear to substantially effect the Langerhans' cells or helper
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cells when compared with azathioprine, perhaps emphasising that 
the effects of both these immunosuppressants on local epithelial 
immunity are secondary to bone marrow suppression.
The effects of immunosuppression on the prevalence of 
abnormalities in the cervix is not confined to the patients which 
have had a renal transplant. A high incidence of abnormal cervical 
cytology has been reported in women treated with azathioprine for 
systemic lupus erythematosis (Nyberg, Eriksson & Westberg 1981). 
Azathioprine has also been implicated in the development of CIN in 
patients treated for chronic active hepatitis (Schramm 1970; 
Norfleet & Sampson 1978).
Routine cervical screening of the female renal transplant 
recipient has been recommended for some time (Porreceo et al. 
1975). Cytological screening only has been performed by some 
groups (Kay, Frable & Hume 1970; Ingoldby et al. 1980). Kay et al. 
(1970) reported two cases of intraepithelial neoplasia developing 
after transplantation in a group of 28 patients. Ingoldby, et al. 
(1980) followed a group of patients undergoing renal transplant 
longitudinally and found pre-existing dysplasia in two of 38 
patients prior to transplant and no new cases on follow-up.
There are four reported studies where colposcopy and cytology 
have been performed. Donohue (1974) reported abnormal cervical 
cytology or colposcopy in nine of 35 patients in his series 
although no CIN was found. Husslein, Breitenecker & Tatra (1978) 
found abnormal cytology in only two of 29 patients although 14 had 
abnormal colposcopic appearances. Dysplastic features were present 
in two cases with a case of endometrial carcinoma being found. The 
photomicrograph presented as Figure 1 in this paper shows changes 
more in keeping with HPV infection, koilocytosis and multinucleate
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cells being present, rather than CIN. Cordiner et al. (1980) found 
five cases of CIN in 26 patients examined, but, if cytology alone 
had been used only two of these cases would have been detected. 
They make no mention of the number of cases where HFV infection 
only was a finding on cytology or colposcopy. MacLean et al. 
(1986) found no cases with CIN in 24 transplant recipients but 
noted genital HPV infection in 21%. They also studied seven 
patients on haemodialysis and found one patient with vulval 
intraepithelial neoplasia and another with an atypical 
transformation zone on colposcopy but negative histology and 
cytology.
In this current study the high prevalence of CIN has been 
further substantiated in women following renal transplantation 
with a prevalence rate of almost 16% being found. In an attempt to 
examine whether this was likely to reflect a true incidence rate a 
separate group of patients, prior to possible transplantation, was 
studied using the same screening techniques (Chapter 7).
The results presented in this chapter confirm those of others 
(Ingoldby et al. 1980; Schneider et al. 1982; Sillman et al. 1984; 
MacLean et al. 1986); Gassenmaier et al. 1986; Rudlinger et al. 
1986) that there is also a high prevalence of HPV infection in the 
genital tract and skin of renal transplant recipients. In the 
cervix evidence of HPV infection, with or without CIN, was found 
in greater than 30% of cases.
It is also clear from this study that cytology alone does not 
appear to be an effective screening method in this high risk 
population with prevalence of CIN >10%, with as many as 60% of 
cases giving false negative results (Cordiner et al. 1980). This 
high false negative rate may be due to the high rate of
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concomitant infection (protozoal, viral or fungal) as noted in 
this study and in others (Ingoldby et al. 1980), but it could 
possibly reflect that exfoliation of cells in this group is 
reduced. It is also clear that available cytological services are 
not being applied to an easily identified high-risk group that 
frequently attend other hospital clinics with over 25% of patients 
never having had a smear and a further 25% not being screened 
within five years. An appropriate screening regime would be to 
recommend that cervical cytology becomes part of the 
pre-transplant work-up and that following transplantation yearly 
colposcopy and cytology is performed.
It is possible that the reduced Langerhans' cell numbers are 
contributing to the high prevalence of CIN and high prevalence of 
HPV infection with or without CIN in the group of female 
transplant recipients examined. They also show a high prevalence 
of cutaneous papillomavirus infection. Others have indicated that 
as many as 80% will develop cutaneous warts on prolonged 
follow-up. The work of Sontheimer et al. (1984) and Ten Berge et 
al. (1981) suggests that functional aberrations in the Langerhans' 
cell may also be implicated.
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Chapter 7
Langerhans' cells and local iircminity in the cervix of women in
renal failure
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Chapter 7
Introduction
Following the observations made in Chapter 6, this chapter 
and the following one extends the study to include examination of 
Langerhans' cells and the lymphocytic infiltrate in the cervix of 
other naturally immunocompromised patients, some of whom are 
reported to show increased prevalence rates of cervical epithelial 
abnormalities.
The group examined in this chapter are patients attending 
with chronic renal failure (CRF), for haemodialysis (Haemo) or 
peritoneal (CAPD) dialysis. They were studied in order to quantify 
the Langerhans' cells and lymphocytic infiltrate in the cervix 
prior to transplantation, since within the time constraints of the 
study, longitudinal examination of patients before transplantation 
through to post-transplant follow-up was not possible. In addition 
these patients have received little consideration in cervical 
screening regimes despite the known risks following 
transplantation and the reported increased risk of neoplasia in 
patients undergoing long- term intermittent dialysis (Linder, 
Farewell & Sherrard 1981). They were therefore used as a control 
group for comparison with the transplant patients, colposcopic and 
cytological screening being performed to determine the prevalence 
of abnormal cervical epithelium before transplantation. Another 
aim was to determine whether the high prevalence of CIN and HPV 
seen after transplantation reflects the role of renal disease or 
immunosuppression by drugs, especially since uraemia, itself, is 
asociated with depressed immune function (Lawrence 1965; 
Dobbelestein 1976).
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Patients
Fifteen patients attending the renal clinic under the care of 
Dr JD Briggs were recruited. All were part of group of both male 
and female patients being investigated by Dr K McKerrow, Dept of 
Dermatology, University of Glasgow. His studies included 
evaluation of the Langerhans' cells and immunocompetent cells in 
skin and in peripheral blood. Patients with multisystem autoimmune 
disease or who had rejected a kidney transplant were excluded. 
Those treated conservatively had a serum creatinine value of less 
than 500 micromoles per litre.
Six patients on continuous ambulatory peritoneal dialysis, 
two patients on haemodialysis and seven patients in chronic renal 
failure were studied. All patients had been in their respective 
subgroup for over six months. Ethical committee approval had been 
given for taking biopsies of skin and of cervix. Informed consent 
was obtained from all patients. Patient details are shown in 
Appendix Hid (p. 258).
Materials and methods
Routine cervical cytology was taken from the patient before 
colposcopic screening. Directed punch biopsies were taken from 
normal transformation zone for immunohistochemical studies. Any 
colposcopically abnormal areas were also biopsied and a second
specimen sent for routine pathology.
Frozen sections were obtained and the same monoclonal 
antibodies and iirmunoperoxidase method used as described 
previously.
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Results
1)Langerhans cells and lynphocytic infiltrate 
Analysis of variance between the individual sub-groups showed 
no significant differences in the numbers of Langerhans' cells or 
in the components of the lymphocytic infiltrate. Close inspection 
of the results did however suggest that the Langerhans' cells may 
be reduced in the sub-group with untreated renal failure returning 
towards normal levels following peritoneal dialysis or 
haemodialysis (Table 31). There are only two patients in the 
latter sub-group making any comparisons on such small numbers 
invalid; they are, however, included in the table.
Table 31. Langerhans' cells per 100 basal cells in the typical
transformation zone of three groups of uraemic patients._________
Group N Mean SD 95% Confidence Interval_______
CAPD 6 7.0 3.6 3.2 to 10.8
CRF 7 5.3 2.7 2.8 to 7.8
Haemo 2 6.0 2.8 -19.4 to 31.4
Total 15 6.1 3.0 4.4 to 7.7
Note. CAPD ^continuous ambulatory peritoneal dialysis 
CRF =chronic renal failure 
_____ Haemo=haemodialys is_____________ __ ________
The results from the 15 patients were pooled for comparison
with other study groups.
Multiple comparisons of means using Scheffe s correction at 
the 5% level shows no significant differences between the 
components of the infiltrate (see Table 10 p.105 & Appendix IV) or 
Langerhans" cells when compared with the results from the typical
page 170
transformation zone (mean 8.0(/100 basal cells); 95% Cl 6.7-9.2) 
presented in Chapter 3. The numbers of Langerhans" cells are 
greater in the pre-transplantation patients (Table 31) than in the 
post transplant group (mean 4.K/100 basal cells); 95%CI 3.1-5.2).
Compared with the results presented in the previous chapter, 
(Table 30 p.161, Appendix IV) there are no significant differences 
in the number of cytotoxic T-cells in either the epithelium or 
stroma, but there is a significant reduction in the cytotoxic 
T-cell infiltrate in both areas in percentage terms in the uraemic 
patients (Table 32). This arises due to the reduction in the 
number of helper T-cells seen in the transplant patients.
Table 32. Analysis of variance of T cell counts per unit area in 
the typical transformation zone of women in "untreated" renal 
failure, on peritoneal or haemodialysis._________________________
Marker/Area Cases Mean SD 95% Confidence Intervals
CD 3 epith (N) 9 160.4 84.3 95.6 to 225.3
CD 8 epith (N) 9 136.7 76.4 77.9 to 195.4
CD 8 epith (%) 9 85.9 8.6 79.3 to 92.5
CD 4 epith (N) 9 35.9 37.7 6.9 to 64.9
CD 4 epith (%) 9 18.8 11.3 10.0 to 27.5
CD 3 stroma (N) 9 419.8 236.9 237.7 to 601.9
CD 8 stroma (N) 9 164.4 104.0 84.4 to 244.3
CD 8 stroma (%) 9 38.6 9.7 31.1 to 46.0
CD 4 stroma (N) 9 303.7 194.2 154.4 to 453.0
CD 4 stroma (%) 9 70.9 11.9 64.7 to 86.0
See Note Table 10 P. 105. ------------ .— ------- --------------
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2)Cytology and Colposcopy
Similar percentages of the pre-transplant and transplanted 
patients had never had a previous smear (4/15 versus 9/38). No
evidence of cervical neoplasia was found in the uraemic patients.
One patient on CAPD had colposcopic features of wart virus 
infection and this was confirmed on histology of the punch biopsy.
Comments
It is difficult to make any comment on the apparent finding 
of reduced numbers of Langerhans' cells in the patients with 
untreated renal failure in view of the small number of patients 
involved. Should this result be confirmed in larger numbers of 
patients it would be tempting to suggest the reduction follows
effects on the bone marrow. In chronic renal failure there is
marrow suppression but following treatment the suppressive effects 
are less, with a possible resultant return towards normal numbers 
of Langerhans' cells in cervix. Following transplantation there is 
exogenous marrow suppression with the various immunosuppressants 
and the Langerhans' cell numbers again decrease.
There is no evidence from this part of the study that the 
pre-transplant patients represent a group at high risk of cervical 
neoplasia or of HPV infection, although the implication from the 
earlier work presented is that patients with chronic renal failure
could be a further high risk group worthy of more in depth
investigation. MacLean et al. (1986) found no cases of cervical
neoplasia in seven patients, but vulval neoplasia was found on 
colposcopic examination of one patient and abnormal findings were 
noted in another although cytology and histology were negative. 
The findings of Linder et al. (1981) suggest that a cautious
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approach be acoco-d in interpreting the results from this small 
number of patients.
Koutine cytolcgical screening of the patients showed few 
inflammatory siears and, although conclusive evidence is lacking, 
the implication is that cervical cytology alone is probably 
adequate in these patients. Recruitment of larger numbers of 
patients to a cytological and colposcopic screening programme 
could substantiate this.
It is difficult bo be certain that the increased prevalence 
of HEV infection and CIM seen following renal transplantation and 
commencement of immunosuppressant regimes represent true increased 
incidence. Screeening all patients with chronic renal failure 
entering the appropriate clinics could answer the question. 
Inevitably some of these patients will receive peritoneal dialysis 
.and haenodialysis, -and some will ultimately receive a donor 
kidney. The actual numbers of such patients are relatively small 
but without long-term follow up the true incidence rates will not 
become apparent.
It is hoped to develop this plan of approach at the Western 
Infirmary with all patients 'entering the transplant programme 
receiving a, cervical smear before transplantation and all those 
attending the relevant clinics who have never had a smear to be 
adequately screened in 'the first instance. In an already busy 
routine colposcopy service It could be argued that it is a misuse 
of resources to use the service as a screening tool, however,In 
women with chronic renal, failure, on peritoneal or haenodialysis 
cytology is likely to be adequate.
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Chapter 8
Langerhans' cells and local imrnunity in the cervix of women in
early pregnancy
page 174
Chapter 8
Introduction
Pregnancy represents a state of endogenous immunosuppression 
with the mother exhibiting tolerance to the fetal allograft. The 
incidence of neoplasia in pregnancy is of the order of one per 
thousand pregnancies (Potter & Schoeneman 1970). Few tumours are 
known to be adversely affected by pregnancy eg malignant melanoma 
and breast carcinoma. However, the changes occuring in the genital 
tract and in the breast in response to pregnancy may influence 
subsequent management. The most common tumour of the lower genital 
tract in pregnancy is carcinoma of cervix with an incidence around 
1 in 2200 pregnancies (Hacker et al. 1982). The reported rate for 
abnormal cervical cytology in pregnancy is about five fold greater 
than in the non-pregnant population (Shepherd 1984). The 
opportunity to perform cervical cytology in this 'captive' 
population probably contributes to the overall detection of 
carcinoma-in-situ in 1 in 750 pregnancies.
As mentioned previously the main immune response to viral 
infections and to tumours is thought to be T-cell mediated. This 
is the same mechanism responsible for graft rejection. An idea of 
in-vivo impaired T-cell function is obtained when the clinical 
course of viral infections in pregnancy are considered. Vulval 
condylomata proliferating throughout pregnancy and regressing 
spontaneously in the peurperium serve as one exanple. In-vitro 
studies of cell mediated immunity in human pregnancy relate to 
results of the mixed lymphocyte reaction (MLR). This reaction 
depends on the ability of specifically sensitised (maternal) 
lymphocytes to undergo cell division and proliferation in response
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to foreign (fetal or paternal) antigens. Purtillo, Ealgren & Yunis 
(1972) reported impaired T-cell blast response to 
phyto-haemaglutinin (PHA) when lymphocytes from peripheral blood 
of pregnant women were compared with the response of non-pregnant 
patients. Hsu (1974) performed similar experiments but found that 
the impaired response to PHA was dependent on the lymphocyte 
culture being performed in serum from the pregnant patient. When 
culture was performed in reference serum the impaired response was 
no longer significant when compared with controls, implying that 
in pregnancy there were inhibitory circulating factors affecting 
normal lymphocyte function.
Since pregnancy also produces a state of naturally 
compromised T-cell function that seems to predispose to cervical 
epithelial abnormalities, the Langerhans' cell numbers and 
lymphocyte sub-populations in cervix were studied in a small group 
of women in early preganncy.
Recruitment of Patients
Pregnant patients undergoing termination of pregnancy gave 
consent to a punch biopsy of cervix being taken during the 
procedure. Ethical Committee approval was obtained prior to 
collection of biopsies. Twenty patients agreed, all were under the 
care of Dr A B MacLean in the Western Infirmary, Glasgow and all 
had negative cervical cytology on smears taken in the outpatient 
department earlier in their pregnancies. Details of their ages, 
parity and time since last menstrual period are shown in Appendix 
Hie (p. 259). It was deemed unjustifiable to take biopsies from 
patients in later continuing pregnancy because of the risk of 
bleeding caused by the increased vascularity of the cervix.
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Patients presenting with abnormal cytology in pregnancy are not 
usually biopsied, unless microinvasion or frank carcinoma is 
suspected on colposcopy, because of the risk of bleeding and are 
hence not studied in this chapter.
Normal histology was confirmed on haematoxylin and eosin 
staining of the frozen sections cut from the punch biopsies taken.
Materials and methods
The punch biopsies taken were mounted and frozen as 
previously described before cryosections were cut. The same 
indirect immunoperoxidase technique and monoclonal antibodies were 
used as throughout this study.
Results
There were no differences in the number of Langerhans' cells 
per 100 basal cells counted in the transformation zone comparing 
the pregnant patients (mean 7.3; SD 2.7; 95% Cl 6.0 to 8.6) with 
the normal (mean 8.0; 95%CI 6.7-9.2) and pre-transplant patients 
(mean 6.1; 95%CI 4.4-7.7). Significantly greater numbers were
found in the pregnant patients when compared with the renal 
transplant recipients (mean 4.1; 95%CI 3.1-5.2). Scheffe s
correction at the 5% level was used for the multiple comparisons 
performed.
Analysis of variance and multiple comparisons using Scheffe s 
correction on the lymphocytic infiltrate showed significantly 
lower percentages of cytotoxic cells in the epithelium of the 
pregnant patients compared with normal (Table 10, p. 105) and with 
the uraemic patients (Table 32, p. 171). The percentage of stromal 
cytotoxic T-cells was also less compared with the transplant
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patients. These features can be explained by the significantly 
reduced number of helper cells seen in the latter group resulting 
in greater percentages of cytotoxic cells. The results of 
quantitative assessment of the infiltrate are shown in Table 33.
Table 33. Analysis of variance of T cell counts per unit area in 
typical transformation zone of women in early pregnancy.
Marker/Area Cases Mean SD 95% Confidence Intervals
CD 3 epith (N) 20 182.8 84.3 143.4 to 222.2
CD 8 epith (N) 20 140.2 59.5 112.4 to 168.0
CD 8 epith (%) 20 78.6 13.5 72.3 to 85.0
CD 4 epith (N) 20 43.3 39.7 24.7 to 61.9
CD 4 epith (%) 20 22.6 15.4 15.4 to 29.9
CD 3 stroma (N) 20 337.5 128.0 277.6 to 397.5
CD 8 stroma (N) 20 137.3 92.8 93.9 to 180.7
CD 8 stroma (%) 20 40.6 21.2 30.7 to 50.6
CD 4 stroma (N) 20 204.2 111.8 151.8 to 256.5
CD 4 stroma (%) 20 62.6 25.6 50.7 to 74.8
See Note Table 10, p. 105.
No differences were apparent between the pregnant patients 
and the pre-transplant patients for any variable examined.
There was no significant difference in the numbers of 
cytotoxic cells in the epithelium or stroma comparing results from 
the transformation zone of the pregnant patients , with the normal 
controls (Chapter 3)/ transplant (Chapter 6) or the uraemic 
patients (Chapter 7). Graphical comparisons of the lymphocytic 
infiltrate in the pregnant patients with the normal, uraemic and 
renal transplant recipients are shown in Appendix IV.
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Comments
The results of investigations in pregnancy show no 
significant changes in the number of Langerhans' cells in the 
transformation zone of cervix and only minor alterations in the 
helper/cytotoxic cell ratio when compared with the normal 
non-pregnant population. The small changes are perhaps an 
indication that there are greater alterations in later pregnancy 
when any effect on the marrow would be expected to be more 
obvious. The drawbacks of pursuing this type of investigation into 
later pregnancy have been mentioned previously.
The comparison with the transplant group shows no difference 
in the number of cytotoxic cells present, but the significantly 
reduced number of helper cells in the exogenously suppressed renal 
transplant recipients produces alterations in the helper/cytotoxic 
ratio.
The higher prevalence of abnormal smears and CIN in pregnancy 
could be explained by opportunistic cervical screening in a 
fairly captive population, many having their first ever smear. 
Because of its transient nature it is difficult to imagine that a 
truly higher incidence of CIN occurs during pregnancy. Although 
marked immunological changes develop in very early pregnancy, this 
is not reflected in the cervical epithelium towards the end of the 
first trimester. The short term immunosuppression of pregnancy 
could result in some lesions developing or progressing, but with 
the completion of pregnancy it would be expected that many of 
these lesions should regress. This is indeed the clinical course
of many genital warts in pregnancy.
The renal transplant recipient is not subject to transient
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immunosuppression but to long-term immunosuppression and it seems 
likely that the increased incidence of CIN is secondary to 
sustained effects on the bone marrow.
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Chapter 9
Langerhans' cells and local immunity in carcinoma of cervix
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Chapter 9
Introduction
Routine histological methods offer little in the way of 
predicting the subsequent behaviour of tumours. The marked 
lymphocytic infiltrate seen in some tumours, eg seminoma of testis 
and medullary carcinoma of breast, stimulated speculation that the 
lymphocytic infiltrate may be of some prognositc significance. 
Underwood (1974) reviewed the published literature and noted that 
positive prognostic correlation had been reported in carcinoma of 
cervix for tumour infiltrates of eosinophils (Schoch 1926) and 
mast cells (Graham & Graham 1966).
The use of monoclonal antibodies permits the examination of 
various facets of the immune response including the lymphocytic 
infiltrate in much greater detail than was possible in earlier 
studies. In-situ studies of Langerhans' cells and the local immune 
response to tumours derived from squamous epithelium have almost 
totally concentrated on skin tumours especially basal cell and 
squamous carcinoma (Synkowski, Schuster & Orlando 1985; Gatter et 
al. 1984; Murphy et al. 1983; Guillen, Day & Murphy 1985).
Squamous carcinoma of cervix is considered by most 
authorities to be the result of progression of a minority of 
pre-invasive lesions (see introduction) and would appear to be a 
suitable end point of a study which has concentrated on the local 
immune response to CIN.
Patients
Specimens from 10 patients undergoing radical hysterectomy 
with node dissection were collected. They were under the care of
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Dr J A Davis, Stobhill General Hospital, Glasgow. All had had 
prior colposcopic assessment and biopsy confirmation of invasive 
squamous carcinoma of clinical stage lb or Ha. None had had prior 
cone biopsy performed. Details of their age and parity, in 
addition to the findings from the routine histology from the gross 
specimen including tumour differentiation, extent of local spread 
and nodal metastases, are shown in Appendix IIIf (p. 260).
Methods
Blocks of cervix were cut from the fresh specimen following
amputation of the cervix and removal of the vaginal cuff. The
blocks were taken from the margin of tumour, where possible to
include the cervical canal and adjacent normal cervix and in such
a manner to cause the least disruption to the specimen. Blocks 
were cut with the pathologist responsible for reporting the 
routine histology in attendance.
The method of orientating, freezing and cutting the blocks 
was similar to that described for the study of blocks cut from 
'normal' patients undergoing hysterectomy in Chapter 2. Every 
fifth section was stained with haematoxylin and eosin for 
comparison with the sections taken from the fixed specimen.
The requirement for a reduced concentration of hydrogen 
peroxide was most evident in the large sections obtained from 
these tumours due to the presence of large amounts of endogenous 
peroxidase activity which caused some sections to 'float'. The 
same panel of monoclonal antibodies as described in previous
chapters was used.
The Langerhans' cells were counted per 100 basal cells in the 
adjacent normal cervix and per high power field (X400
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Figure 15.
Langerhans" cells in cervical carcinoma - abundant cells. 
Langerhans" cells stained with NA 1/34 are seen in large number 
in the tumour (t) being absent from the stroma (s).
Total magnification X 145.
t
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t
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Figure 16.
Langerhans" cells in cervical carcinoma - reduced cells.
The islets of tumour cells (t), the stroma (s) and two 
Langerhans" cells are indicated stained with NA 1/34. 
Total magnification X 362.
magnification) in the nests of invasive squamous cells. The
lymphocytic infiltrate in the tumour was assessed on a semi-
quantitative basis (Whitwell et al. 1984). Image analyser results
were also collected for the Langerhans' cell counts and
lymphocytic infiltrate.
Results
The numbers of Langerhans' cells in the ectocervix adjacent 
to the tumours are shown in Table 34. These are significantly less 
(p<0.05) than those counted in normal ectocervix per 100 basal 
cells (mean 8.2; 95% Cl 6.8-9.6) and with the image analyser (mean 
13.32; 95% Cl 11.86-14.78).
Table 34. Langerhans' cells counted by two methods in ectocervix 
of patients with stage Ib/Ila squamous carcinoma of cervix.______
Measurement Cases Mean SD 95% Confidence Interval
/ 100 basal 
cells
10 5.8 3.5 3.3 to 8.3
/ unit area 10 7.86 4.49 4.6 to 11.07
Note. Mean, SD & 95% Cl (of mean) are of cell counts.
There is no suitable control for the the numbers counted in 
the malignant epithelial islands, but it is apparent that there 
are vast differences in Langerhans' cell densities in these 
squamous tumours (Figures Id & 15; Appendix Illf), with some being 
almost totally devoid of Langerhans' cells while sane tumours 
showed them in large numbers (range 1 to 77 per high power field).
In addition to the vast differences in Langerhans' cell 
numbers, there were also marked differences seen in the patterns 
of epithelial class I and class II antigen staining in the islets
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Figure 17.
Absent epithelial cell MHC class I expression in cervical 
carcinoma.
The islets of tumour cells (t) and stroma (s) are indicated.
The malignant epithelial cells lack MHC class I antigen 
expression when stained with W6/32.
Total magnification X 145.
of malignant cells.
Class II epithelial antigen staining was present in the 
diffuse patterns seen in the cases with CIN previously described. 
Four of the tumours demonstrated MHC class II positivity with five 
being negative. In one patient the normal ectocervix showed 
diffuse positive staining (Table 35).
Class I epithelial antigen staining was subjectively 
increased in all but one of the cases, in which the malignant 
epithelium was virtually devoid of these antigens (Figure 17; 
Table 35). It is also interesting to note that this was the only 
tumour in which nodal metastases were found.
Table 35. Epithelial cell expression of MHC class I and class II 
antigens in stage Ib/Ila squamous carcinoma of cervix._________
Patient MHC class I MHC class II
5022 +++ neg
5025 ++ pos
5031 +++ pos
5046 neg neg
5058 ++ neg
6002 +++ neg
6008 + neg
6012 ++ pos
6014 +++ neg
7041 +++ pos
Note.+=normal expression ++=slight increase -H-+=moderate increase 
pos=positive neg=negative
There was no such vast differences noted in the total 
lymphocytic infiltrate although there were variations in the
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proportion of helper and cytotoxic cells ranging from 4:1 to 
almost 1:1 (Table 36). The bulk of the infiltrate was confined to 
the stroma with little in the malignant epithelium similar to the 
situation in normal cervix. In most tumours the infiltrate was 
maximal at the periphery being lesser towards the centre.
The bulk of the infiltrate was of T-cells, although B-cells 
were noted in four tumours being marked in one. Macrophages were 
scant in two tumours but none was totally devoid. Natural killer 
cells were not recorded in any significant numbers (Table 37).
There was no apparent correlation between the numbers of 
Langerhans' cells, presence or absence of class II positive 
epithelial staining and the lymphocytic infiltrate.
Table 36. Image analyser & semi-quantitative analysis of the T
cell numbers in patients with stage Ib/IIa cervical carcinoma.
Image Analyser Semi-quantitative
Patient CD 3(N) CD 8(%) CD 4(%) CD 3 CD 8 CD 4
5022 485 19 81 +++ + +++
5025 111 46 112 -H-++ + +++
5031 638 33 93 +++ + ++
5046 512 48 59 -H~H- ++ ++
5058
6002 649 49 52 +++ ++ +++
6008
6012 618 33 73 ++ + +++
6014 681 50 68 +++ ++ +++
7041 533 47 171 + ++ +++
Note. N= number of CD3 cells %=(no. cells/total CD3 cells)X100)
0=neq +/--=occ +=slight ++=mod +++=heavy ++++-V heavy
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Table 37. Semi-quantitative assessment of the numbers of B cells, 
macrophages & NK cells in stage lb and IJa carcinoma of cervix.
Patient B-cells 
CD 22
Macrophages 
CD 15
*  +  w * .  v w i ,  v •
Natural Killer (NK) cells
5022 0 + + +
5025 0 +/- 0
5031 + + + + + + +
5046 0 + +/-
5058
6002 0 + + + + +/-
6008
6012 + + + + + +/-
6014 + + . +/- 0
7041 + + + + 0
Note. 0==neg +/-=occ +=slight ++=mod +++=heavy ++++=v heavy
Comments
The tumours studied represent early localised disease in
patients of a generally younger age group than that normally 
associated with invasive cervical carcinoma. This highlights the 
fact that the essential treatment for cervical carcinoma is 
radiotherapy with only a small highly selected group being
eligible for surgery. The methods employed in the in-situ study of
the local immune response requires that representative samples of 
tumour are obtained. Superficial biopsies of Stage III or TV 
tumours, although easily collected in a hospital acting as a
referal centre for radiotherapy, would not have been 
representative of the local immune response because of the
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superficial tumour necrosis and infection that occurs, hence 
specimens were collected only from those with resectable tumours 
who had no more than small superficial biopsies taken previously 
for diagnosis. Those who had cone biopsies taken prior to radical 
hysterectomy were not studied in order to avoid any confusion that 
may have arisen from the healing change following a large biopsy. 
Lastly, all tumours had to be of sufficient size to allow blocks 
to be cut for routine diagnostic histology and for frozen 
section.
The immune response in squamous cell carcinoma of the cervix 
has been studied mostly by examining the lymphocyte subsets in the 
peripheral blood, with additional information on cell mediated 
immunity being obtained from study of the response to cutaneous 
challenge with contact sensitising agents. Work by Rand, Jenkins & 
Bulmer (1977) demonstrated a significantly reduced percentage of
T-cells compared with normal controls in advanced carcinoma of
cervix (stage 3 and 4), but not in stages 1 and 2. Conversely the 
percentage of B-cells was significantly increased in the later 
stages. The significance was lost when absolute numbers of
lymphocytes were counted. Ishiguro, Sugitachi & Katoh (1979) also 
noted decreased numbers of B-cells in advanced carcinoma,
however, they noted decreased numbers of T-cells in all stages. 
They also recorded that the numbers of T-cells binding with sheep 
rosettes after short incubation periods, so called "active' 
T-cells, were also reduced in all stages. In patients with 
cervical carcinoma, Levy et al. (1978) documented impaired T-cell 
mechanisms (as assessed by in-vitro lymphocyte stimulation assays 
and in-vivo delayed hypersenstivity testing to a variety of 
antigens). Once again patients with advanced disease were found to
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have significantly reduced numbers of T-cells and increased
B-cells compared with normals but also significantly reduced 
positive responses to all the contact antigens studied. Lymphocyte 
stimulation with phytohaemagglutinin was significantly reduced in 
advanced disease. Impaired cellular immunity was also detected in 
many of the patients with early disease. When frozen sections of 
the tumours were examined, using immune adherence to detect T and 
B cells, there was no obvious pattern linking the local infiltrate 
in the tumour with the stage of disease and no relation of the 
individual tumour infiltrate with the in-vitvo response. This 
prompted the Levy and colleagues to comment that the immune 
response at the peripheral level is not a good indicator of the 
response in the tumour. From these studies it is evident that 
advanced cervical cancer results in depressed T-cells both
functionally and quantitatively; however, in early disease there 
is less agreement although there is the suggestion that a
substantial proportion of these tumours are associated with 
impaired T-cell mechanisims.
The results presented in this chapter agree in some respects 
with the results from earlier studies, suggesting that there is a 
diverse immune response in early tumours with no obvious pattern 
of cellular infiltrate and great variability between different 
tumours. The predominant infiltrate is of T-cells, with the helper 
subgroup predominating in the vast majority. Robins & Baldwin 
(1985) have suggested that the rejection of tumours is essentially 
a T-cell mediated phenomenon with both main subgroups being 
important. Antibody dependent responses appear to be of little 
consequence. This in-situ study shows that B-cells were only 
present in any quantity in three of the tumours. However, Sano &
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Ueki (1987) have claimed that B-cell derivatives (plasma cells) 
may have a role in limiting the invasive potential of cervical 
carcinoma.
Despite the anti-tumour role of the natural killer cell there
is little evidence that these cells made any significant
contribution to the local immune response in the early tumours 
examined, being only present in the minority of tumours and in 
very small numbers. Macrophages were a consistent finding.
Once again the main interest remains with the T-cells and 
their interactions with one another and with the target cell in 
the efferent response. The great variation in the numbers of
Langerhans" cells seen in the tumours could represent large
differences in the hosts" ability to present neoantigens to the 
immune system. It is difficult to be certain of the significance, 
if any, of the reduced Langerhans" cells adjacent to the lesions 
which may precede the tumour development or be a consequence of 
its presence. The presence or absence of class II antigen
expression on the tumour cells could also be exerting effects on 
the afferent and efferent immune response, although evidence of
this is not apparent in contrast with the results obtained in
CIN. Perhaps the most interesting observation is the loss of class 
I antigens on the one tumour in which nodal metastases were 
detected. The dual recognition by the cytotoxic T-cells of the 
target cell class I antigens and foreign antigen has been
mentioned in previous chapters and loss of these antigens in 
murine virus induced tumours which demonstrate progressive growth 
has been recorded (Bernards et al. 1983), as have similar findings 
in some primary breast tumours (Whitwell et al. 1984). By shedding 
its class I antigens the tumour may effectively be evading the
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immune effector cytotoxic T-cells, thus allowing progressive 
growth and ultimately metastases. Despite this attractive
hypothesis, it should be remembered that this class I negative
tumour was removed from a patient 20 weeks pregnant at Caesarean
hysterectomy and other factors may have been operating to
encourage early nodal metastases in this case.
The loss of cell surface antigens and the association with 
nodal metastases in cervical carcinoma are not totally novel since 
Davidsohn et al. (1973) reported that A, B and H blood group
antigens were lost in 92% of primary tumours and in 91% metastatic 
tumours in a group of patients who all died of metastatic cervical 
carcinoma. They interpreted the loss of these antigens as an
expression of loss of cellular differentation preceding 
metastases. These antigens were present on all benign lesions of 
cervix although their results of findings in preinvasive lesions 
are not clear. The hypothesis presented above suggests that loss 
of cell surface antigens may result in local immunocompromise
facilitating spread of the tumour. Taking this argument further, 
prognostic significance has been attached to loss of A,B and H 
blood group antigens (Lindgren et al. 1986).
The most marked lymphocytic activity was observed in the 
stroma at the periphery of the tumours with in most instances the 
reaction sharply localised to this area. There was very little in 
the islets of malignant epithelium and, although it is difficult 
to infer T-cell activity merely from their presence, the bulk of 
the T-cells were class II positive probably supporting this 
theory. Van Nagel et al. (1978) suggested that a marked 
lynphocytic infiltrate was significantly associated with decreased 
nodal metastases and tumour recurrence, but was of no relation to
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tumour differentiation in the primary or secondary deposits in 
patients with stage lb disease. They found nodal metastases were 
positively associated with vascular like space involvement.
The results of this chapter are not substantially different 
from those in the only other study found in which monoclonal 
antibodies had been used to investigate the local immune response 
in cervical carcinoma. Ferguson, Moore & Fox (1985) reported a 
series of 10 patients with adeno- and squamous cervical carcinoma, 
only five of the latter were definite primary squamous 
carcinomata. Positive nodal metatases were found in three of these 
five tumours. MHC class I activity was absent in two and patchy in 
the other. No obvious relation to tumour differentiation was 
apparent. The point is well made that the results represent a 
qualitative assessment of class I activity and that even the 
negative tumours may be expresssing antigens below levels of 
detection with the immunoperoxidase technique. MHC class II 
activity was present in one of the tumours. A heavy leukocytic 
infiltrate was present in most, the bulk being stromal T-cells of 
the cytotoxic/suppresssor subtype. They also reported moderate 
numbers of macrophages and occasional heavy infiltrates of 13- 
cells. Once again natural killer cells were rarely present in the 
infiltrate. Langerhans" cells were not studied.
From studies containing small numbers of patients and others 
including various tumour cell types it is impossible to 
substantiate the claims of Van Nagel et al. (1978), but their 
conclusions certainly suggest that the local response to the 
tumour is of importance. Combined with the findings of Davidsohn 
et al. (1973), Lindgren et al. (1986) and Ferguson et al. (1985) 
together, with the results of the work presented in this chapter,
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it seems apparent that the local immune response in cervical 
cancer should be studied in larger numbers of patients using 
monoclonal antibodies to identify the local immunocompetent cells. 
The results from Langerhans" cell counts and the presence or 
absence of the major histocompatibility antigens would appear to 
be greatest interest in the earlier stages of squamous cell 
cervical carcinoma.
An interesting group to study would have been the very early 
microinvasive tumours. Most of these, however, are diagnosed on 
cone biopsies following abnormal cytology and unsatisfactory or 
suspicious colposcopy. Study of Langerhans" cells in these lesions 
was attempted using S-100 in specimens recovered from the files 
of the Pathology Department of the Western Infirmary, Glasgow, 
which had been diagnosed between 1977 and 1987. Staining with 
S-100 produced no consistent identification of Langerhans" cells 
in the areas where the breech in basement membrane had taken 
place, nor in any adjacent normal or abnormal epithelium, despite 
the clear staining of nerve fibres present in most blocks. The 
same problems were encountered in the study of S-100 positive 
Langerhans' cells in normal cervix (see Chapter 2).
Taking frozen sections from cone biopsies was considered 
unsuitable since considerable disruption to the specimen could 
have resulted in less than adequate sampling, with the possibiltiy 
that prognostically important vascular or lymphatic involvement 
would have been missed. Study of the local immune response in 
microinvasive carcinoma was therefore not pursued.
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CHAPTER 10 
General summary and conclusions
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CHAPTER 10
The malignant potential of CIN has been dicussed by many 
authors. It is now established that CIN represents a continuous 
spectrum of epithelial abnormality which, in a minority of cases, 
can progress to carcinoma of the cervix. It remains, however, 
impossible to predict which lesions will progress and which will 
not. Factors such as specific subtypes of human papillomavirus eg 
types 16 and 18 are said to be important in determining the 
malignant potential of these lesions, but convincing evidence 
supporting this hypothesis is awaited. Although there is an 
association between the presence of HPV infection and cervical 
neoplasia, HPV alone seems unlikely to be the causal agent since 
viral genomes are now being reported in controlled studies in the 
normal cervix. Papillomaviruses have been shown to be oncogenic in 
many species, but in all cases a cofactor has been identified to 
promote the malignant transformation. Such cofactors, identified 
in animals, include chemical carcinogens and ultraviolet light.
Ultraviolet light has many effects on squamous epithelium, 
and amongst these a reduction in the number and antigen presenting 
capabilities of Langerhans" cells have been identified. 
Langerhans" cells are a consistent component of normal squamous 
epithelium, and it has been postulated that they are the sentinels 
of a local immune system that involves a complex interaction 
between these cells, squamous epithelial cells and lymphocytes 
which preferentially circulate through the epithelium and local 
lymph nodes.
Dermatological research has shown that reduction in the 
number of Langerhans" cells can impair normal T-cell immune
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mechanisms and may, in some instances, result in tolerance to the 
challenging antigens. Moreover, in epidermodysplasia verruciformis 
there appears to be a link between HPV infection, reduction in 
Langerhans cells, exposure to ultraviolet light and malignant 
transformation of cutaneous lesions.
Impaired T-cell function is also a feature of 
epidermodysplasia verruciformis, and has been linked to the 
development of CIN, with systemically inmunosuppressed women being 
recognised as a group at high risk of cervical neoplasia.
Several studies have examined the relationship between 
Langerhans" cells and local immunity to cervical neoplasia. Most 
have examined relatively few cases and none have used control 
tissue in their studies. Difficulties arise in interpreting 
results from uncontrolled studies since factors associated with 
cervical neoplasia, such as smoking, oral contraceptive use and 
exposure to semen, are immunosuppressive in their own right. 
Moreover, it is only since control tissue has been probed for HPV 
genomes that the relation between HPV and cervical neoplasia has 
been doubted.
The work described in this thesis examined the cellular 
elements involved in local cervical immunity, particularly any 
changes occurring in these cells in association with cervical 
neoplasia. Since the main imnune response to tumours is thought to 
involve T-cell mechanisms, the work focussed on the T-cell subsets 
of helper/inducer and cytotoxic/suppressor cells and on factors 
stimulating their response. Special interest was therefore 
directed on antigen presenting Langerhans" cells and MHC class II 
antigens.
Preliminary work established that the best and most
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consistent marker for identifying Langerhans" cells was an anti 
T-6 monoclonal antibody (NA 1/34) used in an indirect 
immunoperoxidase method with Diaminobenzidene as the chromogen. 
Frozen sections cut from biopsies were necessary for application 
of this method. Substitution of NA 1/34 by alternative monoclonal 
antibodies allowed other cells of the immune system to be 
demonstrated.
For satisfactory histological interpretation of the frozen 
sections, the biopsies from which they were cut had to be 
carefully prepared and optimally orientated. Tissue-Tek II OCT, 
frozen in carbon dioxide ice, was the best embedding medium. The 
most notable conclusion from evaluation of other methods was that 
S-100 was an unreliable and inconsistent Langerhans" cell marker 
in routinely fixed and processed biopsies of cervix.
Quantitation of Langerhans" cells was best achieved using a 
standard length of cervical epithelium basement membrane (100 
basal cells) as the denominator. This measurement correlated well 
with other methods described in this work, but had the benefits of 
simplicity and reliability. Quantification of the lymphocytic 
infiltrate was best achieved using a computerised image analyser.
This study confirmed that in the cervix of normal patients 
the majority of the cellular infiltrate is of T-cells, with helper 
(T-4) cells predominating in the stroma and cytotoxic (T-8) cells 
in the epithelium. As no difference was found comparing the 
infiltrate in the ectocervix with that of the transformation zone, 
it was concluded that the transformation zone did not represent an 
area of enhanced immunological activity. More importantly, 
comparison of the Langerhans" cell numbers in these two areas of 
cervix, using different methods of enumeration and identification,
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indicated that the ectocervix was an appropriate internal control 
for the transformation zone. For the reasons disdussed previously 
the ready availability of such a validated control was considered 
important for the subsequent study of Langerhans" cells in CIN.
In the biopsies examined from 142 patients with CIN, a 
reduction in the number of Langerhans" cells was found in those 
lesions where the presence of human papillomavirus infection was 
shown on histological criteria and by DNA-DNA hybridisation 
studies. The latter studies showed that the reduced numbers of 
Langerhans" cells are related to the HPV subtype and amount of 
virus present.
Impaired local immunity mediated via reduced Langerhans" 
cells may thus be an important cofactor in HPV related cervical 
neoplasia, but it is impossible to determine frcm this type of 
study whether reduced Langerhans" cell numbers predispose to HPV 
infection and to cervical neoplasia in otherwise normal women. The 
increase in Langerhans" cells seen in the absence of HPV in the 
hybridisation studies suggests that factors other than HPV and 
impaired antigen presentation are implicated, but when the larger 
number of biopsies in the main study (see Chapter 4) are examined 
it is evident that a number of the lesions showing CIN only 
exhibit reduced Langerhans" cells. Thus in CIN the Langerhans" 
cell numbers range widely in the lesions showing HPV and in those 
without, with no significant between the various grades within 
each subgroup. This effect is not wholly surprising since CIN 
itself represents a continuous spectrum of disease. One further 
suggestion from the results, assuming that the immune response is 
dependent on the number of Langerhans cells, is that lesions with 
concomitant evidence of viral infection may be more likely to
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progress as a result of local immunocompromise than lesions 
without HPV.
The results from Chapter 4 also suggest that the neoplastic 
epithelial cells are implicated in the immune response to cervical 
neoplasia since the lymphocytic infiltrate was shown to be 
significantly greater in CIN with virus which expressed MHC class 
II antigens compared with those lesions which did not. Since the 
correlation between the number of Langerhans" cells and the 
lymphocytic infiltrate was only significant where low numbers of 
Langerhans" cells were present (under 7 per 100 basal cells), and 
then only in lesions lacking class II antigens, suggests that the 
cervical epithelium may have a threshold antigen presenting 
capacity determining local cervical immunocompetence. Compromise 
appears only to occur in the absence of epithelial cells 
expressing MHC class II antigens and when low numbers of 
Langerhans" cells are present. The antigen presentating capacity 
of abnormal cervical epithelium may thus be influenced by both 
qualitative and quantitative changes in MHC class II antigen 
expression, with Langerhans" cells determining the former and the 
epithelial cells being able to influence the latter. Thus, escape 
from local immune surveillance in the cervix, secondary to a low 
antigen presenting capability, could result in tolerance to 
neoantigens and may ultimately determine the natural history of 
the lesion. It is possible that the quantitative effect of the 
epithelial cells in CIN is the most important factor, since their 
influence was shown to involve the infiltrate in the epithelium 
and stroma. In addition, the percentage of cases lacking MHC class 
II antigens almost fits the percentage of cases of CIN that would 
be expected to progess, some eventually to carcinoma, without
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taking account of the number of Langerhans" cells in the lesion.
Although a low antigen capacity may result in immunological 
compromise, lack of MHC class II antigens and Langerhans" cells 
are not consistent findings in invasive carcinoma of the cervix. 
The results emphasise the need to consider other factors, such as 
loss of MHC class I antigens, in escape from inmune surveillance. 
In the pre-invasive changes of CIN, however, this does not appear 
to be a feature since the afferent T-cell mechanism seems to be 
the limiting factor in determining the resultant immune response.
The above conclusions suggest that Langerhans" cells are 
reduced as a consequence of HPV infection, perhaps due to a 
cytopathic effect of the virus. However, this hypothesis may be 
invalid since reduced Langerhans" cells and helper T-cells were 
shown to be features of the typical transformation zone of "high 
risk" renal transplant recipients on immunosuppressive therapy. 
Thus impairment of antigen presentation by cervical epithelium may 
permit the development of cervical neoplasia (and HPV infection) 
in the compromised host. In the non-immune compromised woman, 
cervical neoplasia may develop as a consequence of a local immune 
defect in the cervix that is potentiated by cigarette smoking, 
oral contraceptive use and exposure to semen.
The results from the renal transplant recipients also suggest 
that, despite the theoretical risk of neoplasia associated with 
the use of cyclosporin, especially in relation to its effects on 
helper T-cells, the effects are not seen locally in the cervix nor 
reflected in a higher prevalence of CIN in women treated with this 
drug than in those on azathioprine. Indeed, the converse is true.
The increased prevalence of cervical neoplasia in renal 
transplant recipients seems to result from systemic
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immunosuppression, and is not a consequence of long term renal 
disease as indicated by examination of the patients in Chapter 7. 
As patients in renal failure are also reported to be immune
suppressed, this lends support to the notion that slight
reductions in immunocompetence may be not sufficient to place
women at risk of cervical neoplasia. However, patients in chronic 
renal failure who are not being actively dialysed may be a
potential high risk category, since they show reduced numbers of 
Langerhans" cells in the transformation zone. There are reports 
suggesting that uraemic patients are also at risk of cervical 
neoplasia but whether or not this relates to the dialysed and/or 
un-dialysed woman is not known.
The results described in Chapter 7 may be explained on the 
basis that treatment of renal failure lessens the suppressive 
effects of uraemia on the bone marrow so that the Langerhans" 
cells of the transformation zone of cervix return to the normal 
range, when compared with the reduction seen in the non-dialysed 
women.
Pregnant patients are another group in which T-cell function 
is compromised and in which an increased prevalence of CIN is 
reported. Examination of the cervices from patients in early 
pregnancy showed no differences in the number of Langerhans" 
cells or in the lymphocytic infiltrate when compared with normal 
cervices. This may support the hypothesis that the duration of 
immune suppression is an important factor in determining the risk 
of neoplasia. It also implies that factors other than local immune 
compromise in the cervix contribute to the high prevalence of 
abnormal smears in pregnancy. Since many women receive their first 
smear in pregnancy, this may explain most of the reported increase
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in abnormal cervical cytology.
It is possible to conclude from the clinical work presented 
in this thesis that women at high risk of cervical neoplasia 
represent a screening problem on two counts. Firstly, it has been 
shown such patients are not being screened effectively by cervical 
cytology alone; secondly, and of more concern, many are not being 
screened at all, presumably because they are not thought of as 
being at high risk. Therefore, further education of patients and 
practitioners alike seems appropriate since the failure of the 
current cervical screening programme is mainly due to failure to 
screen the at risk patient. This situation could be improved if 
the small number of renal transplant recipients in whom there is 
poor correlation between histology and cytology had yearly 
colposcopy as a screening procedure.
Longitudinal screening of patients awaiting renal 
transplantation should confirm that the high prevalence of CIN, 
and HPV infection, seen in women after transplantation represents 
secondary effects of prolonged systemic immunosuppression. It 
remains to be determined whether or not changes in the surface 
major histocompatibilty antigens have any prognostic significance 
in defining the malignant or invasive potential of CIN. This could 
not be investigated further in the work described in this thesis 
because it is not considered ethical to leave CIN untreated. 
Long-term follow-up of patients with cervical carcinoma should 
determine whether or not there are any features of the local 
immune response able to predict the behaviour of the tumour. 
Therefore more detailed examination of the surface antigenic 
changes on the epithelial cells, throughout the complete spectrum 
of cervical neoplasia, could form the basis for future studies.
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APPENDIX I - STAINING TECHNIQUES
la. Indirect immunoperoxidase technique on
using Monoclonal Antibodies (MacKie 1982).
1) Frozen sections on gelatinised slides 
Air dry
2) Fix in 100% acetone
3) Wash in tris saline
4) 3% H202 (diluted in tris buffer)
5) Wash tris saline - 3 changes
6) Normal rabbit serum 
(1:5 in tris buffer)
7) Pour off
8) Add monoclonal antibody
(1:100 tris buffer)
9) Wash tris saline - 3 changes
10) Rabbit anti-mouse antibody/
Peroxidase congugated (DAKO) 1:20
(in 1:1 normal human serum:tris buffer)
11) Wash tris saline - 3 changes
12) 0.03% Diaminobenzidene (in 100 mis tris 
buffer + 1 drop
13
14
15
16
17 
16
18
19
20 
21 
22
100 vol H202)
Wash in running tap water '
Counterstain with Harris's haematoxylin
Wash in running tap water
Differentiate in 1% acid alcohol
Wash in running tap water
Blue in Scotts tap water substitute
Wash in running tap water
Dehydrate in methylated spirit
Absolute alcohol - 2 changes
Xylene
Mount in Histomount
frozen sections
3 minutes 
10 minutes 
1 minute 
15 minutes 
5 minutes
20 minutes
60 minutes 
5 minutes
45 minutes 
5 minutes
5 minutes 
5 minutes
2 minutes 
1 minute
30 seconds 
1 minute 
30 seconds
3 minutes 
5 minutes 
5 minutes 
5 minutes
Acetone fixation, all washes, hydrogen peroxide treatment, 
and diaminobenzidene incubation are performed in COPLN JARS.
Normal rabbit serum blocking, and antibody incubations are 
performed in moist chambers at room temperature after 
carefully wiping round sections to ensure a concentrated drop 
of fluid on each.
Reagents 
Tris Buffer
0.01M pH 7.6
6.06g Trizma Hydrochloride (Sigma)
1.39g Trizma Base (SIGMA) 
dissolved in 1 litre distilled water 
Tris Saline
900mls 0.85% saline 
lOOmls tris buffer 
3,3 Diaminobenzidene (Pelliniemi et al. 1980)
600mgs 3,3 Diaminobenzidene Tetrahydrochloride (Sigma) 
dissolved in lOOmls tris buffer Q
aliquoted into 5mls vials and frozen at -20 C 
thawed before use and added to 95mls tris buffer
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Ib. Monoclonal antibody technique on fixed tissue sections 
(including periodate lysine paraformaldehyde fixation).
1) Take sections to water 
Xylene
Absolute Alcohol 
Methylated Spirit
2) Wash in tris saline
3) Methanol (100 ml) + 0.5% BLXt, (0.5 ml) + 
0.01% HC1 (0.2 ml) z 1
4) Wash tris saline - 3 changes
5) Normal rabbit serum 
(1:5 in tris buffer)
Pour off
Add monoclonal antibody at varying dilution 
tris buffer (room temperature or 37 C)
Wash tris saline - 3 changes 
10) Rabbit anti-mouse antibody/
Peroxidase congugated (DAKO) (1:20 
in 1:1 normal human serum:tris buffer)
Wash tris saline - 3 changes 
0.03% Diaminobenzidene (in 100 mis tris
6)
8)
9)
11
12
13
14
15
16
17 
16
18
19
20 
21 
22
buffer + 1 drop 100 vol HJD-x
Wash in running tap water '
Counterstain with Harris's haematoxylin
Wash in running tap water
Differentiate in 1% acid alcohol
Wash in running tap water
Blue in Scotts tap water substitute
Wash in running tap water
Dehydrate in methylated spirit
Absolute alcohol - 2 changes
Xylene
Mount in Histomount
in
7 minutes 
5 minutes 
3 minutes 
1 minute
15 minutes 
5 minutes
20 minutes
60 minutes 
5 minutes
45 minutes 
5 minutes
minutes
minutes
minutes
minute
30 seconds
1
30
3
5
5
5
minute
seconds
minutes
minutes
minutes
minutes
Tretment with Trypsin was tried before staining (see S-100 on 
fixed sections) with no effect. The amplification afforded by 
the use of the alkaline phosphatase method also showed no 
significant improvement in staining (see APAAP on fixed and 
frozen sections).
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Ic. Alkaline Phosphatase ( APAAP ) on frozen sections.
1) Sections on gelatinised slides. Air dry
2) Fix in acetone
3) Allow to dry
4) Normal rabbit serum 1:5 tris buffer
5) Pour off
6) Add appropriate monoclonal antibody 
at correct dilution, at room temperature
7) Wash tris saline - 3 changes
8) Uncongugated rabbit-anti-mouse antibody 
1:50 ( in 1:1 tris buffer and normal 
human serum) at room temperature
9) Wash tris saline - 3 changes
10) Add APAAP complex - 1:100 tris buffer
11) Wash tris saline - 3 changes 
Repeat steps 8 to 11 to enhance reaction 
using 10 minute incubations
12) Add alkaline phosphatase substrate
13) Wash tris saline - 3 changes
14) Wash in tap water
15) Counterstain lightly in haematoxylin, only 
blued in Scotts tap water substitute
16) Water mount
17) Seal with nail varnish
Reagents.
Alkaline phosphatase substrate.
Naphthol AS-MX Phosphate (Sigma) 2 milligrammes (mg) 
in 0.2 millilitres (ml) Dimethylformamide 
+ 9.8 ml tris buffer pH 8.2 
+ 2.4 mg Levamisole (Sigma)
Mix and add Fast Red salts (Sigma) 1 mg per ml 
Filter mixture on to slides
5 minutes 
10 minutes
10 minutes
60 minutes 
5 minutes
30 minutes 
5 minutes 
30 minutes 
5 minutes
15 minutes 
5 minutes
30 seconds
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Id. Alkaline Phosphatase ( APAAP ) on fixed tissue sections.
1) Take sections to water 
Xylene
Absolute Alcohol 
Methylated Spirit
2) Wash in tris saline
3) Normal rabbit serum 1:5 tris buffer
4) Pour off
5) Add appropriate monoclonal antibody
at correct dilution, at room temperature
6) Wash tris saline - 3 changes
7) Uncongugated rabbit-anti-mouse antibody 
1:50 ( in 1:1 tris buffer and normal 
human serum) at room temperature
8) Wash tris saline, 3 changes
9) Add APAAP complex, 1:100 tris buffer
10) Wash Tris saline - 3 changes
Repeat steps 8 to 11 to enhance reaction 
using 10 minute incubations
11) Add alkaline phosphatase substrate
12) Wash tris saline - 3 changes
13) Wash in tap water
14) Lightly counterstain in haematoxylin only 
blued in Scotts tap water subsitute
15) Water mount
16) Seal with nail varnish
Reagents as for APAAP on frozen sections.
5 minutes 
3 minutes 
1 minute 
5 minutes 
10 minutes
60 minutes 
5 minutes
30 minutes 
5 minutes 
30 minutes 
5 minutes
15 minutes 
5 minutes
30 seconds
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Ie. Adenosine triphosphatase ( ATP-ase ) on frozen sections.
3 minutes
90 minutes
5 minutes
90 minutes
5 minutes
3 minutes
5 minutes
3 minutes
5 minutes
1) Twenty micron frozen sections - air dry
2) Fix in Formol-Cacodylate-Sucrose at 4 C
3) Wash well in running tap water, finally 
rinse in distilled water
4) Place in incubating medium at 37° C
5) Wash in 1% calcium chloride - 3 changes
6) Treat in 2% cobalt chloride
7) Wash in running tap water
8) Develop in 1% ammonium sulphide
9) Wash well in running tap water
10) Dehydrate through methylated spirit, 
alcohol, Tartrazine in Cellosolve and
clear in Xylene - mount in Histomount
Result ATP-ase activity - Black / Brown 
Background - Yellow
Reagents
Formol-cacodylate-sucrose fixative
( Hayashi & Freiman ( 1966 ). Journal of Histochemistry and 
Cytochemistry, 14, 577-581 )
Digsolve 40 g paraformaldehyde in 100 ml distilled water
at 65 C, add 40% sodium hydroxide dropwise until solution
clears to produce methanol-free formaldehyde
0.1 m cacodylate buffer pH 7.2 90 ml
40% methanol-free formaldehyde 10 ml
sucrose 12.5 g
sodium pyrophosphate 125 mg
Adjust pH to 7.4 before use with N sodium hydroxide 
added dropwise.
Incubating medium
( Padykula and Herman, as in Pearse (1968) Histochemistry, 
edition III, volume l,pp 720 )
Solution made freshly before use
0.1 m sodium barbiturate 20 ml
0.18 m calcium chloride 10 ml
distilled water 30 ml
Disodium Adenosine Triphosphatase 
(Sigma) 152 mg
As soon as the ATP has dissolved the pH is 
adjusted to 9.4 with 0.1 m sodium hydroxide.
Slight turbidity may be cleared by filtration.
Tartrazine in Cellosolve
Saturated solution of Tartrazine in Cellosolve
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If. Adenosine triphosphatase (ATP-ase) on epithelial sheets.
1) Flatten sheets in normal saline
2) Transfer to Cacodylate Formaldehyde, 4°C
3) Wash in normal saline, 3 changes
4) Add 1:10 dilution of 2% Lead Nitrate
in Stock ATP and mix well
Incubate at 37°C
5) Wash in normal saline - 3 changes
6) Develop in 5% ammonium sulphide
7) Allow to dry
8) Mount in glycerin
9) Seal with nail varnish
Reagents.
Cacodylate formaldehyde
Sucrose 6.85 g
40% Formaldehyde 10 ml
0.2M Cacodylic Acid 40 ml
Distilled water 50 ml
Stock adenosine triphosphatase (ATP)
DiSodium ATP (Sigma) 50 mg
Glucose 5 g
tris buffer 40 ml
1.2% Magnesium Sulphate 10 ml
Stock ATP lead nitrate
Stock ATP 5.4 ml + 0.6 ml Lead Nitrate sufficient for 10 
sheets.
10 minutes 
10 minutes
60 minutes 
5 minutes 
90 seconds
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Ig. S-100 on fixed tissue sections.
1) Sections on Polylysine slides 
Take to water as above
2) Wash tris saline
3) Wash in pre-warmed tris saline (37 C)
4) Trypsinse. 0.1% CaCl / 0.1% Trypsin (Sigma) 
in H~0 . Adjust pH to 7.8 with 0.1M
NaOH and bring to 37 C
5) Wash in cold running water
6) Methanol (100 ml) + H.,0, (0.5 ml) +
HCl (0.2 ml)
7) Wash in tris saline
8) Normal swine serum : tris buffer (1:5)
9) S-100 at 1:50, 1:100, 1:200 in tris buffer
10) Wash tris saline - 3 changes
11) Swine anti-rabbit immunoglobulins (1:40)
(in 1:1 normal human serum:tris buffer)
12) Wash tris saline - 3 changes
13) Peroxidase anti-peroxidase 1:100 in tris 
buffer
14) Wash tris saline - 3 changes
15) 0.03% Diaminobenzidene + 1 drop H^CL
16) Wash in tap water
17) Dehydrate and counterstain as monoclonal 
antibodies in frozen sections
The APAAP method was used as an alternative 
amplify any reaction but was no better than DAB
1 minute 
10 minutes
30 minutes 
2 minutes
15 minutes 
5 minutes 
15 minutes 
60 minutes 
5 minutes
30 minutes 
5 minutes
30 minutes 
5 minutes 
10 minutes 
1 minute
in order to 
above.
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Ih. Immuno-elctron microscopy method.
1) Fix in fresh 3% paraformaldehyde with 8.5% 
sucrose in PBS
2) Wash in 8.5% sucrose
3) Embed biopsy in OCT and freeze
4) Cut cryosections
5) Air dry sections
6) 3.5% 1 0^2 in tris buffer
7) Wash tris saline - 3 changes
8) Normal rabbit serum 1:5 in tris buffer
9) Pour off
10) NA 1/34 (dilutions 1:5 to 1:100) 1 hour
11) Wash tris saline - 3 changes
12) Peroxidase congugated rabbit anti-mouse 
antibody (DAKO) 1:20 in 1:1 NHS
tris buffer
13) Wash tris saline - 3 changes
14) Post fix 2% glutaraldehyde
15) Wash tris saline - 3 changes
16) Excess stroma removed from section with 
aid of stereo dissecting microscope
17) 3,3 Diaminobenzidene 5 mis in 95 mis 
tris buffer + 1 drop H202
18) Post fix 2% osmium tetroXide
19) Dehyrate through 50%, 70% and 100% alcohol
20) Propylene oxide
21) Place araldite resin capsules over section 
allow to harden
freeze and snap capsule off slide
4 hours 
overnight
10 minutes 
10 minutes 
to overnight
45 minutes
10 minutes
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APPENDIX II-Monoclonal & other antibodies & reagents. 
Monoclonal Antibodies. 
anti-Human Thymocyte Antigen 
Sera-Lab
MAS 036C Ascitic fluid 
Clone NA 1/34 
HLA-A.B.C 
Sera-Lab
Mouse IgG ascitic fluid 
Clone W6/32
UCHT 1
Unipath 
Code MF 22 
UCHT 4
Unipath 
Code MF 25 
OK T4a 
ORTHO 
Code 50140 
OK Ml
ORTHO 
Code 50050 
Leu 7
Becton Dickinson 
Code 7390 
Leu lib
Becton Dickinson 
Code 7530 
Leu 12
Becton Dickinson 
Code 7540
Cost £ 45.00
Cost £ 60.00 
Cost £ 90.00 
Cost £ 90.00 
Cost £ 207.00 
Cost £ 207.00 
Cost £ 205.00 
Cost £ 205.00 
Cost £ 123.00
Anit-HLA Class II monoclonal antibodies DA6 231 and DA6 147 
were available from the MRC Unit, Edinburgh, free of charge.
The Scottish Antiboby Production Unit (SAPU) at Law Hospital 
is now able to provide some antibodies with the same 
specificities as those above, free of charge for research 
purposes.
All antibodies diluted 1:100 in tris buffer for optimal 
results.
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lib. Other antibodies used.
Peroxidase-congugated Rabbit Iromunoglobulins to Mouse 
Inmunoglobulins
DAKO
Code P. 260 Cost £ 165.00
Uncongugated Rabbit Immunoglobulins to Mouse 
Immunoglobulins
DAKO
Code Z. 259 Cost £ 34.00
Peroxidase Anti-Peroxidase (rabbit)
DAKO
Code Z. 113 Cost £ 59.00
Alkaline Phosphatase Complex (rabbit)
DAKO
Code D. 306 Cost £ 63.00
Alkaline Phosphatase Complex (mouse)
DAKO
Code D. 651 Cost £ 100.00
Swine Anti-Rabbit Serum 
DAKO
Code Z. 196 Cost £ 30.00
Other reagents 
Normal Swine Serum
DAKO
Code X. 901 Cost £ 17.00
Normal rabbit serum was provided by SAPU free of charge.
page 252
CO O  > O i—I rH
roCM cn vo CN CN CN
<0COCO •H O  OViH
VO LO lO 00 CO
X CO
•h a; > uU (00)
B4-JO Ow o
00 CN LO ro• • • • •
LO LO cr\LD IDrH rH 1—1i—1
O'!ror**O 00
o  ro 
o  vo
ro o
ro v o  c n  c n  ro 
• • • • •
cn ^  ov ro o
oo pH o  h  in
CN
o
IT)
oo i—i oo ro ■N1 cn ro 
• • • • * •  •ro ^  r- ro Ttf oo
oo a> rH i-t ro
<13
6csa
CO 00 OV o IT)ro
g 03 • > • • •
o U CN ro CN ro ro•H CO 
4J \ rH i—i
i—1i—iiH§
OMH O  CQ O  C rH t0 \  u
I"* H  00 H  vo
00 rH ro O  O  00 VO CN
• • • • • • • •
oo ^  oo in h  co oo oo
roo^vo o  oo cn O'i ro
^cNcoin^Hai^r'Coo iH
Or'CN(NrOtfO>COCNCC)t^ oo
i—I i—I rH rl i—I i—I <—I i—I
^cooMTicnoocoinoocNco•—i i—i
S a\Oi—i''3,vor'-cN'3,'or-~coo>coa'^rovoo>>r~-cT><NrO''3,0'irHir)'<3,r''-r~'-rHr~-' oo HCNcNCNcNCNrocorocororo^^minmHHCNrororo^oooro^ocoro O O O O O O O O O O O O O O O O O O O O O O O O O O i —I i—I i—ICNCN CN^  LOinLomirjiniomLniommininmmmvovovovovDvovovovovovovovovo
W4J
G
<13•H
4
>14->•HH
COCM
rH i—lo O o O o o o O rH O O rH o rH rH O i—1
+ + + + + + + + + + + + + + + + + + +rorH CN ro CN ro LO r—1ro CNr—1ro CN N1 CN CN
i—l O O O O O i —IOOCNCN O + + + + + + + +  + + + + ^HrOHCNCNCN^rOCOCN o
coooooo^Hcrioc^ot^HiTiroooocNffirocNvoooincNCNrot^r^coooin r~~ r M n c N O c N < n n ^ M s'OMr)roHco(0\ocNcN^^iciniciMno^H^ro(N
r - ' O c o - " M o o m c N H v o o o o i r ) r - ' ' O o o o o o o o c N a ' 1r ^ v o o o o r - ~ o o c N o o c o H <  co^cTiCNinHHCNoocococnoocNromi^h-rovoo^cor'OOOr'Hr'CN cn
OOMNCNrOCOOHCN^CNHON'^'CNinOOHiniyiHCNVOinl ro rH ro vo (N C N C N i n > ' X » ( O N , N, y 3 i n i n H c o ^ S v o > - H N ' r ' i n c o c o > r ' V D c o i n i n i n c o
in^,t^t^^,omooin>vocoLn<,^ 'CNcriincNffiHroinoco^r'CNooinoovoro^co^r'Vo^cncN^ini^co^'^inN’oooorocNrocon^'^^^'Coro
CO 2 DC ^ W m
U  x1 2 W  ^  H J fflbCQ^ U W H 2  CJ CO 2 5 Q £.a u u EHu 5i & u CO
pa
ge
 
25
3
Illb - Patients with cervical intraepithelial neoplasia.
Name Age Parity Spec No Grade Ecto Cx Abn Tz Post Rx
MMcM 33 0+1 6018 II 7 10
AS 30 0+0 6029 II 6 3 5
MP 33 1+0 6069 II 9 19 11
LP 27 0+3 6121 II 6 3.9 9 13.6 12
AA 23 3+0 6146 II 7 10
CG 29 2+0 6249 II 6 8.3 6 9.4
JG 24 0+0 6264 II 5 11
EB 41 1+0 6338 II 5 6.9 7 7.9
EC 32 1+0 6340 II 7 6.5 5 8.1
TY 20 0+0 6352 II 7 22.6 6 14.8
EMcD 31 4+0 6004 III 4 3
HQ 26 0+0 6007 III 7 15
EF 30 1+0 6011 III 6 12 6
PT 27 2+0 6013 III 7 4 6
CM 28 3+0 6016 III 3
MR 31 0+0 6044 III 4 4.7 15 17.3 5
JMcC 31 1+0 6048 III 6 14 10
AP 25 0+0 6054 III 11 13.2 5 5.6 7
MS 27 1+0 6060 III 4 11 8
EF 27 2+1 6098 III 10 9.6 13 15.4 11
GM 32 1+3 6100 III 15 4
LS 29 1+0 6120 III 7 12
JG 31 3+0 6143 III 10 7
EC 27 2+0 6145 III 5 7
RS 27 0+1 6149 III 5 14
RD 34 1+0 6150 III 7 3
MS 29 4+0 6153 III 6 7
IB 36 2+4 6154 III 7 9
CB 29 3+0 6160 III 12 4
MR 29 1+0 6167 III 7 9
EW 28 1+0 6169 III 7 2
IM 26 2+0 6183 III 5 14
CB 31 1+0 6203 III 7 10.1 5 10.3
MS 40 0+0 6206 III 6 10.9 10 14.9
JW 32 1+0 6207 III 5 14.1 11 19.5
AW 29 3+1 6229 III 11 15.4 5 9.6
WE 25 1+0 6250 III 9 1
HMcN 28 2+1 6259 III 5 2
AB 32 1+0 6265 III 5 3
GC 27 2+0 6266 III 8 6
LS 26 1+0 6272 III 6 10.6 4 9.4
LMcK 34 1+0 6280 III 12 10.2 20 24.0
AB 36 0+0 6281 III 7 9.4 5 6.4
ST 34 2+0 6284 III 11 10.5 21 21.9
JL 33 2+0 6289 III 11 15.5 14 17.7
ID 29 1+0 6290 III 8 9
AS 30 2+0 6300 III 9 11.6 8 16.6
RMcG 37 4+1 6305 III 10 15.6 6 8.9
MMcQ 32 0+3 6309 III 9 6.5 19 18.7
AK 24 1+0 6329 III 9 7.3 2 2.5
AP 29 1+1 6335 III 8 9.2 17 17.9
AS 22 1+0 6350 III 16 14.0
AM 31 0+0 6351 III 9 16.1
KD 34 0+0 6355 III 6 11.3 9 14.1
CH 29 0+1 6359 III 13 13.1 22 29.4
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m b  (contd) - Patients with cervical intraepithelial neoplasia.
Name Age Parity Spec No Grade Ecto Cx Abn Tz Post Rx
LB 17 0+1 6005 I+V 4 3
LT 22 1+0 6124 I+V 4 8 6
AMcL 22 0+1 6126 I+V 2
JG 23 1+0 6148 I+V 8 9
MB 40 3+0 6168 I+V 6 1
ST 46 3+0 6193 I+V 6 1
AA 37 2+0 6235 I+V 7 3
EC 25 1+0 6245 I+V 9 3
CG 26 2+0 6003 II+V 7 4
EB 30 1+0 6030 II+V 8 18 8
LW 26 2+0 6037 II+V 8 10.2 1 1.3 9
AC 26 1+0 6038 II+V 3 2.5
JM 33 3+0 6103 II+V 8 1
AK 25 0+0 6128 II+V 8 14
SH 34 0+0 6164 II+V 7 1
AC 28 2+0 6185 II+V 12 2
JN 29 0+1 6194 II+V 12 9
JS 35 3+2 6231 II+V 5 5
LM 28 2+0 6244 II+V 6 1
JL 23 0+0 6251 II+V 6 6
EF 23 0+0 6252 II+V 11 7
SS 20 0+0 6260 II+V 11 5
. MK 28 0+0 6267 II+V 14 15.2 10 9.1
GG 22 0+0 6274 II+V 9 9.2 2 1.7
AF 33 0+0 6276 II+V 12 14.1 7 9.0
PB 23 1+0 6277 II+V 14 20.3 11 12.1
JS 34 4+0 6279 II+V 7 4
MC 24 0+0 6285 II+V 8 5
IB 27 1+0 6288 II+V 7 7.8 5 3.8
SO 32 2+1 6296 II+V 5 9.1 4 2.0
SM 29 2+0 6311 II+V 12 12.7 4 1.3
m 27 4+0 6314 II+V 4 4.4 2 1.7
FM 40 2+0 6316 II+V 7 11.4 1 2.8
FR 33 2+0 6325 II+V 9 12.3 6 11.4
SC 35 0+0 6330 II+V 11 15.4 5 10.8
RG 27 0+0 6333 II+V 7 12.1 2 6.2
MOB 34 2+0 6337 II+V 10 8.5 4 6.5
MN 19 1+0 6341 II+V 6 8
YR 22 1+0 6346 II+V 6 19.7 8 22.1
AM 31 0+0 6354 II+V 9 4.6 5 3.1
ED 25 1+3 6358 II+V 15 17.6 8 6.2
BMcP 25 1+0 6360 II+V 10 19.4 2 5.9
MF 25 0+0 6027 III+V 7 2 8
JR 31 1+0 6032 III+V 6 3 9
EH 25 2+1 6035 III+V 9 4 8
CM 30 2+0 6046 III+V 5 3 4
LI 26 0+0 6050 III+V 8 14.8 4 5.7 8
VL 32 0+0 6051 III+V 1 5
CB 28 2+0 6061 III+V 5 3 12
CP 27 0+0 6067 III+V 7 10 7
CMcD 30 0+1 6068 III+V 5 1 8
CW 29 3+1 6099 III+V 6 3
JMcD 28 0+1 6125 III+V 21 5
FC 21 0+0 6129 III+V 10 1
page 255
m b  (contd) - Patients with cervical intraepithelial neoplasia.
Name Age Parity Spec No Grade Ecto Cx Abn Tz Post Rx
EH 39 2+0 6130 III+V 4 5
JMcK 23 0+1 6131 III+V 6 3
IK 37 2+0 6134 III+V 4 4
CC 26 0+0 6138 III+V 9 12
JB 26 0+1 6139 III+V 8 3
RA 27 1+1 6151 III+V 10 3
DM 28 0+0 6161 III+V 11 7
LN 28 0+0 6163 III+V 7 5
SG 31 2+0 6166 III+V 5 1
MC 20 1+0 6177 III+V 7 8.2 2 2.2
AB 28 3+0 6178 III+V 8 7.9 2 3.0
CG 29 1+1 6179 III+V 12 8
PM 28 2+1 6180 III+V 11 5
EMcK 33 2+0 6184 III+V 8 3
MH 31 2+0 6202 III+V 6 9.2 3 3.9
JMcL 22 0+1 6205 III+V 7 7.2 1 2.0
PP 22 1+0 6230 III+V 9 5
JS 35 3+2 6234 III+V 8 4
MF 22 1+0 6248 III+V 5 4
EMcN 32 2+1 6273 III+V 4 2
LC 29 2+0 6278 III+V 12 14.2 6 5.8
JS 34 4+0 6279 III+V 10 15.5 1 0.9
EC 25 0+0 6297 III+V 10 1
MMcD 35 2+1 6302 III+V 9 6.5 12 14.2
LMcD 26 2+0 6306 III+V 17 12.0 4 1.2
FR 27 0+0 6315 III+V 8 10.3 4 5.0
IB 35 2+0 6317 III+V 7 5.2 4 1.9
JW 32 3+0 6319 III+V 12 10.1 10 5.6
EF 21 2+0 6320 III+V 8 6.2 6 4.8
JC 26 1+0 6321 III+V 10 16
CD 24 1+0 6326 III+V 8 9.6 1 1.5
El 26 0+0 6331 III+V 8 9.2 3 4.9
MB 34 4+0 6334 III+V 11 9.4 1 3.3
Grade = histological grade of CIN
+V = with histological evidence of HPV infection
Ecto Cx = ectocervix 
Abn Tz = abnormal transformation zone 
Post Rx = post laser cervical epithelium 
(first number in each column indicates Langerhans' cell
count per 100 basal cells and the second indicates 
the count with the image analyser)
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IIIc - Renal transplant recipients
Abn TzName Age Parity Spec No RX Norm Tz
EMcD 48 4+1 6286 CP
MS 45 2+0 6287 CP 4 1.7
BM 47 5+0 6291 CP 6 4.6
MB 44 2+1 6292 CP 4 6.6
MMcL 36 1+0 6294 P 10 6.2
CW 41 4+0 6298 CP 2 0.2
JB 35 1+0 6299 CP 6 1.2
AC 52 2+0 6304 CP 3 1.7
EB 37 1+3 6308 CP 4
CK 23 0+0 6312 CP 6 4.6
BS 57 2+0 6313 P 1 0.1
AB 57 0+0 6318 CP 1 0.1
CC 27 1+0 6322 AC
MMcK 32 1+0 6323 A P
AM 25 0+1 6324 CP 1 0.2
FP 41 1+0 6327 A P
LL 27 1+0 6328 A P 6 11.6
CMcC 37 5+1 6332 CP 10 22.7
HH 54 4+0 6336 C 1 1.4
VD 29 1+0 6339 A P 1 1.3
MG 38 1+0 6345 A P 4 6.8
CB 20 0+0 6347 CP 3 2.8
MH 62 1+0 6348 CP 1 3.9
EG 32 0+0 6353 A P
MMcD 60 6+0 6356 A P 1 3.8
EMcM 51 1+0 6357 A P 4 6.3
MH 34 0+1 7002 A P 5 9.8
JMcG 42 2+0 7003 CP
EMcI 51 3+1 7004 A P 7 12.0
WG 34 2+1 7005 CP 8 10.7
MMcD 30 0+0 7006 A P 1 0.4
JC 52 4+0 7007 CP 3 3.2
JM 30 1+1 7014 A P
JH 50 5+1 7015 CP 7 4.1
SB 45 2+0 7019 P
MH 39 3+0 7020 CP
AMcK 34 0+0 7040 A P
DB 26 1+0 7047 A P 6
3 3.7 
5 3.8 2 1.3
6 8.0 7 6.5
7 10.3 3 4.5
6 9.1 6 8.6
RX = Immunosuppressant regime 
I = Azathioprine 
C = Cycolsporin A 
P = Prednisolone
Norm Tz = normal transformation zone 
Cont Ecto = control ectocervix (with Abn Tz)
Abn Tz = abnormal transformation zone 
(first number in each column indicates Langerhans' cell
count per 100 basal cells and the second indicates the 
count with the image analyser)
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Hid - Women in renal failure
Name Age Parity Spec No Type Norm
RC 58 3+0 7023 CAPD 4
WMcM 48 0+0 7024 HAEMO 8
RD 46 2+0 7025 CAPD 6
MS 47 6+0 7027 CRF 8
SC 60 3+0 7043 CRF 8
AF 61 6+0 7044 CRF
AW 52 5+1 7045 CAPD 11
GMcA 59 0+0 7046 CRF/CA 5
MG 60 3+0 7048 HAEMO 4
MB 55 3+0 7049 CRF 2
HC 45 2+0 7050 CRF 3
AH 54 3+2 7052 CRF 3
ML 44 2+0 7053 CRF 8
SMcL 48 3+1 7060 CAPD 4
MS 48 1+0 7062 CAPD 12
SH 54 3+0 7063 CAPD 5
TYPE = type of regime
CAPD = continuous ambulatory peritoneal dialysis 
CRF = end stage renal failure 
HAEMO = haemodialysis
Norm Tz = normal transformation zone 
(first number in each column indicates Langerhans' cell 
count per 100 basal cells)
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IHe - Pregnant patients (Normal transformation zone)
Name Age Parity Gest Age Spec No Lc's 
/100 /area
JH 32 0+0 10 6020 10 14.8
MW 23 0+0 7 6021 2 7.9
MMcK 29 0+0 10 6024 5 7.9
PP 19 0+0 9 6025 9 9.1
SP 19 0+0 8 6036 7 10.0
KC 19 0+0 10 6042 8 12.1
KH 28 0+0 10 6043 10 14.2
CC 19 1+0 8 6097 6 13.3
MMcD 17 0+0 11 6122 5 8.2
KS 27 1+0 9 6127 6 6.2
SH 27 2+0 9 6156 8 8.2
LMcD 25 0+0 11 6165 9 13.3
LN 20 0+0 7 6192 3 4.2
LC 34 1+0 7 6197 9 8.7
HR 26 0+0 10 6208 10 13.1
MMcK 19 1+0 8 6209 6 7.0
VB 23 0+0 8 6253 3 3.6
OM 22 0+0 8 6254 8 6.2
JL 19 0+0 10 6269 11 8.6
RS 32 1+0 7 6270 11 5.7
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Appendix iVa.
Graphical comparison of T-cell infiltrate (pixel count) per unit 
area by image analyser of CD3/T1 positive (Pan T) cells, CD4/T4 
positive (Helper) and CD8/T8 (Cytotoxic) T-cell subsets from the 
epithelium of the transformation zones of normal, renal 
transplant, uraemic and pregnant patients.
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Appendix TVb.
Graphical comparison of T-cell infiltrate (pixel count) per unit 
area by image analyser of CD3/T1 positive (Pan T) cells, CD4/T4 
positive (Helper) and CD8/T8 (Cytotoxic) T-cell subsets from the 
stromal of the transformation zones of normal, renal transplant, 
uraemic and pregnant patients.
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Appendix IVc.
Graphical comparison of percentages of CD 8/T8 positive 
(cytotoxic) and CD 4/T4 (helper) T-cells in the epithelium and 
stroma of the transformation zones of normal, renal transplant, 
uraemic and pregnant patients.
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T-CELL SUBSETS
Note. 95% Confidence intervals of means for % number of cells per 
unit area of transformation zone are shown |— — |.
% =((number CD 8 or 4 cells X 100)/ number of CD 3 positive cells! 
a s % cell counts from transformation zone of normal patients
b = % cell counts from transformation zone of renal transplant
patients
c = % cell counts from transformation zone of uraemic patients
d = % cell counts from transformation zone of pregnant patients
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